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Abstract 
Vertebrate kidney organogenesis is characterised by the successive formation of the 
pronephros, the mesonephros and the metanephros. They all have a similar function 
and organisation and all arise from mesodermal tissue, with their differences being 
that of temporal and spatial organisation. The pronephros is the first to form and is the 
functional embryonic kidney of lower vertebrates and although it is vestigial in higher 
vertebrates, it is a necessary precursor for the other kidney types. The Xenopus 
pronephros is a simple paired organ; each nephron consists of a single large glomus, 
one set of tubules and a single duct. Previous work done in our laboratory 
demonstrates that the tubules and duct are specified at stages 12.5 and 14 respectively 
and the glomus is specified at stage 12.5. The kidney unit functions to control water 
balance and dispose of wastes. The simple organisation of the pronephros and the 
amenability of Xenopus laevis embryos to manipulation make the Xenopus 
pronephros an attractive system in which to study organogenesis. It has been shown 
that pronephric tubules can be induced to form in presumptive ectodermal tissue by 
treatment with RA and activin. Members of this laboratory have used this system in a 
subtractive hybridisation screen that resulted in the cloning of Xenopus laevis annexin 
IV (Xanx-4). In this thesis it has been demonstrated that Xanx-4 transcripts are 
specifically located to the developing pronephric tubules, and the protein to the 
luminal surface of these tubules. Temporal expression shows zygotic transcription is 
upregulated at the time of pronephric tubule specification. The temporal and spatial 
expression pattern of Xanx-4 suggests it may have a role in pronephric tubule 
development. Overexpression of Xanx-4 yields no apparent phenotype. Depletion of 
Xanx-4 by dsRNA was tested and was shown to specifically reduce levels of Xanx-4 
protein in oocytes. Xanx-4 siRNA was also tested for efficacy and was shown to cause 
a reduced pronephric tubule phenotype. However analysis of the effects of dsRNA 
and siRNA on mRNA levels have proved inconclusive and cast doubt on the 
usefulness of dsRNAs in Xenopus laevis. Further studies on RNAi in Xenopus will be 
required before it can be judged a reliable method for interfering with gene 
expression. Xanx-4 depletion, using morpholinos produces a shortened, enlarged 
tubule phenotype. The phenotype observed can be rescued by coinjection of Xanx-4 
mRNA. Thus, Xanx-4 can be successfully depleted in embryos using morpholino 
oligos. Although the function of annexins is not yet clear, studies have suggested a 
xvi 
role for annexins in a number of cellular processes. It is argued that the enlarged 
pronephric tubule phenotype observed in the Xanx-4 depleted embryos is the 
consequence of aberrant control of cell division in the extending pronephric tubules. 
Further work will be required to substantiate this theory. 
xvii 
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1 Introduction 
1.1 The vertebrate kidney 
Vertebrate kidney organogenesis is characterised by the successive formation of 
three temporally and spatially distinct organs; the pronephros, the mesonephros 
and the metanephros (Saxen, 1987). All three have a similar function and 
organisation and all arise from the intermediate mesoderm by an inductive 
process that is dependent for its formation on the previous temporal form. The 
pronephros is the first to form, it is the functional embryonic kidney of lower 
vertebrates and although it is vestigial in higher vertebrates, it is a necessary 
precursor for the other kidney types. The mesonephros is the adult kidney in 
amphibia and fish and is the functional embryonic kidney in higher vertebrates. 
The metanephros is the mature adult kidney in mammals and birds. Vertebrates 
require a series of more complex kidneys as they grow and develop. The 
pronephros consists of a single nephron (the basic functional unit of the kidney). 
The mesonephros contains 10-50 nephrons and the final, metanephric kidney 
contains over 1 million nephrons (figure 1.1). All three kidney forms function to 
control water balance and dispose of wastes (Saxen, 1987; Vize et al., 1997; 
Brändli, 1999; Dressler, 1999). 
1.2 The pronephros 
The simplicity of this organ, coupled with the fact that it displays the same basic 
organisation and function as the more complex mesonephros and metanephros, 
make this an attractive model to study the earliest events in vertebrate kidney 
morphogenesis. The development of the pronephros has been studied in a 
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Figure 1.1: Organisation of the nephrons of the pronephros, 
mesonephros and metanephros. The pronephros is composed of a single 
nephron comprising of one set of tubules, a single duct and a capsule 
(coelom and glomus). As development progesses the pronephros regresses 
and the mesonephros forms in a more posterior position. The mesonephros 
is composed of 10-50 nephrons. The metanephros forms from a branch of 
the ureteric bud and on maturation, is composed of 1 million nephrons. pn: 
pronephros, mnd: mesonephric duct. (Reproduced from Vize et al., 1997). 
number of vertebrate model organisms. Studies conducted in lampreys, 
(Lampetrafluviatilis and Petromyzon marinus, Kluge and Fischer, 2000), in fish 
including mudskipper (Periophthalmus koelreuteri, Safer et al., 1982) and trout 
(Salmo trutta, Tytler, 1988) and several amphibians including, the green toad 
(Bufo viridis, Mobjerg et al., 2000), and the axolotl (Ambystoma mexicanunt, 
Drawbridge and Steinberg, 1996) have all provided detailed accounts of 
pronephric development and morphology. However, the most intensely studied 
and best understood lower vertebrate model organisms for early nephrogenesis 
are the zebrafish, Danio rerio (Drummond, 2000), and the frog Xenopus laevis 
(Vize et al., 1997). 
1.2.1 The Xenopus pronephros structure and function 
The pronephros is a simple paired organ that consists of a single non-integrated 
nephron found in a lateral position of the embryo. Each nephron consists of a 
single fused pronephric corpuscle, one set of tubules and a single duct (figure 
1.2). The pronephric corpuscle is composed of two parts, the nephrocoel and the 
glomus. The glomus is a capillary network formed from branches of the dorsal 
aorta, it filters waste from the blood by size-selective pressure filtration. The 
nephrocoel is the pronephric filtration chamber lined with visceral and parietal 
epithelium. The pronephric tubules are composed of the nephrostomes, the 
connecting tubules and the common tubule, which is connected to the pronephric 
duct. The tubules are composed of a single layer of polarised epithelial cells. The 
filtrate passes into the nephrocoel, where it is swept by ciliated funnels 
(nephrostomes) into the connecting tubules and subsequently into the common 
tubule. The sinus surrounding the tubules allows ions, water and other molecules 
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Figure 1.2: Schematic representation of the pronephros in Xenopus 
laevis. Pressure filtration of blood occurs in the glomus, a branch of the 
dorsal aorta. The filtrate passes into the nephrocoel where it is swept into 
the pronephic tubules through the cilliated nephrostomes. Water, ions and 
other molecules are transported out of the tubules and returned to the 
circulation system via the pronephric sinus and the common cardiac vein 
(ccv). The balance of filtrate passes out of the tubules into the duct and 
out of the body via the cloaca. acv: anterior cardinal vein, pcv: posterior 
cardinal vein. (Reproduced from Brändli, 1999). 
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to be recovered from the filtrate and returned to the blood via the common 
cardiac vein. Rostrally, the pronephric duct connects with the tubules. It then 
runs caudally along the length of the body, ventral to the somites, until it fuses 
with the rectal diverticulum outgrowth of the cloaca. Molecules that are not 
recovered from the filtrate, flow along the pronephric duct and are disposed of to 
the exterior, via the cloaca-(Saxen, 1987; Vize et al., 1995; Vize et al., 1997; 
Brändli, 1999). 
1.2.2 The organogenesis of the Xenopus pronephros 
The three pronephric components develop independently and are all derived from 
intermediate mesoderm. The pronephric duct and the pronephric tubules are 
derived from the somatic lateral plate mesoderm, and the nephrocoel is derived 
from the splanchnic lateral plate mesoderm. The first histological indication of 
pronephric development can be seen as a small condensation of cells 
immediately below somites 3-5 at stage 21 (figure 1.3). This condensation is the 
primordia of both the tubules and duct which segregates into its two components 
by stage 24. The pronephric, or Wolffian, duct commences its extension 
posteriorly towards the cloaca. By stage 27, the pronephros has a distinct tubular 
organisation, branching of the tubules follows, and the nephrostomes form 
around stage 29/30. The glomus develops as a fold in the splanchnic lateral plate 
that extends into the coelom. At stage 37 the pronephros becomes fully 
functional. At stage 37/38 the tubules resemble the Greek letter i (figure 1.4A, 
1.4B) at which time they begin to extend and coil and by stage 42 the tubules 
have lengthened and form a highly coiled, convoluted structure (figure 1.4C, 
1.4D). At stage 54 the pronephric tubules undergo a process of atrophy and 
5 
Figure 1.3 
I. P. 
stage 21+ stage 24 stage 27 stage 27 
Figure 1.3: The segregation of the pronephric anlagen from the 
intermediate mesoderm. Transverse sections Xenopus laevis embryos at 
stage 21,24 and 27. The pronephric anlagen is histologically distinct as a 
condensation of cells of the intermediate mesoderm by stage 21. At stage 24 
the cells become columnar, this compact mass of cells distends the overlying 
ectoderm and can be seen as a swelling on the outside of the embryo. By 
stage 27 the cells display a tubular arrangement and a lumen forms in the 
centre by stage 28. l. p.: lateral plate. (Reproduced from Vize et al., 1997). 
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Figure 1.4: Pronephric tubule formation in Xenopus laevis. All embryos are 
stained with pronephric tubule specific monoclonal antibody 3G8. (A) 
Wholemount Xenopus embryo stage 35/36. Tubules can be seen in the 
characteristic Tor shape ventral to somites 3-5, the three nephrostomes are clearly 
visible (B), ventrally the tubules connect to the duct (arrowed). (C and D) By stage 
40 the tubules have elongated and are tightly coiled. (A, B and D are reproduced 
from Vize et al., 1995). 
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regression, with their function being replaced by the second amphibian kidney, 
the mesonephros (Nieuwkoop and Faber, 1994; Vize et al., 1995). 
1.2.3 The zebrafish pronephros structure and function 
Essentially the teleost pronephros is very similar to the amphibian pronephros in 
function, position and structure, except that it has no connection with the body 
cavity (coelom) and functions as a closed system (Tytler, 1988). The teleost 
pronephros is composed of a pair of nephrons with two glomeruli fused at the 
midline, pronephric tubules connecting directly to the glomeruli via a neck 
segment and paired bilateral pronephric ducts which convey the waste blood 
filtrate outside the animal (figure 1.5. Drummond et al., 1998). 
1.2.4 The zebrafish pronephros organogenesis 
Using histological studies and pronephric specific molecular markers, 
Drummond et al., (1998) have described the development of the zebrafish 
pronephros to occur in 4 stages (figure 1.6). The first stage involves the 
establishment of the pronephric field, 10-13 hours post fertilisation (hpf), as 
demonstrated by the expression patterns of pax2.1 and lim-1. In the second stage, 
pronephric duct development follows the onset of somitogenesis and is complete 
by 24 hpf. The primordium of the nephron (glomerulus and tubules) can be 
histologically detected as a coelomic fold ventral to the third somite, at 24 hpf. 
By the third stage, 32-33 hpf, this condensation of cells, now distinct from the 
coelom, forms a vesicle with a distinct lumen. The tips of the forming pronephric 
duct appear adjacent and lateral to the cellular condensate. The pronephric 
primordium appears to be partitioned into a lateral and a medial region; the 
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Figure 1.5: The zebrafish pronephros. (A) A schematic representation of 
the zebrafish pronephros, showing the position of the tubules, duct and 
glomerulus. (B) 84hpf zebrafish embryo stained with anti-Na+/K+-ATPase 
alpha subunit momclonal antibody ((x6F). The pronephric tubules are just 
formed and will continue to elongate and coil to maturity. The duct can be 
seen running the length of the body either side of the mid-line. 
(C)Wholemount antibody 3G8 staining with rhodamine secondary. 
Although 3G8 is tubule specific in Xenopus laevis, in zebrafish it 
recognises the lateral pronephric tubules and the anterior of the pronephric 
duct. (D) Transverse section of a 72hpf zebrafish embryo, the pronephric 
components form between the gut (g) and the notochord (nc). (E) 
Transverse section of a 6.5 day zebrafish embryo, Bowmans space (bs) is 
observable. pt: pronephric tubules, pd: pronephric duct, gl: glomerulus. 
(Reproduced from Drummond et al., 1998). 
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Figure 1.6: The four-step model of zebrafish pronephric development. (A) 
8-somite stage zebrafish embryo. Pronephric anlagen is specified as detected by 
expression pattern of pax2.1 and lim-1 in the intermediate mesoderm (im). (B) 
At 12-24 hpf early somitogensis the pronephric duct (pnd)grows posteriorly 
along the length of the embryo, ventral to the somites and the nephron forms at 
the anterior tip of the duct by 24hpf. (C) At 24-42 hpf the nephric primordia 
(tip), below somite 3, segregates into tubules and glomerulus primordia. (D) At 
42-48 hpf vascularisation occurs over the next 24hrs as does the onset of 
glomerular filtration. (Reproduced from Drummond et al., 1998). 
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presumptive tubules and glomerulus respectively. During the fourth stage, from 
40 hpf, the medial region forms a capsule and the lateral region takes on a tubule 
appearance. The two glomeruli have fused at the midline by 50 hpf, the tubules 
and duct are connected and a lumen is visible. By 60 hpf the connection between 
the glomerulus and the tubules is apparent. A development progresses, the 
tubules become progressively more convoluted. The pronephros persists in 
position for at least 1 month after hatching (Drummond et al., 1998). 
1.3 Molecular markers of pronephric development. 
In order to unravel the molecular control of early kidney induction and patterning 
a molecular map of many of the early markers of the pronephric field and 
pronephric anlagen is being built up. In previous studies, more than 30 genes 
have been shown to be expressed in the pronephros and their temporal and 
spatial patterns of expression established (for reviews see Davies and Brändli, 
1997, Vize et at., 1995, Vize et al., 1997, Brändli, 1999). A selection of in situ 
patterns for marker genes expressed in the pronephros, some of which are 
utilised in this thesis, are shown in figure 1.7. Interestingly, many of these 
pronephric genes are also expressed in mesonephric and metanephric kidneys in 
higher vertebrates. 
1.3.1 LIM class transcription factors 
The LIM class homeobox gene lim-1 is required for anterior patterning and 
nephrogenesis in the mouse. Loss-of-function mutation in the mouse causes 
failure of development of head structures, mesonephros and metanephros 
(Shawlot and Behringer, 1995). The Xenopus ortholog Xlim-1 is expressed in the 
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Figure 1.7: A selection of in situ patterns for marker genes of the pronephros 
in Xenopus laevis. (A) XPax-8 stage 32, expression is detected in the pronephric 
tubules (arrowed) and at lower levels in the duct. (B) XPax-2 stage 36, expression is 
detected in the nephrostomes (arrowed) and at lower levels in the developing 
tubules and duct. (C) Delta-1 stage 30, expression is detected in the tubule 
primordia (T). (D) xWnt-4 stage 32, expression strong in the nephrostomes and very 
weak in the tubules. (E) Iro-3 stage 36, expression is detected in the common 
pronephric tubule. (F) Sal-1 stage 38, expression is detected in the lower common 
tubule (arrowed) and the anterior pronephric duct (D). (G) xWTI stage 30 
expression is detected exclusively in the developing pronephric capsule. (H) Msr 
stage 34, expression is restircted to the developing vasculature ACV: anterior 
cardinal vein, PCV: posterior cardinal vein, PS: pronephric sinus, CCV: common 
cardinal vein. T: tubules, D: duct (Reproduced from Brändli, 1999). 
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Spemann organiser, pronephros, notochord and central nervous system. The 
pronephric expression commences in lateral mesoderm at stage 13. At stage 14 a 
stripe of expression encircling the embryo is observed and at stages 15-18 
expression condenses to a dorso-lateral domain. Pronephric expression 
condenses to the pronephric tubules and duct during nephrogenesis and is also 
detectable in the adult kidney (Taira et al., 1992,1994). Mim-1 expression is up- 
regulated in gastrula embryos by treatment with retinoic acid (RA). RA also 
induces Mim-1 expression in animal cap explants and this induction is enhanced 
by a combination RA with activin A (Taira et al., 1992). Injection of dominant- 
negative Mim-1 inhibited pronephric tubule development at the late tail-bud 
stage, suggesting that Mim-1 does not initiate pronephric differentiation, but that 
it is necessary for growth and elongation (tubulogenesis) of the pronephric 
tubules (Chan et al., 2000). 
1.3.2 Paired-box transcription factors. 
Mutations in Pax-2, a paired box transcription factor, cause renal-coloboma 
syndrome in humans; the patients display eye defects and renal hypoplasia 
(Sanyanusin et al., 1995). In mouse, targeted mutagenesis of the Pax-2 gene 
causes dose-dependent phenotypes with the most severe phenotypes observed in 
the homozygous mutants displaying a complete lack of the mesonephros and 
metanephros, ureters and genital tracts (Torres et al., 1995, Favor et al., 1996). 
Mutations in the Pax-2 homologue in zebrafish (pax2.1), the no isthmus (noi) 
mutation, results in a lack of pronephric tubules and duct, combined with defects 
of the nervous system and sensory organs (Brand et al., 1996). This has been 
shown to be the result of a patterning defect during differentiation of the 
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pronephric primordium. It appears that pax2.1 expression is required, in the 
lateral cells of the presumptive pronephros, to restrict the domains of wt] and 
VEGF expression to the podocytes of the future glomerulus (Majumdar et al., 
2000). In Xenopus XPax-2 is expressed in the tubule and duct primordium from 
stage 22, in the developing tubules and duct (figure 1.7B) to at least stage 42, 
with highest expression in nephrostomes (Heller and Brändli, 1997). Depletion of 
XPax-2 in Xenopus has not been examined to date. 
Another member of the paired box transcription factor family, Pax-8, is also 
expressed in the kidney in a number of species. In the mouse, although Pax-8 is 
expressed in the mesonephros and metanephros, targeted ablation gives no 
aberrant kidney phenotype (Torres et al., 1995). In Xenopus, XPax-8 is expressed 
in the intermediate mesoderm from stage 14. At stages 15-18, this expression 
condenses to a dorso-lateral domain. Duct and tubule expression can be observed 
as development continues (figure 1.7A) and at stage 36 expression is lost from 
duct but maintained in tubules (Carroll and Vize, 1999). Ectopic co-expression of 
either XPax-2 or XPax-8 with Mim-1 results in a synergistic effect producing 
increased pronephric tubule complexity, enlarged tubules and ectopic tubules. 
Ectopic expression of either XPax-2 or XPax-8 alone has a moderate effect. This 
suggests that Mim-1 is acting as a co-factor for XPax-2 and XPax-8 function 
(Carroll and Vize, 1999). In zebrafish pax8 is expressed in the intermediate 
mesoderm at the 1-somite stage, but not in the pronephros as it is forming. It is 
suggested that pax8 expression occurs too early to have a major role in zebrafish 
nephrogenesis (Pfeffer et al., 1998). 
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1.3.3 Hepatocyte nuclear factors (HNF). 
Three members of the hepatocyte nuclear factor (HNF) family of tissue specific 
transcription factors are known to be expressed in the Xenopus pronephros, HNF- 
1,8, HNF-la and HNF-4. HNF-ß is first detected in the pronephric anlagen 
from around stage 15 and in the tubules and duct as nephrogenesis proceeds 
(Demartis et al., 1994). HNF-1 a and HNF-4 are both expressed from stage 20 
onwards, and are expressed later in the pronephric tubules but not in the duct 
(Weber et al., 1996; Holewa et al., 1996). These HNFs are also expressed in the 
murine kidney. Loss-of-function studies have been hampered due to lethality 
upon gastrulation, thus preventing analysis of any kidney phenotype (Chen et al., 
1994). HNF-1 a mutant mice have dysfunctional kidneys but appear 
morphologically normal, functional redundancies between family members are 
thought to be responsible for this. In a more recent study Pontoglio et al., (2000) 
have shown that the mutant mice are diabetic and the kidney dysfunction is due 
to reduced tubular glucose reabsorption. It appears that HNF-la controls 
expression of the glucose transporter SGLT2 gene. Mutations in HNF-1,8 causes 
early on set diabetes and severe primary renal defects in humans. Expression of a 
mutated form of the human HNF-1ß in Xenopus embryos causes defective 
development and agenesis of the pronephros demonstrating a conserved role of 
HNF-1 ß in renal development (Wild et al., 2000). 
1.3.4 Wilms' Tumor 
The Wilms' tumor suppressor gene, WTI, is a zinc finger transcription factor and 
was first identified in humans, where it is implicated in paediatric tumours of the 
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kidney and gonads (Call et al., 1990). The WTI knockout mouse has reduced 
mesonephric tubules and metanephros formation is completely blocked 
(Kreidberg et al., 1993). In Xenopus xWT1 expression is detected in the 
splanchnic mesoderm, ventral to somites 3 and 4. From stage 20, xWT1 is 
expressed in the glomus primordium and later in developing glomus (figure 
1.7G). From stage 38 onwards, xWTJ is also expressed in developing heart 
(Carroll and Vize, 1996). Overexpression of xWT1 by injection of mRNA 
inhibited pronephric tubule development and represses expression of XPax-2. It 
was suggested that xWT1 acts to repress tubule-specific gene expression in the 
portion of the pronephros fated to become the glomus (Wallingford et al., 1998). 
The zebrafish ortholog wt] is also expressed in the glomerulus of embryos 
commencing 30 hpf (Serluca and Fishman, 2001). 
1.3.5 Helix-loop-helix transcription factors. 
Tissue-specific bHLH proteins have been found to be essential transcription 
factors which control the fate of cells in the nervous system and in muscle 
formation (Murre et al., 1994). Xenopus xld-2 is expressed in the pronephros 
throughout development (Wilson and Mohun, 1995). Another bHLH gene, xArnt 
has been cloned in Xenopus and shown to be expressed in the marginal zone at 
gastrula stages, and later in branchial arches, optical and otic vesicles and at a 
high level in the developing pronephros at tailbud stages (Bollerot et al., 2001). 
In zebrafish two homologs of the amt genes have been cloned. arnt2 and amt2A 
are expressed in the developing pronephros and on overexpression cause severe 
defects in the sensory organs heart and gut (Hsu et al., 2001). 
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1.3.6 Vascular Endothelial Growth Factor (VEGF). 
Vascular Endothelial Growth Factor (VEGF) is involved in neovascularisation 
and is expressed strongly in the glomerulus. Knockout mice die very early due to 
severe defects in the developing vasculature (Carmeliet, 1999), which does not 
allow the analysis of any glomerular phenotype. In Xenopus VEGF is expressed 
in the glomus from stage 28 onwards and it is suggested to have a role in 
populating the glomus with endothelial cells (Cleaver and Kreig, 1998). 
1.3.7 Wingless family members (Wnt) 
Three members of the Wnt family of secreted growth factors, Wnt-4, Wnt-7b and 
Wnt-11, have highly characteristic expression patterns during murine 
nephrogenesis (Parr and McMahon, 1994). Loss-of-function mutations in wnt-4 
result in severe defects in mesenchyme-to-epithelial transition during 
metanephric development, the kidneys are small and dysgenic (Stark et al., 
1994). Wnt-7b expression is localised to the ureteric bud and collecting ducts 
late on in development and is unlikely to play a major role in metanephric kidney 
development. Wnt-11 is expressed in the caudal end of the elongating nephric 
duct and upon ureteric bud formation, it is strongly expressed in the tips as 
branching occurs. Mutations causing loss-of-function of wnt-11 in mouse results 
in the loss of branching of ureteric bud, however, Wnt-11 is not sufficient to 
induce tubulogenesis in vitro (Kispert et al., 1998). 
The Wnt-4 Xenopus ortholog, Xwnt-4 is weakly expressed throughout pronephric 
mesoderm at stage 18 and as development progresses, expression is seen in the 
tubule and duct anlagen. Expression is strong in the tips of the tubules 
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(nephrostomes) and weak in duct, figure 1.7D (Carroll et al., 1999). Ungar et at., 
(1995) have reported wnt-4 expression in the zebrafish pronephros. 
Overexpression of wnt-4 and wnt-5A in zebrafish caused cyclopia, mis-folding of 
the brain and notochord forking; the authors suggest writs inhibit cell movements 
(Ungar et al., 1995). In Xenopus, although Xwnt-11 is not expressed in the 
pronephros, it is expressed in the developing somites (Ku and Melton, 1993), the 
tissue that may be responsible for the pronephric inducing signals (Seufert et al., 
1999). 
1.3.8 Frizzled Receptors of Wnt family ligands 
Members of the Frizzled family, of seven-pass transmembrane receptors, act as 
receptors of the wnt family ligands. Xfrizzled-3 is expressed at high levels in the 
nervous system and at low levels optic and otic vesicles. Overexpression of Xfz3 
block neural tube closure and results in embryos with shortened anterio-posterior 
axis, but does not effect the expression of organiser specific genes or 
gastrulation. Expression is also detected in the pronephros in overlapping 
domains with Xwnt-4, although it is not known if Xwnt-4 is the ligand of Xfz-3 
(Shi et al., 1998). A related frizzled gene, Xenopus Crescent contains a frizzled- 
like domain and is expressed in the organiser, endomesoderm and later in the 
pronephros. In animal cap assays crescent gene expression was synergistically 
upregulated by coexpression of Mim-1, Ldb-1 and Siamois but not by activin A 
(Shibata et al., 2000). 
1.3.9 Bone Morphogenetic Proteins (BMP). 
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In mouse, BMP-7 is expressed in the Wolffian duct, mesonephric tubules and 
condensing mesenchyme of the metanephros. It has been shown to induce 
tubulogenesis in isolated mesenchyme (Vukicevic et at., 1996). BMP-7 null mice 
possess dysplasic kidneys that appear arrested in development and die soon after 
birth (Dudley et at., 1995). The Xenopus XBMP-7 and XBMP-4 are expressed in 
a wide variety of domains including presumptive pronephric regions (Wang et 
al., 1997). Overexpression of XBMP-7 causes ectopic alpha-globin expression 
(ventral) and suppression of dorsal anterior structures (dorsal). The authors 
suggest XBMP-7 has a role in haematogenesis (Wang et at., 1997). In zebrafish 
bmp2b, 4 and 7 are expressed in discrete areas of otic epithelium and the authors 
suggest a role for bmp in the developing vertebrate ear (Mowbray et at., 2001). 
1.3.10 Hedgehog family 
Members of the hedgehog family of secreted glycoproteins are known for their 
essential morphogenic roles in early embryos (for review see Capdevila and 
Johnson, 2000; Chuong et al., 2000). A member of this family, banded 
hedgehog, is expressed in the developing pronephric tubules, although no 
function has yet been assigned to this observation (Ekker et al., 1995). 
1.3.11 Glial-derived neurotrophic factor. 
It has been suggested that guidance cues direct the migration of the developing 
pronephric duct from the pronephric anlagen to the rectal diverticula in the 
axolotl embryo (Drawbridge and Steinberg, 1996). The TGFß superfamily 
member GDNF and its receptor complex the GPI-linked GFRa-1 co-receptor 
and the Ret tyrosine kinase receptor, have expression patterns which suggest 
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their involvement in the development of the collecting ducts. Murine GDNF is 
expressed in the uncondensed metanephric mesenchyme and the receptor (c-ret) 
is expressed in the Wolffian duct and the tips of the branching collecting tubules. 
Mouse knockouts of GDNF and c-ret have severe renal agenesis (Sanchez et al., 
1996; Schuchart et al., 1996). Interestingly, the Xenopus ortholog X-ret is 
expressed in the caudal tip of the migrating pronephric duct and at low levels in 
the tubules (Carroll et al., 1999). In zebrafish, although GDNF is expressed in the 
nervous system and the pronephros, depletion of GDNF causes major defects in 
the enteric nervous system but has no effect on kidney organogenesis (Shepherd 
et al., 2001). The zebrafish homolog of c-ret, retl, is expressed in the developing 
pronephros and in the migrating pronephric duct (Marcos-Gutierrez, 1997). In 
axolotl, the work of Drawbridge et al., (2000) demonstrates that GDNF and th 
co-receptor GFRa-1 are required in the pathfinding behaviour of the axolotl 
pronephric duct primordium. 
1.3.12 Fibroblast growth factor (FGF) pathway. 
The FGF receptor (FGFR) signal tranduction pathway regulates the posterior 
development of embryos in Xenopus. Using a dominant-negative approach, it 
was discovered that blocking activation of endogenous FGFR caused severe 
posterior truncations with only minimal anterior defects (Amaya et al., 1991). 
FGFR was shown to perform critical functions in the Spemann's organiser to 
induce formation of somitic muscle and the pronephros (Mitchell and Sheets, 
2001). 
1.3.13 The Notch and Delta family. 
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The notch signalling pathway is an evolutionarily conserved mechanism that is 
used by multicellular organisms to control cell fates through local cell 
interactions, the Notch transmembrane receptor is activated by its ligands Delta 
and Serrate (Artavanis-Tsakonas et al., 1999). In Xenopus Notch-1 and Delta-1 
are expressed in the pronephric anlagen from stage 20. At later stages, Notch-1 is 
restricted to tubules until stage 38, whereas Delta-1 is restricted to the most 
dorso-anterior region (figure 1.7C) and is down regulated by stage 34. Serrate-1 
is expressed in the pronephric anlagen from stage 25-26 and later, during tailbud, 
is restricted to tubules and nephrostomes until stage 38. The expression of Notch- 
1 is maintained in a pattern overlapping the domains of the two ligands; Delta-1 
is restricted to the margin between the tubules and the corpuscle, Serrate-1 is 
also expressed in the dorsoanterior region of the tubules but more ventral than 
Delta-1. Expression in duct was not observed. The authors showed that 
activation of the Notch pathway altered or ablated the expression of duct markers 
(Xlim-1, c-ret and 4A6), and inhibition of Notch pathway appeared to recruit 
cells to the duct anlagen. Thus suggesting that Notch-1 functions to repress duct 
cell differentiation in the region of pronephric tubule cell fate. In addition, Notch- 
1 pathway activation increased the region of expression of tubule markers XPax- 
8 and XPax-2 in the ventroposterior region destined to become duct, and of the 
xWT1 expression domain in the glomus. It seems likely that the Notch-1 
signalling pathway is required for partitioning of the pronephric primordia 
destined for particular cellular fates (McLaughlin et al., 2000). Four homologs of 
the Notch ligands, deltaA-D, have been identified in zebrafish. All these 
homologs are expressed in the nervous system and sensory organs, but only 
deltaC is expressed in the pronephros (Smithers et al., 2000). 
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1.3.14 Integrins and cadherins. 
Integrins are a family of enzyme-linked cell-surface receptors that bind to the 
extracellular matrix and mediate intracellular signalling events. In humans the 
integrin o6 is expressed in the basal region of the cells of the glomerulus and 
tubules where it is thought to maintain cell polarity (for review see DeSimone, 
1994). Xenopus integrin a6 is expressed in the early nervous system and in the 
pronephros. Using antisense oligonucleotides, the authors produced embryos 
depleted in integrin c6 that caused severe neural defects, but any pronephric 
abnormalities were not reported. It is suggested that integrin o6 may be involved 
in the mesenchyme-to-epithelial transition during nephrogenesis (Lallier et al., 
1996). 
Cadherins are a family of calcium-dependent cell adhesion molecules implicated 
in the formation and development of epithelial tissues. Surprisingly, Xenopus E- 
cadherin is not expressed in the developing pronephros although it is present in 
tissues of the mesonephros (Levi et al., 1991). In contrast the Xenopus ortholog 
of N-cadherin is expressed at high levels in the pronephros, heart and brain 
(Simonneau et al., 1992). 
1.3.15 Cold-inducible RNA binding protein (CIRP). 
The Xenopus homolog of cold-inducible RNA-binding protein, XCIRP, is 
transiently expressed in the pronephros and nervous system. Expression was 
observed in the presumptive pronephros from early tail bud stages, and in the 
pronephric field through to stage 35 (Uochi and Asashima, 1998). A homolog of 
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XCIRP, XCIRP-1 has been demonstrated to be required for kidney formation. 
Targeted suppression, using full-length antisense mRNA of XCIRP-1 (C3), 
altered the morphogenetic lineage movement of the C3 cells and resulted in a 
defective pronephros at tailbud stages. Furthermore, animal caps dissected from 
embryos injected with antisense XCIRP-1 mRNA and cultured in activin and RA 
(which normally results in the induction of pronephric tubules), were induced to 
form mesoderm but did not express pronephric markers (Mim-1 and xWTI). 
These effects could be rescued by coinjection of sense strand XCIRP-1 mRNA. 
XCIRP-1 is an RNA binding protein, it is suggested that XCIRP-1 may be 
required for marking gene transcripts, perhaps by changing their conformation to 
establish competence for future differentiation programs (Peng et al., 2000). 
1.3.16 Other useful markers of pronephric components. 
Two antibodies, tubule specific 3G8 monoclonal and duct specific 4A6 
monoclonal antibodies, are excellent pronephric markers, although the epitopes 
are unknown (Vize et al., 1995). Xclaax-1, although an unknown gene, is a useful 
marker for pronephros as it is located to the baso-lateral domain of the 
pronephric tubules (Cornish et al., 1992). There are numerous other genes which 
show expression patterns in the pronephros as well as other tissues. The review 
above is a representation of the most prominent players in pronephrogenesis at 
this time (for other markers see Davies and Brändli, 1997). 
In summary, it appears that the different kidney forms express the same genes in 
analogous structures, and orthologous genes in the same kidney form in different 
species. This observation leads to the hypothesis that similar signalling cascades 
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are utilised by the different kidney types to form similar structures and perform 
similar functions. Genes that play significant roles or display partial redundancy 
in one form appear to do so in others. For induction, specification and subsequent 
development of the pronephros, cascades of molecular events are required to 
orchestrate the cellular and tissue events involved in these processes. A summary 
of the timing of onset of pronephric gene expression is shown in figure 1.8. 
Studies conducted in the various model organisms all contribute, in their own 
particular way, to create an overall picture of nephrogenesis. 
1.4 Mutagenesis studies in the zebrafish pronephros 
Xenopus laevis has limited usefulness as a genetic system due to its psuedo- 
tetraploidy and long life cycle. However, the zebrafish is a particularly useful 
model system as its diploid genome is amenable to genetic studies. Recently, a 
large scale ENU mutagenesis screen for zebrafish developmental mutants was 
carried out (Driever et al., 1996). Work by Drummond et al., (1998) has isolated 
eighteen independent recessive mutations affecting pronephric development 
(Table 1.1). A common theme for the phenotypes of these mutants was the 
appearance of fluid-filled cysts in the pronephric region followed by general 
oedema. Obstruction or extirpation of the pronephric duct has been shown to 
cause tubule dilation followed by general oedema (Fales 1935). On closer 
examination of the mutant phenotypes, duct obstruction and axis deformity were 
ruled out as possible explanations. The authors suggest that the phenotypes 
observed are the consequence of pronephric failure and altered osmoregulation. 
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Figure 1.8 
Stage 12.5/13 Stage 20-25 Stage 30 Stage 37/38 
XPax-2 
Pronephric 
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Pronephric XLim-1 XPax-2 
Duct XPax-8 xld-2 Na+/K+-ATPase 4A6 
HNF-1(3 Integrin-a6 
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Figure 1.8: The onset of pronephric gene expression in Xenopus laevis. The 
coloured boxes indicate those genes expressed in the corresponding region, red: 
pronephric tubules, blue: pronephric duct, yellow: pronephric capsule. (Redrawn 
based on Brandli, 1999). 
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Table 1.1 
Mutant Alleles 
Phronephric cyst, body axis curvature 
double bubble (dbb) m468, m153 & m587 
bazook Joe (b) m453 & m527 
dizzy (dzz) m605 
junior 'nr m304 
mr. bubble (mrb) m305 
blow up (bl) m348 
fusen sn m478 
bubblicious (bcs) m620 
big league chew blc m696 
hubba bubba (hba) m194 
inflated (i m786 
Pronephric tubule cyst 
pao pao tang (pap) m629 
cyster (cst) m329 
Pronephric cystbody axis curvature ee degeneration 
Heer (flr) m477 
elipsa (eli) m649 
Table 1.1: Aberrant pronephric phenotypes isolated from a zebrafish 
mutant screen. Mutants shown were isolated from a large-scale zebrafish 
mutant screen. The best characterised thus far is the double bubble (dbb) which 
displays glomerula malformations leading to general oedema and cyst 
formation in the glomerula, tubules and later in the duct (Reproduced from 
Drummond, 2000). 
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The double bubble mutation, as a representative of the largest group, was 
analysed in detail. Histological analysis of the mutant shows that the glomerulus 
is loose and distorted, swelling is apparent and the cells appear flattened. The 
glomerulus overall architecture is disorganised and the basement membrane is 
severely distorted. The timing of the formation of the glomerula cysts coincides 
with the onset of glomerula filtration. Some mutants also showed altered 
polarisation of the duct epithelium. The authors suggest that the phenotype 
observed points to a primary defect in formation of the glomerulus (Drummond 
et al., 1998). The zebrafish mutants floating head, sonic you and you-too are 
defective in midline structures. It is suggested that notochord provides the signals 
for glomerula differentiation in zebrafish. In these mutants glomerulogenesis is 
blocked, but podocyte formation (cells of the glomerula basement membrane) 
was found to develop independently of the notochord (Majumdar and 
Drummond, 2000). Further detailed studies of these and other pronephric gene 
mutations, discovered in zebrafish screens, will no doubt, provide essential 
information on the mechanisms underlying organogenesis of the pronephros. 
1.5 Specification and induction of the pronephros in Xenopus laevis 
In the early Xenopus embryo, mesoderm is induced at the equator by signals 
from the endoderm converting overlying ectoderm cells to a mesodermal fate, 
thus creating the three primary germ layers (Nieuwkoop, 1969). Candidate 
molecules for mesoderm induction include FGF family members and vegetally 
localized members of the TGF-(3 superfamily. It is widely accepted that a 
maternal T-box transcription factor VegT activates zygotic Derriere, Xnr-1, -2, - 
4, -5 and -6. Dorso-ventral patterning of the mesoderm appears to involve 
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differential regulation of these downstream targets of VegT. Xnr-1 and Xnr-2 are 
expressed at higher levels in the dorsal side than the ventral side due to the action 
of the Wnt pathway effector (3-catenin (Agius et al., 2000). Xnr-1 and Xnr-2 
expression also requires TGF-ß signalling probably in the form of maternal Vgl 
and/or an autoregulatory loop, whereas Xnr-4 and Derriere do not (Clements et 
al., 1999). 
The pronephros is derived from tissues of the intermediate mesoderm. The 
inductive signals that specify and pattern the pronephric mesoderm in vivo 
remain elusive. It is thought that the initial signals occur during gastrulation and 
by early neurula the pronephros is specified (Saxen, 1987). The experiments of 
Fales (1935) demonstrate that the prospective pronephric region in urodeles is 
capable of self-differentiation by midneurula stages. More recently, the temporal 
specification of all three components of the kidney in Xenopus laevis have been 
established; the tubules and duct are specified at stages 12.5 and 14 respectively 
and the glomus is specified at stage 12.5 (Brennan et al., 1998, Brennan et al., 
1999). Although a number of genes that are expressed early in this region have 
been cloned and characterised, their roles in pronephric induction and 
specification are as yet unknown. Studies of pronephric development in UV- 
ventralised and lithium-dorsalised embryos, demonstrated that dorsal tissues, 
especially anterior somites are responsible for the establishment of the 
intermediate mesoderm and induction of the embryonic kidney (Seufert et al., 
1999). A model of pronephric organogenesis in Xenopus is shown in figure 1.9 
(Brändli, 1999). 
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Figure 1.9 
11 
Stage 12.5/13 PA NM 1 Pronephric anlagen specification 
Stage 20/21 T NM Pronephric anlagen 
patterning 
Pronephric tubule formation Stage 30/35 NM RD 
and duct migration 
Stage 38/40 Pronephric maturation 
Figure 1.9: Specification and patterning of intermediate mesoderm 
forming the lineage of the pronephric components during 
pronephrogenesis. Pronephric anlagen specification (stage 12.5/13), the 
pronephric anlagen (PA) is specified in the anterior portion of the 
nephrogenic mesoderm (NM). Pronephric anlagen patterning (stage 20/21), 
tubule anlagen (TA) is specified in the dorso-anterior region and the duct 
anlagen (DA) in the more ventro-posterior region of the PA. Capsule 
anlagen (CA) is specified in the most dorso-anterior region of the PA, 
although no markers of this region are yet known (see figure 1.8). 
Pronephric tubule formation and duct migration (stage 30/35), the tubules 
form (T) and the duct (D) begins to migrate posteriorly and the rectal 
diverticulum (RD) begins to migrate anteriorly into the NM. Pronephric 
maturation (stage 38/40) the tubules extend and coil and the duct joins with 
the rectal diverticulum. (Redrawn based on Brandli, 1999). 
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The pronephric kidney components are specified by stage 12.5 and 14 (tubules, 
glomus and duct respectively) probably at least in part from signals produced by 
the anterior somites; xwnt-11 may be a candidate signalling molecule. The 
tubules and duct are induced in the lateral mesoderm ventral to somites 3-5, with 
the tubules specified in the more anterior region as opposed to the duct. 
Molecular candidates for molecules involved in the initial steps of tubule and 
duct specification are Mim-1, XPax-8 (which may act together with Xlim-1) and 
HNF-1,8. The corpuscle is induced in the most dorso-anterior region of the 
presumptive pronephric anlagen. There are currently no candidates for the early 
inductive events in glomus/capsule formation. xWTI is the earliest marker 
expressed in this region (stage 20) and is thought to reserve cells for a 
glomus/capsule fate. The pronephric anlagen forms as a condensate of cells 
which, can easily be observed in wholemount by stage 21. Expression of a range 
of molecules commences at this stage in the pronephric anlagen. Notch and its 
ligands Delta and Serrate, commence expression at this time and have been 
suggested to have roles in the partitioning of the capsule and tubule anlagen. 
Little is known regarding the action of BMP-4 and -7 in the pronephros in 
Xenopus, but they may well serve to pattern the lateral mesoderm. In the tubules 
Xwnt-4 and its proposed receptor Xfz3 are expressed and at particularly high 
levels in the nephrostomes. The differentiation and onset of function of the 
various pronephric components coincides with the beginning of expression of 
genes with known tissue specific functions. From around stage 27 the lumen 
forms in the tubules. At this stage the expression of the Na+/K+-ATPase (sodium 
pump) commences, together with integrin as a marker of epithelial polarisation. 
The expression of VEGF in the glomus from around stage 30 is a signature of 
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podocyte differentiation. As development proceeds, most of the genes display 
continued, but more restricted, patterns of expression (e. g. Xwnt-4 restricts to the 
nephrostomes) whereas some are replaced by family members (XPax-8 is 
replaced by XPax-2). Duct differentiation and caudal migration probably 
involves GDNF signalling, as identified in the axolotl model system. The current 
picture of the molecular mechanisms underlying the development of the 
pronephros is far from complete, only further investigation of these molecules 
and the identification of new ones will provide a full picture of the principles of 
nephrogenesis. 
1.6 Pronephric cell lineages in Zebrafish 
In zebrafish the origin of the different cell types that make up the pronephric 
lineages have been mapped (figure 1.10). Serluca and Fishman (2001) 
discovered that by using laser GFP un-caging to label a subset of intermediate 
mesoderm cells (8-10 somite stage), they were able to track these cells through 
development and determine their fate. They also used in situ probes, shown to be 
good markers of pronephric rudiments in other species, wtl (glomus), pax2.1 
(tubules) and siml (duct). The most anterior cells in the pronephric field gave 
rise to podocytes (glomus) and the wtl expressing region. The more posterior 
cells gave rise to the tubules and express both wtl and pax2.1. The most posterior 
cells contribute to the duct and express pax2.1 and siml but not wtl. Thus 
demonstrating that the intermediate mesoderm is pre-patterned and that this 
pattern corresponds to particular combinations of transcription factor gene 
expression. This data is in good agreement with the analysis of the pronephric 
lineages in Xenopus (Seufert et al., 1999). 
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Figure 1.10 
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Figure 1.10: Patterning of the intermediate mesoderm 
giving rise to the components of the zebrafish pronephros. 
(A) Expression of wt] (orange), pax2.1 (blue) and siml (brown) 
at the 8-10 somite stage. Notochord (N) and somites (S) are 
shown for axial reference. The glomerula progenitors are in 
yellow, tubule in green and duct in horizontal lines. (B) 
Diagram of the mature pronephros including colours relating to 
the positon (A-P) and gene expression patterns (Reproduced 
from Serluca and Fishman, 2001) 
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1.7 In vitro induction of pronephric tissues 
Members of the FGF and TGF-ß families of secreted growth factors can mimic 
the induction of mesoderm in vitro in ectodermal tissues (Green and Smith, 1990, 
Green et al., 1990, Gurdon et al., 1994). The explant can be induced to form 
different types of mesoderm in a dose dependent manner, with higher doses of 
activin inducing more dorso-anterior tissues (Figure 1.11) (Moriya et al., 2000; 
Ariizumi and Asashima, 2001). It has been shown that pronephric tubules can be 
induced to form in presumptive ectodermal tissue by treatment with retinoic acid 
(RA) (10-5M) plus activin A (Moriya et at., 1993). Evidence from histological 
studies indicate that tubules induced in animal caps have normal morphology and 
by analysis of marker genes their development appears to parallel normal 
developmental timing (Uochi and Asashima, 1996). Furthermore, the kidney 
tubules formed have been reported to rescue pronephric function in tadpoles in 
which the pronephros has been extirpated by dissection (Ariizumi and Asashima 
2001). Glomus can be induced in animal caps by treatment with RA (10-4 M) plus 
activin A or RA (104M) plus bFGF (Brennan et al., 1999). No combination of 
RA, activin or bFGF has been found to induce pronephric duct at high frequency 
(EAJ unpublished). 
1.8 Cloning of Xenopus laevis annexin IV (Xanx-4) 
In order to identify novel genes that may be involved in pronephros development 
a subtractive hybridisation strategy was adopted that enriches for those genes 
expressed early in kidney development (Nijjar and Jones unpublished). This 
approach was based on the observations that animal caps treated with a 
combination of retinoic acid and activin develop in vitro into differentiated 
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Figure 1.11 
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Figure 1.11: Tissue types induced by activin in Xenopus and newt 
animal caps. Treatment of animal caps with different concentrations of 
activin will induce different kinds of mesoderm. As concentration 
increases the type of mesoderm induced changes from ventral to more 
dorsal type (Reproduced from Ariizumi and Asashima, 2001). 
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kidney tubules (Moriya et al., 1993, Brennan and Jones unpublished 
observations). Treatment of animal cap ectoderm, dissected from blastula stage 
Xenopus embryos, with 5ng activin A and 10"5 M retinoic acid (RA) results in the 
formation of pronephric tubules at high frequency (figure 1.12), whereas, 
treatment of animal caps with activin A or RA alone does not. cDNA synthesized 
from poly A+ mRNA extracted from animal caps treated with RA and activin A 
was therefore subtracted with cDNA synthesized from a mixture of polyA+ 
mRNA synthesized from animal caps treated with RA alone pooled with that 
prepared from animal caps treated with activin A alone using the Clontech PCR- 
Select Kit. This allowed the production of a probe enriched for molecules 
expressed at the time of induction and specification of pronephric tubules (figure 
1.13). 
The subtracted probe was used to screen a Xenopus laevis whole embryo stage 
13 Xgt 11 cDNA library (kindly provided by I. Dawid) in order to identify genes 
expressed early in pronephric organogenesis. A number of positive clones were 
identified and taken through four rounds of screening until the clones were 
plaque pure. One of the clones, K2, was a 1131bp cDNA insert and was 
subcloned into pGEM-T Easy (appendix 1). Partial sequencing revealed K2 to be 
the Xenopus laevis ortholog of Bovine annexin IV and preliminary in situ data 
showed it to be expressed in the pronephros. 
During the course of this study a similar subtractive hybridisation strategy was 
used to successfully clone the pronephros specific genes XCIRP (Uochi and 
Asashima, 1998) and XSMP-30 (Sato et al., 2000). In vitro induction followed by 
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Figure 1.12 
Animal Animal cap explant 
Retinoic acid & activin 
Stage 9 
Vegetal Pronephric tubules at high frequency 
Figure 1.12: Induction of pronephric tubules in animal caps of Xenopus 
laevis. Animal caps taken from stage 9 embryos are cultured in Barth X 
containing retinoic acid and activin. Pronephric tubules are induced at high 
frequency. Incubation of animal caps in activin or retinoic acid alone does 
not. 
36 
Figure 1.13 
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Figure 1.13: Preparation of the subtracted probe. Animal caps were 
incubated in retinoic acid (RA) alone and activin alone, polyA+ RNA and 
cDNA was prepared and the two samples pooled producing Driver 
cDNA. Animal caps were incubated in a combination of RA and activin 
(induces tubules), polyA+ RNA was prepared and cDNA producing the 
Tester cDNA. Subtraction of Driver from tester allowed the production of 
a probe enriched in molecules involved in the 
tubules. This probe was then used to screen a 
library, which resulted in the cloning of Xanx-4. 
induction of pronephric 
stage 13 Xenopus cDNA 
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differential display resulted in the isolation of Xsal-3 that is also expressed in the 
pronephros (Onuma et al., 1999). 
1.9 The aims of this thesis. 
The general aim of this thesis was to investigate the function of K2 (Xenopus 
annexin IV, Xanx-4) in the development of the pronephros of Xenopus laevis. 
Initially, characterisation investigations were carried out to: (1) complete the 
sequencing (and compare with annexin IV homologs identified in other species), 
(2) establish the temporal expression profile (3) establish the spatial expression 
of the RNA and protein products of the gene. With these results in mind, a series 
of experiments were carried out to investigate the function of Xanzz-4 in 
pronephros development. Over-expression of Xanx-4 by injection of Xanx-4 
mRNA and depletion of Xanx-4 expression by RNAi and antisense morpholino 
technology was carried out. Any pronephric phenotype observed was described 
and analysed with respect to current knowledge. 
During the course of this work, descriptions of a variety of techniques for 
interfering with gene expression were published. This provided an ideal 
opportunity for them to be assessed in the Xenopus system for their efficacy. At 
the time when our RNAi experiments were started (May 1999) there were no 
published examples of the RNAi technique having been used either with or 
without success in Xenopus. The utilisation of the siRNA approach has not yet 
been published in Xenopus and to our knowledge this thesis represents the first 
time it has been tested. Therefore this thesis describes a series of experiments 
which attempt to assess the usefulness of these technologies with a gene which 
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we have shown by morpholino studies provides a phenotype in pronephros 
development. In our view it reports studies which fail to support the usefulness of 
RNAi and siRNA in Xenopus embryos. 
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Chapter 2 Materials and Methods 
2.1 Materials 
Bench chemicals were supplied by Sigma, Merck or Melford. DNA 
oligonucleotides were synthesized by Life Technologies (Gibco BRL). RNA 
oligonucleotides were synthesized by MWG-Biotech UK Ltd. Morpholino 
oligonucleotides were synthesized by Gene Tools (Oregan USA). Enzymes were 
supplied by Life Technologies (Gibco BRL) except proteinase K which was 
supplied by Boehringer-Mannheim, T4 DNA Ligase was supplied by Fermentas 
and Roche supplied DNase I and calf intestinal phosphatase. 32P-dGTP was 
supplied by Amersham Pharmacia Biotech and 35S-methionine was supplied by 
NEN. Automated sequencing reagents by PE Applied Biosystems (Perkin- 
Elmer). Protein markers were from New England BioLabs and DNA marker 
from Life Technologies (Gibco BRL). In situ hybridisation reagents were 
supplied by Roche, except for the Fast Red TR/Napthol AS/MX alkaline 
phosphatase colour substrate which was supplied by Sigma. Secondary 
antibodies were supplied by Sigma. Nylon membranes for blotting protocols 
were supplied by Amersham. Trizol for RNA isolation was supplied by Life 
Technologies (Gibco BRL). Chemiluminescent Protein detection kit was 
supplied by Bio-Rad. In vitro translation reticulocyte lysate system was supplied 
by Promega. Hoescht stain (33258) and FLDX was supplied by Sigma. 
2.2 Media and stock solutions 
All general media and stock solutions were prepared according to Sambrook et 
al, 1989. 
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2.3 Vectors 
pGEM-T Easy (Promega) contained the original K2 (Xanx-4) clone from the 
library screen (appendix 1). 
pBluescript RN3 (Kreig and Melton, 1984) was used as an expression vector. 
This vector contains a 5' ß3 globin UTR sequence 5' to the insert and a 3' /j globin 
UTR sequence 3' to the insert which stabilises the mRNA when expressed in the 
embryo or oocyte (appendix 2). 
PCS3+MT (Vojtek 1995, FHCRC) was used as an expression vector, it contains 
CMV IE94 promoter and 6 myc epitope tags, which allows translation products 
from this vector to be detected using anti-myc antibody (appendix 3). 
2.4 DNA techniques 
2.4.1 Agarose gel electrophoresis 
Agarose gels of between 1%-2% were prepared using lx TBE with ethidium 
bromide added to give a final concentration of 0.5µg/ml. The DNA/RNA was 
separated by electrophoresis in lx TBE at 80-150V and were then photographed 
under UV light. Where required, DNA was extracted from the gel using a Qiagen 
gel extraction kit according to the manufacturer's instructions. 
2.4.2 Restriction enzyme digests 
Restriction digests were carried out according to supplier's instructions. 
Following digestion of plasmids for ligation, the plasmid was treated with 
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phosphatase to prevent re-ligation. 1µl of calf intestinal alkaline phosphatase 
was added for each lOµ1 of reaction, and the reaction was incubated at 37°C for a 
further 20 minutes. The phosphatase was removed by phenol extraction, before 
ligation. 
2.4.3 DNA minipreps 
An overnight culture of 5mls was set up and was used with a Qiagen miniprep kit 
(27104) according to the instructions. 
2.4.4 Ligation of DNA into plasmid vectors 
For the ligation of Xanx-4 into the pBluescriptRN3 (appendix 2) vector, the 
insert was first released from Xanx-4/pGEM-T Easy construct (appendix 1) by 
digestion with EcoRI restriction enzyme. The digested plasmid was then 
separated on an agarose gel and the insert extracted using the QlAquick kit 
(28704). The insert was added to plasmid vector previously digested with EcoRI 
with a 1-3 molar excess of insert to vector. Ligation reactions were made up to a 
final volume of lOµ1 including T4 DNA ligase and ligation buffer and incubated 
for 1 hour at RT. 
2.4.5 Preparation of the myc-Xanx-4 and Xanx-4-MUT inserts and their 
ligation into plasmid vectors. 
This technique was used in the preparation of myc-tagged (myc-Xanx- 
4/pCS3+MT, appendix 3) and mutant (Xanx-4-MUT/RN3, appendix 4) Xanx-4 
constructs. The technique allows insertion of restriction enzyme sites and/or 
simple mutations. The PCR primers AN4-MYC 1 and AN4-MYC2 (Table 2.2) 
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were used to amplify the Xanx-4 coding region and produce the myc-Xanx-4 
insert, the restriction enzyme site is in bold. PCR was performed using 
pGEMTEasy/Xanx-4 construct (appendix 1) as a template and the product 
phenol/choroform, choroform extracted and ethanol precipitated. The pellet was 
taken up in lOµ1 ddH2O and digested with BamHl. The digest was then 
separated on an agarose gel and the insert extracted using the QlAquick Gel 
Extraction Kit. The insert was added to pCS3+MT plasmid vector previously 
linearised with BamHI with a 1-3 molar excess of insert to vector. Ligation 
reactions were made up to a final volume of lOµ1 including T4 DNA ligase and 
ligation buffer and incubated for 1 hour at RT. 
The PCR primers AN4-MUT and T7 were used to amplify the Xanx-4 coding 
region and produce the Xanx-4-MUT insert (see chapter 6.2.5 for details of 
mutations). Table 2.3 shows the primer sequences and conditions, the restriction 
enzyme sites are in bold and the mutations are underlined. PCR was performed 
using pGEMTEasy/Xanx-4 construct (appendix 1) as a template and the product 
phenol/choroform, choroform extracted and ethanol precipitated. The pellet was 
taken up in lOµ1 ddH2O and digested with EcoRI. The digest was then separated 
on an agarose gel and the insert extracted using the QlAquick Gel Extraction Kit 
(28704). The insert was added to pBluescript RN3 plasmid vector previously 
linearised with EcoRI, with a 1-3 molar excess of insert to vector. Ligation 
reactions were made up to a final volume of 10µl, including T4 DNA ligase and 
ligation buffer and incubated for 1 hour at RT. 
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Table 2.2 Primer pairs used for preparation of myc-Xanx-4 and Xanx-4- 
MUT inserts. 
Primer name Primer sequence 
(5'-3') 
Annealing temperature, 
No. of cycles 
AN4-MYC 1 u-gccgggatcccatggcagcacctc 50°C -5 cycles 
AN4-MYC2 d-cggcggatccgtcttcccctccg 60°C - 25 cycles 
AN4-MUT u-gccgggaattccatggccgcactgggaac 50°C -5 cycles 
T7 (Promega) d-taatacgactcactataggg 60°C - 25 cycles 
Automated sequencing was carried out on all new constructs to ensure correct 
sequence and orientation. 
2.4.6 Transformation of plasmid DNA into competent E. coli by heat shock. 
E. coli strains DH5a or XL1B competent cells were prepared for heat shock 
transformation according to Sambrook et al., (1989). lOng of ligation mix was 
mixed with l00µ1 of E. coli competent cells and incubated on ice for 15 minutes. 
The cells were then placed at 42°C for 1 minute and incubated on ice for 2 
minutes. The cells were transferred to lml L-broth and incubated at 37°C for 1 
hour. Following this incubation the cells were microcentrifuged for 5 minutes at 
2,500g, resuspended in 50 µl L-broth and plated out on L-broth plates containing 
ampicillin at 100µg/ml. Plates were incubated overnight at 37°C. 
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2.4.7 DNA sequencing 
Automated sequencing reactions were set up as follows. 500ng of plasmid DNA 
was added to 2.5pmol primer and 4µi sequencing buffer (200mM Tris pH9, 
50mM MgC12) and made up to a total volume of 16µ1 with H20.4µl sequencing 
reaction mix was added and the reactions were subjected to PCR on the 
following program: 94°C 10 seconds, 50°C 5 seconds, 60°C 4 minutes - 30 
cycles. The samples were then precipitated with 50µ1 ethanol and 2R1 3M 
NaOAc p14.6 at room temperature for 30 minutes. Samples were then 
microcentrifuged at 10,000g for 20 minutes, washed with 70% ethanol and the 
pellet was provided to the departmental automated sequencing for gel loading 
and running. 
2.5 RNA techniques 
2.5.1 RNA extraction from embryos and animal caps 
Volumes given below are for extraction of RNA from five whole embryos, for 
different numbers of embryos the volumes were adjusted accordingly. Five 
embryos were homogenised in 450µ1 extraction buffer (300mM NaCl, 20mM 
Tris pH7.5,1mM EDTA pH8,1% SDS) with 6 t1 proteinase K (15mg/ml) and 
incubated at 37°C for 15 minutes. The homogenate was phenol extracted with an 
equal volume of phenol and 5µg of glycogen was added to the upper phase. The 
RNA was precipitated with two volumes of ethanol at -20°C for at least 30 
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minutes. Following precipitation the sample was microcentrifuged at 10,000g for 
20 minutes and the pellet was resuspended in 90µl DNase buffer (20mM Tris 
pH8.3,30mM NaCl, 2.5mM MgC12) containing 2x1 DNasel (40U) and 2µl 
placental RNase inhibitor (40U) and incubated at 37°C for 15 minutes. 360µl 
extraction buffer and 6 µl proteinase K were added and the sample was incubated 
for a further 20 minutes at 37°C. The samples were phenol extracted and then 
phenol/chloroform extracted before precipitation with 2 volumes ethanol at room 
temperature for no longer than 30 minutes. The samples were microcentrifuged 
as before and the RNA pellet was resuspended in 30µl H2O. 1µl RNA was 
loaded on a I% agarose gel to determine purity and yield. 
2.5.2 Reverse transcription PCR 
RT-PCR was performed as described by Barnett et al., (1998). RNA extracted 
from animal caps or whole embryos was mixed with water to give a final volume 
of 21.1 . t1, heated to 75°C for 5 minutes and placed on ice. Volumes of RNA 
used were adjusted according to concentration of the RNA as determined by 
separation on an agarose gel. 7.9 t1 of reaction mix (3.3µM random hexamers, lx 
PCR buffer, 3mM MgC12,500pM dNTPs, IU/µl RNase inhibitor) was added to 
each sample and the reactions were incubated at 37°C for 5 minutes. 2µl MMLV 
reverse transcriptase was added to each sample and the reactions were incubated 
for a further 1 hour at 37°C. After this time the samples were heated to 95°C for 
5 minutes and then cooled on ice and stored at -20°C. The resulting cDNA was 
used in PCR analysis. 1µl each cDNA was made up to a final volume of 25µl 
with reaction mix: lx PCR buffer, 1.5mM MgC12,200µM dNTPs, ltM each 
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primer, lµCi a32P-dGTP and 1U Taq polymerase. The samples were overlaid 
with oil. The number of cycles and standard PCR conditions were: 
Step 1.94°C 3 minutes, 55°C 1 minute, 72°C 1 minute -1 cycle 
Step 2.94°C 30 seconds, 55°C 1 minute, 72°C 1 minute - 18 cycles 
Step 3.72°C 5 minutes -1 cycle 
Amplifications were as above for EFl a primers or ODC primers and the 
volumes of cDNA were adjusted to ensure equal loading. These adjusted 
volumes were then used in all subsequent PCR reactions. Primers used, cycles 
and annealing temperatures for different genes are shown in table 2.1. 
7.5gl of each PCR reaction was mixed with 7.5µl loading buffer (95% deionised 
formamide, 10mM EDTA pH8,0.1% xylene cyanol, 0.1% bromophenol blue) 
and heated to 95°C for 5 minutes before being loaded on a 6% denaturing 
acrylamide gel and separated at 650V for approximately 1 hour. The gel was 
dried and exposed to X-ray film or a phosphorimager screen. 
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Table 2.1 Sequences of primers and conditions used for RT-PCR analysis of 
RNA samples (u-upstream, d-downstream) 
Gene Primer sequence (5' to 3') Annealing Reference 
temperature, 
No. of cycles 
Xanx-4 u-agcaggcacgatgaagatg 57°C This work 
d-tcattcacggtgctgctctg 27 
Xlim-1 u-gaaggatgagaccactggtgg 55°C Witta & Sato, 1997 
d-cactgccgtttcgttcatttc 25 
XPax-2 u-tcggaagaagagtggtctac 60°C This work 
d-ggtattcatattccgcattc 24 
XPax-8 u-ccaacagcagcatcagatc 53°C This work 
d-caatgacacctggccggata 24 
Xwnt-4 u-gagtggaatgcaagtgtc 57°C This work 
d-tacactgccgaccagttg 25 Accession No. U13183 
Xwnt-11 u-gaagtcaagcaagtctgctgg 55°C http: //www. lifesci. ucla. edu/hhmi/ 
d-gcagtagtcaggggaactaaccag 25 derobertis/index. html 
XWT1 u-cacacgcacggggtct 55°C Carroll & Vize, 1996 
d-tgcatgttgtgatgacg 27 
ODC u-ggagctgcaagtttggaga 55°C Bassez et al., 1990 
d-tcagttgccagtgtggtc 18 
EFl a u-cagattggtgctggatatgc 55°C Mohun et al., 1989 
d-cactgccttgatgactccta 18 
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2.5.3 In vitro transcription of mRNA 
Plasmid template was linearized with the appropriate restriction enzyme and 
purified using a Qiagen gel extraction column. The template was eluted in 30 tl 
H2O and 6 µl used as a template for transcription with mMESSAGE 
mMACHINE kit from Ambion. Transcriptions were incubated for 1 hour with 
T7 or T3 polymerase or 2 hours with SP6 polymerase. The RNA concentration 
was quantified by agarose gel electrophoresis and UV absorbance. 
Xmad2 mRNA was prepared from pSP64TNE-Xmad2 construct (gift from 
D. Melton, Harvard MA) linearised with Xbal and transcribed with SP6 RNA 
polymerase. Xsoxl7ß mRNA was prepared from pSPXsox17[3 construct (gift 
from D. Clements, Warwick) linearised with XhoI and transcribed with SP6 RNA 
polymerase. Truncated activin receptor (OMXAR1) mRNA was prepared from 
p64T-DMNI/Stop construct (gift from A. Hemmati-Brivanlou, Harvard MA) 
linearised with EcoRl and transcribed with SP6 RNA polymerase. 
2.5.4 Wholemount in situ hybridization 
Wholemount in situ hybridization was carried out as described in Harland, 1991. 
The embryos were fixed in MEMFA (0.5M MOPS, pH7.4,100mM EGTA, 1 mM 
MgSO4,4% formaldehyde) and hybridised with RNA probes produced from 
cDNA clones. 
The Xanx-4 antisense probe was transcribed from the pGEM-T Easy/Xanx-4 
construct (appendix 1) previously linearised with Ncol, with SP6 RNA 
polymerase. The sense control probe was linearised with Sall and transcribed 
with T7 RNA polymerase. Probes were synthesised and labelled using a DIG 
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labelling kit (Boehringer) and visualised using anti-DIG-alkaline phosphatase 
secondary and NBTBCIP for the colour reaction according to manufacturer's 
recommendations (Boehringer). 
Xlim-1 antisense probe was prepared from construct pBlueKS-lim-1 (gift from 
T. Carroll, Texas) linearised with XhoI and transcribed with T7 RNA polymerase. 
xWT-1 antisense probe was prepared from construct pGEM7-WT1 (gift from 
T. Carroll, Texas) linearised with EcoRI and transcribed with T7 RNA 
polymerase. XPax-8 antisense probe was prepared from construct pSP64T-Pax8 
(gift from T. Carroll, Texas) linearised with XhoI and transcribed with T3 RNA 
polymerase. 
2.5.5 Northern blot analysis 
Total RNA was extracted from different adult tissues using Trizol (Gibco-BRL 
Life Technologies) following the manufacturer's protocol. Samples of denatured 
RNA (30 µg per lane) were fractionated by electrophoresis through 1.2% 
agarose, 2.2M formaldehyde gels in MOPS buffer (50mM MOPS pH7; 1mM 
EDTA; 20mM sodium acetate), blotted for 48 hours in lOX SSC onto a Hybond- 
N membrane (Amersham) and fixed by baking for 2 hours at 80°C. The filters 
were hybridized overnight at 42°C with 32P-labelled Xanx-4 specific probe in 
0.5M phosphate buffer pH 7.2 in the presence of 7% SDS and 5mM EDTA. The 
probe was prepared from 3' specific fragment, by PCR amplification (Primers 5'- 
3', u-gcataaagagcaggccagcc, d-cgattggttatgtgttcaat). After hybridization, the 
filters were washed at room temperature in 2XSSC, 0.1%SDS, twice for 15min 
at 42°C, and then for 15 min at 65°C in 1XSSC, 0.1%SDS. Autoradiographs 
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were obtained by exposing Fuji super RX films with intensifying screens at - 
80°C. 
2.6 Protein techniques 
2.6.1 Protein expression in oocytes 
Oocytes were injected with 10 ng of mRNA. Two hours after injection they 
were transferred to a dish of Barth's medium containing 10 4Ci 35S-methionine. 
The oocytes were then incubated overnight at 18°C before being harvested for 
protein extraction. 
2.6.2 Protein extraction from oocytes and embryos 
Oocytes or embryos were washed in Barth's medium then homogenised in 
groups of 5 oocytes in 50µ1 cell-lysis buffer (150 mM NaCl, 1% NP-40,50 mM 
Tris-Cl pH8) and 1 mM PMSF. The samples were microcentrifuged at 10,000g 
for 5 minutes and the middle layer of supernatant was removed. 5µl of 
supernatant was mixed with 5 µl of protein loading buffer and heated to 95°C for 
3 minutes before loading. Samples were stacked at 100V through a 5% 
acrylamide stacking gel and separated at 200V through a 12% acrylamide 
resolving gel in tris/glycine running buffer using the BioRad Mini Protean II 
system. The gel was then either dried and exposed to x-ray film or subjected to 
western immunoblot analysis. 
2.6.3 Sucrose gradient fractionation of oocytes 
Oocytes injected with lOng of mRNA, were allowed to recover for 2 hours at 
18°C. Groups of five oocytes were transferred into 50µ1 Barth's medium 
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containing lORCi 35S-methionine in a microtitre well and incubated overnight at 
18°C. Oocytes were enucleated and groups of five nuclei were homogenised in 
50µ1 cell lysis buffer at 4°C. The following protocol was conducted at 4°C. The 
enucleated oocytes were homogenised in groups of five in 50µ1 sucrose T buffer 
(10% sucrose 150mM NaCl, 1%NP-40,1mM PMSF) and loaded onto a 3m150- 
20-10% sucrose column. The column was then centrifuged for 30 minutes at 
15,000g. The appropriate fractions were removed using a Pasteur pipette; the 
cytosolic fraction within top 10% layer and the membrane fraction at the 20-50% 
border. lOµ1 of each sample was mixed with lOµ1 of protein loading buffer and 
heated to 95°C for 3 minutes before being separated on a 12% acrylamide gel as 
for oocyte protein extracts. The gel was dried and exposed to X-ray film. 
2.6.4 In vitro translation 
In vitro translation of mRNA was carried out using the Promega rabbit 
reticulocyte lysate system. Reactions were incubated for 90 minutes at 30°C. 5 
t1 of product was mixed with 5 µl of protein loading buffer and heated to 95°C 
for 3 minutes before being separated on a 5%-12% acrylamide gel as for oocyte 
protein extracts. 
2.6.5 Western immunoblot analysis. 
SDS-PAGE was performed on 5%-12% (w/v) resolving gel using a vertical 
BioRad minigel apparatus for 1 hour at 20mA. The proteins were transferred to 
nitrocellulose membrane (Amersham) according to Harlow and Lane, (1988) for 
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2 hours at 35OmA or overnight at 5OmA. After transfer the nitrocellulose was 
incubated for 1 hour at room temperature in TBS-Tween (0.15M NaCl, 10mM 
Tris-Cl, pH7.4,0.1% Tween-20) containing 3% (w/v) powdered milk. The blots 
were then incubated in 1: 1000 anti-myc monoclonal antibody (gift from D. Stott, 
Warwick) in TBS-Tween overnight at room temperature. After washing the 
blots were incubated in 1: 2,000 alkaline phosphatase-conjugated goat anti-mouse 
(Sigma) in TBS-Tween for 1 hour at room temperature. Immuno-star Detection 
Kit (BioRad) was used for detection according to manufacturer's 
recommendations. 
2.7 Wholemount immunohistochemistry 
Wholemount immunohistochemistry was performed by standard methods 
(Sambrook et al., 1989, Sive et al., 2000) on MEMFA (0.5M MOPS, pH7.4, 
100mM EGTA, 1mM MgSO4,4% formaldehyde) fixed embryos. The primary 
antibodies used were as follows and the concentrations are in brackets. 
Pronephric tubule specific monoclonal antibody 3G8 (1: 1), pronephric duct 
specific monoclonal antibody 4A6 (1: 1) (Vize et al., 1995) and anti-annexin IV 
monoclonal antibodies BUB 1 (1: 1) (Massey et al., 1991a) and AS 17 (1: 500) 
(Satoh et al., 1997). The secondary antibodies were alkaline phosphatase- 
conjugated goat anti-mouse (Sigma S-3635) (1: 500) and FITC-conjugated goat 
anti-mouse (Sigma F-2012) (1: 100) for 3G8,4A6 and AS 17. For BUBI the 
secondary antibodies used were alkaline phosphatase-conjugated goat anti-rat 
(Sigma S-3656) (1: 500) and FITC-conjugated goat anti-rat (Sigma F-7546) 
(1: 100). BCIP/NBT (Boehringer) or Fast Red TR/Napthol AS/MX (Sigma) was 
used for the colour reaction according to manufacturer's recommendations. 
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2.8 Histology 
2.8.1 Acrylamide embedding and cryostat sectioning 
Embryos were fixed in MEMFA overnight at 4°C, rinsed in PBS and incubated 
at 4°C for 5 hours in embedding acrylamide (8.4g acrylamide, 13.4mg bis- 
acrylamide, 700µl TEMED to 100mis in PBS). The embryos were embedded in 
acrylamide using 5pJml 10% ammonium persulphate to polymerise overnight at 
4°C. The acrylamide blocks were frozen in iso-pentane over liquid nitrogen for 5 
minutes. The blocks were then allowed to warm to -20°C and sectioned on a 
cryostat at 12µm. The sections were lifted onto 0.1% gelatin subbed slides (300 
bloom), fixed in acetone and mounted in 50% PBS/50% glycerol. 
2.8.2 Histological staining 
Nuclear staining was carried out using Hoescht stain (33258) at a concentration 
of lµg/ml on acrylamide embedded sections for 10 mins at RT. The slides were 
washed twice in PBS, mounted in glycerol and viewed on a Nikon microscope 
using a UV filter. 
2.9 Embryo manipulations 
2.9.1 In vitro fertilization of Xenopus eggs 
Eggs were laid into Barth X (88mM NaCl; 1mM KCI; 24mM NaHCO3; 15mM 
Tris-HC1; 0.33mM Ca(N03)2; 0.41mM CaC12; 0.8mM MgSO4 pH7.5) and were 
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removed into a petri dish for fertilisation. The Barth X was removed from the 
dish and a testis that had been broken open a little was used to brush over the 
eggs. 1-2 mis H2O was then added to the dish and the eggs left to fertilise. After 
30-40 minutes embryos were dejellied by removal of the water and addition of 
2% (w/v) cysteine pH8. The cysteine was removed after 5-10 minutes and the 
embryos were washed several times with 1/10 Barth X solution. Embryos were 
cultured in 1/10 Barth X solution with 10 µg/ml gentamycin at 12-24°C to the 
required stage. 
2.9.2 Micro-injection of embryos 
Embryos were microinjected at either the 1-cell stage or into one cell of two at 
the two-cell stage (left vs right comparisons) or 1-cell of the 32-cell stage 
embryos (targeted lineage labelling). Injections were performed in 4% Ficoll in 
Barth X. Quantities of mRNA injected are described for individual mRNAs. 
Lineage label, when used, was FLDX (Fluorescein Lysine Dextran) at a final 
concentration of 50ng per embryo. Embryos were allowed to recover overnight 
and then cultured to the required stage in 1/10 Barth X solution with 10 µg/ml 
gentamycin. 
2.10 Bespoke oligonucleotides for gene expression perturbation 
Only technical data is contained in the following methods section. The scheme 
used to prepare all the constructs in this section are detailed within the 
introduction to chapter 5. 
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2.10.1 dsRNA constructs 
PCR was performed as follows: Ing plasmid template DNA was made up to a 
final volume of 25 µl with reaction mix: 1x PCR buffer, 1.5 mM MgC12,200 µM 
dNTPs, 1 µM each primer (Table 2.3) and 1U Taq polymerase. The samples 
were overlaid with oil. The number of cycles and PCR conditions were: 
Step 1.94°C 20 seconds, 50°C 20 seconds, 72°C 20 seconds -5 cycles 
Step 2.94°C 20 seconds, 60°C 20 seconds, 72°C 30 seconds - 25 cycles 
Step 3.72°C 5 minutes -1 cycle 
Table 2.3: Primers used for preparation of dsRNA. 
Sequence (5'-3') Modification 
Primer & Position 
Name 
sl (T7) taatacgactcactataggggagcagcaccgtgaatgaag T7,491 
S2 (T7) taatacgactcactatagggcccacttcttctcaccggcttc T7,616 
(complement) 
L1 (T7) taatacgactcactatagggatggcagcactcggaactaagg T7,1 
L2 (T7) taatacgactcactatagggctcctctgcgctgcgagatg T7,365 
(complement) 
L2 (T3) attaaccctcactaaagggactcctctgcgctgcgagatg T3,365 
(complement) 
XEZR 1 taatacgactcactatagggcgttagctaggctagcttagc T7 
XEZR2 taatacgactcactatagggtagtctagcctagtgctgaag T7 
(complement) 
In vitro transcription was performed with an input of 6 t1 of PCR reaction using 
T7 mMESSAGE mMACHINE Kit (Ambion) according to manufacturer's 
recommendations, using termination and recovery method 1 and resuspending 
the precipitate in lOµ1 ddH2O. The mixture is then treated with 0.5µg/ml RNase 
A in 300mM NaCl for 30 minutes at 37°C to remove single stranded RNA. The 
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product was separated on an agarose gel and extracted using Qiagen gel 
extraction kit. The concentration was determined on an agarose gel and by UV 
absorbance. 
For the single stranded RNA constructs, the PCR was performed using a 
combination of Xanx-41T7 and Xanx-41T3 primers. For the in vitro transcription 
T7 RNA polymerase or T3 RNA polymerase was used to transcribe only Xanx- 
41T7 sense or Xanx-41T3 antisense RNA. For the sense and antisense not- 
annealed samples equal amounts of sense and antisense single stranded RNA 
molecules were mixed thoroughly and snap frozen on dry ice. 
For the sense and antisense annealed, equal amounts of single stranded sense and 
antisense RNA molecules were mixed in annealing buffer (10mM Tris-HCI 
pH7.4,0.1mM EDTA) incubated for 10 minutes at 68°C and 37°C for 3-4 hours. 
The mixture is then treated with 0.5µg/ml RNase A in 300mM NaCl for 30 
minutes at 37°C to remove single stranded RNA. The product was separated on 
an agarose gel and extracted using QlAquick Gel Extraction Kit. Following gel 
extraction the concentration of the resultant product was determined on an 
agarose gel and by UV absorbance. 
2.10.2 siRNA constructs 
The siRNA oligos synthesised by MWG Biotech. (0.2µM synthesis) were 
deprotected using RNA Deblocking Kit supplied by Cruachem Ltd (Glasgow) 
according to manufacturer's recommendations. All steps were conducted under 
ribonuclease free conditions, according to Sambrook et at., 1989. The 
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oligonucleotide pellet was resuspended in 0.5m1 aqueous ammonia (SG 0.88) by 
vortexing and incubated at 55°C overnight. The sample was cooled, centrifuged 
at 10,000g for 2 minutes and pelleted by vacuum centrifugation. 500µ1 acidic 
buffer (Cruachem Ltd) was added and the pellet was resuspended by sonication 
in an ultrasonic water bath for 2 minutes and incubated at 25-30°C for 36 hours. 
To the 500µ1 acidic solution, 1O0µ1 of the neutralising buffer was added, the 
mixture vortexed for 1 minute and centrifuged at 8000g for 3 minutes. The 
supernatant was transferred to a fresh microfuge tube and vortexed for 1 minute. 
Precipitation of the RNA oligo was carried out in 3x analytical grade ethanol at - 
20°C for 30 minutes and pelleted by centrifugation for 5 minutes at 8,000g. The 
supernatant was discarded and the pellet dried by vacuum centrifugation. The 
pellet was then resuspended in ddH2O and the concentration determined by UV 
absorbance. 
For the double stranded siRNA, equal amounts of single stranded sense and 
antisense RNA molecules were mixed in annealing buffer (10mM Tris-HCI 
pH7.4,0.1mM EDTA), incubated for 10 minutes at 68°C and then 37°C for 3-4 
hours. The mixture was then treated with 0.5µg/ml RNase A in 300mM NaCl 
for 30 minutes at 37°C to remove single stranded RNA. Following 
phenol/chloroform extraction and ethanol precipitation the concentration of the 
resultant product was determined by UV absorbance. 
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2.10.3 Morpholinos 
Xanx-4 MO1, Xanx-4 M02, Xsox17ß (gift from D. Clements) and control 
Morpholinos were designed and supplied by GeneTools, LLC (Corrallis, OR) 
(Xanx-4 MO1: 5 -acccttagttccgagtgctgccatg-3, Xanx-4 M02: 5'- 
tccgagtgctgccatgatgtccacc-3', control MO: 5'-cctcttacctcagttacaatttata-3'). The 
morpholinos were dissolved in ddH2O to a stock concentration of 10µg/ml. 5,10 
or 20ng was injected into one cell stage embryos alone or in combination with 
mRNA as specified in the text. 
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Chapter 3: Characterisation of the clone K2 
3.1 Introduction 
Initial events in kidney organogenesis are not yet fully understood and Xenopus 
provides an ideal vertebrate system to identify and establish the functional role of 
genes involved in early kidney development. The simplicity of the pronephros 
coupled with the fact that it displays the same basic organisation and function as 
the more complex mesonephros and metanephros make this an attractive model 
to study the earliest events in vertebrate kidney morphogenesis (Vize et al., 
1997). 
Some of the biological parameters that control pronephros formation have 
already been established. The temporal specification of all three components of 
the kidney have been established and all occur between stages 12.5 and 14 
(Brennan et al., 1998; Brennan et al., 1999). A molecular map of many of the 
early markers of the pronephric field and pronephric anlagen is also being built 
up in order to unravel the molecular control of early kidney induction and 
patterning. Using a variety of strategies, previous studies have identified more 
than 30 genes that are expressed in the pronephros (section 1.3). Many of these 
genes are also expressed in mesonephric and metanephric kidneys in higher 
vertebrates. 
In order to identify novel genes that may be involved in pronephros 
development, previous members of the research group adopted a subtractive 
hybridisation strategy that enriches for those genes expressed early in kidney 
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development (section 1.4). The strategy adopted led to the cloning of K2 cDNA 
and the analysis of this clone formed the main area of interest of my three-year 
research work and the basis of my thesis. 
A full characterisation is the first fundamental step in the explorational analysis 
of a novel gene. Certain basic information is required which provides a 
foundation upon which one can design approaches that will eventually lead to the 
establishment of the function of the gene in question. Initially nucleic acid 
sequence information allows database searching and can place a gene within a 
family whose functions maybe known. Amino acid sequence can then be 
deduced and by comparison with information collected on databases, protein 
structure and motif analysis can be derived. To developmental biologists when 
and where a gene is expressed is' the fundamental basis on which further 
exploration can be based. The normal expression pattern, timing and localisation 
can often lead to insights into the function of a gene. 
The central questions addressed in the following chapter are: 
(1) What is the sequence of the clone K2? 
(2) What is the temporal expression profile during embryonic development? 
(3) What is the spatial expression profile during embryonic development? 
(4) What is the spatial expression profile of the gene in the adult organism? 
(5) What does this information tell us about the gene? 
In the course of this study, nucleic acid sequencing was carried out and the 
deduced amino acid sequence was confirmed. The temporal and spatial 
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expression patterns both of mRNA and protein in embryos and the mRNA 
expression pattern by Northern analysis in the adult organism, was established. 
Finally, this information was analysed in the context of current scientific 
knowledge and understanding. 
3.2 Results 
3.2.1 The cDNA clone K2 was identified as Xenopus laevis annexin IV 
The first step in the analysis of a novel clone is sequencing and database 
comparisons. Sequencing revealed K2 to be a clone of 1131 nucleotides, 
containing an in-frame coding sequence confirming identification as Xenopus 
laevis annexin IV (Xanx-4), including 50 bases 5'UTR and 118 bases 3'UTR. 
Conceptual translation of Xanx-4 yielded a predicted amino acid sequence of 321 
amino acids (figure 3.1). Annexin IV (anx-4) has been cloned and sequenced in a 
number of species including plants, fungi, invertebrates and higher and lower 
vertebrates (section 7.1). Figure 3.2 shows an alignment using DNA Star 
software of the predicted amino acid sequence of Xanx-4 against a selection of 
vertebrate Anx-4 predicted amino acid sequences available on the database 
(NCBI GenBank). The alignment shows that Xanx-4 displays identity with Anx- 
4 in other vertebrate species of between 67-74%, with Medaka killifish being the 
least similar at 67% and bovine annexin IV being the most similar at 74%. 
Analysis of the predicted amino acid (aa) sequence using motif analysis software 
(Prosite) confirmed that Xanx-4 contained the archetypal conserved C-terminal 
annexin domain (figure 3.3) previously identified (Raynal and Pollard, 1994). 
The N-terminal region (aa 1-32) contains the protein kinase C phosphorylation 
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I Figure 3.1 
Xenopus laevis annexin 4 nucleotide sequence and 
deduced amino acid sequence. 
CCGCAGCCGACATCTGCTTAGAAATTCTCTGCTTCACAGTTGGTGGACATC ATG GCA GCA CTC GGA 66 
MAALG5 
ACT AAG GGT ACA ATT AAA CCC TAC CCC AAT TTC AAT GCA GCA GAT GAT GTG CAG 120 
TKGTIKPYPNFNAADDVQ 23 
AAG CTG AGG AAC GCC ATG AAA GGA GCA GGC ACC GAT GAA GAT GCT GTC ATT GAC 174 
KLRNAMKGAGTDEDAVID 41 
GTC ATT GCA AAC AGG ACT CTT TCT CAG CGC CAG GAA ATC AAG ACT GCT TAT AAA 228 
VIANRTLSQRQEIKTAYK 59 
ACC ACT GTT GGA AAA GAT CTT GAT GAT GAT TTA AAA TCC GAA CTG ACA GGG AAC 282 
TTVGKDLDDDLKSELTGN 77 
TTT GAA AAA GTC ATC CTG GGA CTT ATA ACC TCA TCC ACT CTC TAT GAT GTG GAG 336 
FEKVILGLITSSTLYDVE 95 
GAA CTG AAA AAA GCC ATG AAG GGT GCA GGG ACA GAC GAG GGC TGT TTG ATT GAG 390 
ELKKAMKGAGTDEGCLIE 113 
ATT TTG GCA TCT CGC AGC GCA GAG GAG ATC AAG AAC ATA AAT ATC ACC TAC AAA 444 
ILASRSAEEIKNINITYK 131 
ATA AAA TAT GGT AAA TCT CTG GAG GAC GAT ATT TGC TCA GAC ACG TCT TTC ATG 498 
IKYGKSLEDDICSDTSFM 149 
TTC CAG AGA GTT CTG GTA TCT TTG GCT GCT GGT GGG AGA GAC CAG AGC AGC ACC 552 
FQRVLVSLAAGGRDQSST 167 
GTG AAT GAA GAC CTT GCA AAA CAA GAT GCC AAT GAC CTA TAT GAA GCC GGT GAG 606 
VNEDLAKQDANDLYEAGE 185 
AAG AAG TGG GGG ACC GAT GAG GTG AAA TTC CTG ACT ATC CTT TGC AGC AGA AAC 660 
K K W GTDEV KFLTILCS R N 203 
CGG AAC CAC TTA CTG AAA GTT TTT GAA GAG TAC AAA AAG ATT GCA AAG AAA GAT 714 
R N H LLKVF EEYKKIAK K D 221 
CTT GAG GCC AGT ATA AAA TCT GAA ATG TCG GGA CAC TTA GAA GAT TCT CTT TTG 768 
L E A SIKSE MSGHLEDS L L 239 
GCA ATC GTG AAA TGC ATA AAG AGC AGG CCA GCC TAC TTT GCA GAA CGA TTG TAT 822 
A I V KCIKS RPAYFAER L Y 257 
AAA TCT ATG AAG GGT CTG GGG ACA GAC GAT AAA ACT CTG ATC AGA GTT ATG GTT 876 
KSMKGLGTDDKTLIRVMV 275 
TCT CGT TGT GAA ATT GAC ATG CTG GAA ATC CGC TGC GAG TTC AAG AAG ATG TAT 930 
SRCEIDMLEIRCEFKKMY 293 
GGC AAA TCT CTG CAT TCA TTT ATT AAG GGT GAC TGC TCG GGA GAT TAC AGG AAG 984 
GKSLHSFIKGDCSGDYRK 311 
GTG CTC TTG AAA CTT TGC GGA GGG GAA GAC TAA GTA ACA TAG CCT TTC TGT GTG 1038 
VLLKLCGGED* 321 
TCC AAG AAA AGT CTG TTG TGT CTA ATT GAA CAC ATA ACC AAT GCA AAA TAA AAA 1092 
CCT TCT GAT GCC TTT TTT AAA AAA AAA AAA AAA AAA A 1129 
Figure 3.1: Xenopus laevis annexin 4 nucleotide sequence and deduced amino acid 
sequence. Nucleotide sequence of Xanx-4 (1131 nucleotides) including 50 bases 
5'UTR and 118 bases 3'UTR and below the predicted amino acid sequence (321 aa) 
performed using DNA Star software. 
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Figure 3.2 
xanx-4 1 - 321 (321 aa) Homology 
Human 1 - 321 (321 aa) 72% 
Rat 1 - 319 (319 aa) 72% 
Mouse 1 - 319 (319 aa) 71% 
Cow 1 - 319 (319 aa) 74% 
Medaka 1 - 320 (320 aa) 67% 
Xenopus 1) maalgtkgtikpypnfnaaddvgklrnamkgagtdedavidvianrtlsqrqeiktaykt 
Human 1) .. matkg.. v. aasg... me. a. t.. 
k.... 1 ...... i. s. l. y. nta ..... r.... s 
Rat 1) . etk. --.. v. aasg... te. a. v.. 
k.... 1 ...... i. g. l. c. nta ..... r.... s 
Mouse 1) . e. k. --.. v. aasg... te. a. t.. 
k.... 1 ...... i. gil. y. nta ..... rs... s 
Cow 1) ... k. --.. v. aasg.... e. a. t.. 
k.... 1 ...... i. n. l. y. sta ..... r..... 
Medaka 1) ... i. nr.. vteasg.. pd.. a.... e.... . .... a. 
i. k. l. h.. ia ... r.. 1... q 
(61) tvgkdldddlkseltgnfekvilglitsstlydveelkkamkgagtdegclieilasrsa 
(61) . i. r.. i....... s.... q.. v. mm. ptv .... q.. rr ................... 
tp 
(59) . i. r.. le...... ss... q.... mm. ptv .... q.. rr ................... np 
(59) . i. r.. ie...... ss... q..... m. ptv .... q.. rr ................... tp 
(59) . i. r.. m....... s.... q.... mm. ptv .... q. vr . ................... tp 
(61) s..... ae.. s... s. h. gs. v... lmpapv.. ay... a ....... e. a... d...... n 
(121) eeikninitykikygksleddicsdtsfmfgrvlvslaaggrdqsstvnedlakqdandl 
(121) ... rr. sq.. qqq.. r...... r .............. s..... egnyldda. vr... q.. 
(119) ... rr.. q.. qqq.. r... e ................. t..... egnyldda. vr... q.. 
(119) ... rr.. q.. qqq.. r... e ............... 
f. s. a... egnyldda. m.... ge. 
(119) ... rr.. q.. qlq.. r...... r .............. s..... e. nyldda. mr... q.. 
(121) s. mna.. ev.. ke... t... av. g... g......... lta... e. dk. d. aq. vk.. k. i 
(181) yeagekkwgtdevkfltilcsrnrnhllkvfeeykkiakkdleasiksemsghledslla 
(181) ................. v.......... 
h.. d... r. sq.. i. q..... t.. sf.. a... 
(179) ...... r......... s........... 
h.. d... r. sq.. i. q..... t.. sf.. a... 
(179) ...... r......... s........... 
h.. d... r. sq.. i. q..... t.. sf.. a... 
(179) ................. v.......... 
h.. dk.. r.. q.. i. q..... t.. sf.. a... 
(181) f.... ar.......... v.. v....... r.. d..... s. r. i. d... r.... s... vf.. 
(241) ivkciksrpayfaerlyksmkglgtddktlirvmvsrceidmleircefkkmygkslhsf 
(241) .... mrnks..... 
k............ n......... a..... d.. ah.. rl ..... y.. 
(239) .... mrnk ................... s......... p..... 
d. pan.. rv ..... y.. 
(239) .... mr. k. s ................. n......... a..... 
d.. as.. rl ..... y.. 
(239) .... mrnks .................. d......... a..... 
d.. an.. r] ..... y.. 
(241) .... lr. k.. f .............. t. sv... 
i.... a..... d. keh. l. t ........ 
(301) ikgdcsgdyrkvllklcgged 
(301) .... t......... v.... 
d. 
(299) .... t......... i.... 
d. 
(299) .... t......... i.... d. 
(299) .... t......... 
i.... d. 
(301) .... t...... 
i.. e...... 
Figure 3.2: Predicted amino acid sequence for Xenopus laevis annexin IV 
aligned against deduced amino acid sequences of annexin IV proteins 
identified in other vertebrate species. The alignment was performed using 
DNA Star software with sequences retrieved from NCBI Genbank database. 
Stops indicate identity or conserved substitutions, hyphens indicate missing 
residues. 
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site threonine 9 (TIK) and an N-myristoylation site at G1y5 (GTKGTI). The C- 
terminal annexin fold region (aa 33-316) is composed of four highly conserved 
70 amino acid repeats (aa 33-85,105-157,189-241,264-316), containing the 
Ca2+ and phospholipid-binding sites. N-myristoylation sites were identified at 
as 84-89 (GLITSS) and as 105-110 (GTDEGC) and ASN-glycosylation sites 
were identified at as 45-48 (NRTL) and as 127-130 (NITY). 
3.2.2 Xanx-4 is expressed at the right time to have a role in pronephric 
specification and organogenesis. 
In order to investigate the possibility of Xanx-4 being involved in organogenesis 
of the pronephros, it was necessary to discover when the gene is expressed 
during embryonic development. Total RNA was extracted from egg and embryo 
stages 32 cell through to 41 and subjected to RT-PCR using primers designed 
specifically against Xanx-4. The temporal expression profile of Xanx-4 
transcripts was revealed as shown in figure 3.4. Maternal expression of Xanx-4 
was detected in the egg but subsequently declined rapidly and was substantially 
reduced by the 32-cell stage. Zygotic expression was detected at a very low level 
between stages 9-12.5 and at a significantly increased level at stage 13. This 
coincides with the time of pronephric tubule specification (Brennan et al., 1998). 
Expression then continues at a similar level up to and beyond the stage when the 
pronephros becomes functional (stage 37). ODC was used as a loading control. 
3.2.3 Xanx-4 transcripts are present throughout the Xenopus laevis oocyte. 
In order to investigate possible roles for the maternal Xanx-4 transcripts, 
localisation of Xanx-4 transcripts in oocytes was determined. Oocytes were snap 
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Figure 3.4: Xanx-4 is expressed at the right time to have a role in pronephric 
specification and organogenesis. The temporal expression profile of Xanx-4 
transcripts was revealed by RT-PCR. Total RNA extracts from egg and stages 32 
cell through to 41 were subjected to RT-PCR using primers designed specifically 
to Xanx-4. The figure shows maternal Xunx-4 expression in the egg, which is 
barely detectable by the 32 cell stage. Zygotic transcription was detected at a 
very low level between stage 9-12.5, which is substantially increased by stage 13 
and persists through to stage 41. ODC was used as a loading control. The 
controls used were, no input of RNA into the reverse transcription (-RNA), no 
input of reverse transcriptase (-RT) and no input of cDNA into the PCR reaction. 
The O. 2µ1, O. 41A 0.8µl and 1.6µ1 input cDNA into the PCR reaction were 
included so as to ensure the PCR was within the linear range. 
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frozen on dry ice and manually dissected into animal and vegetal poles. Groups 
of five poles and whole oocytes (in duplicate) were subjected to RT-PCR using 
Xanx-4 specific primers (figure 3.5). It was found that Xanx-4 transcripts are 
present in virtually equal amounts in the animal and vegetal poles of the Xenopus 
oocyte. No specific localisation of Xanx-4 transcripts in the oocyte was therefore 
observed. ODC was used as a loading control. 
3.2.4 Xanx-4 protein is localised to all fractions of the Xenopus oocytes. 
The subcellular localisation of a given protein can often help to elucidate 
possible roles of that protein in a given tissue. In order to ascertain the 
localisation of Xanx-4 protein in oocytes, subcellular fractionation of Xenopus 
oocytes was conducted. Due to the lack of an anti-Anx-4 antibody which could 
be used to detect Xanx-4 in Western immunoblotting, an experiment involving 
labelling protein translated from exogenous injected Xanx-4 mRNA was 
designed. 
Oocytes were injected with Xanx-4 mRNA, incubated overnight in 35S- 
methionine. Groups of five oocytes were enucleated, and the remaining tissues 
subjected to sucrose gradient fractionation. The sucrose layers were selected so 
as to allow clean separation of cytosolic and membrane fractions. Samples taken 
from the sucrose gradient along with the appropriate nuclear fraction (equal 
relative amounts) and a sample of incubation medium, were denatured at 95°C 
and subjected to SDS-PAGE and autoradiography. Notwithstanding the 
assumption that protein translated from exogenous injected mRNA will localise 
to the same region as endogenous protein, the experiment included carefully 
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Figure 3.5: Xanx-4 transcripts are present throughout the Xenopus 
laevis oocyte. Oocytes were manually dissected into animal and vegetal 
poles and duplicate samples were subjected to RT-PCR using Xanx-4 
specific primers. ODC was used as a loading control. Xanx-4 transcripts 
were detected at equal levels in both the animal and vegetal pole 
samples. The controls used were, no input of RNA into the reverse 
transcription (-RNA), no input of reverse transcriptase (-RT) and no 
input of cDNA into the PCR reaction. The 0.2µI, O. 4pl, 0.8µI and 1.6µl 
input cDNA into the PCR reaction were included so as to ensure the 
PCR was within the linear range. 
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chosen controls. mRNA, prepared from a range of clones with known protein 
size and specific localisation in oocytes, was injected into oocytes which were 
then analysed in the same way. The controls used were as follows; Xmad2, 
58kDa, predominantly cytosolic, small amount nuclear membrane (Graff et al., 
1996); Xsox 17(3, doublet 50-54kDa, nuclear (Hudson et al., 1997); O1 XAR 1 
(truncated activin receptor), 30kDa, plasma membrane (Hemmati-Brivanlou & 
Melton 1992). All control proteins localised to the expected fraction. The 
analysis revealed that Xanx-4 protein is present in approximately equal 
proportions in the cytosol, nuclear and plasma membrane fractions, throughout 
the oocyte but is not exported across the plasma membrane into the incubation 
media (figure 3.6). 
3.2.5 Expression of Xanx4 transcripts is restricted to the otic vesicle and to 
the pronephric tubules in Xenopus laevis embryos 
To test whether the active transcription detected in the stage series RT-PCR 
experiment (figure 3.4) was localised to particular tissues in the developing 
embryo, wholemount in situ hybridisation was carried out on a range of stages 
of albino Xenopus laevis embryos. The protocol was performed using a DIG 
labelled Xanx-4 antisense probe prepared from full-length cDNA clone in 
pGEM-T Easy (Appendix 1). For the antisense probe the construct was 
linearised with NcoI and transcribed with Sp6 RNA polymerase and for sense 
control probe the construct was linearised with Sall and transcribed with T7 
RNA polymerase. Xanx-4 transcripts were detected in the pronephric anlagen 
throughout organogenesis. 
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Figure 3.6: Xanx-4 protein is localised to all fractions of the Xenopus oocytes. 
Oocytes injected with Xanx-4 mRNA were incubated overnight in 35S-methionine, 
subjected to sucrose gradient fractionation, SDS-PAGE and autoradiography. The 
results show that Xanx-4 protein is localised to all subcellular fractions isolated in 
equal proportions, and is not transported out of the cell. Uninjected, Xmad2, 
Xsoxl7ß and ActivinR were used as controls for the fractionation. The control 
mRNA translated to a protein of the correct size and appear in the appropriate 
fraction as previously described. 
72 
At stage 26, Xanx-4 transcripts were detected in the pronephric anlagen and in 
the otic vesicle (figure 3.7A, 0: otic vesicle, P: pronephric anlagen). Expression 
in the otic vesicle was not detected in later stages. As the pronephric tubules 
continue to develop transcripts were detected specifically in the tubules, at stage 
36/37 (figure 3.7C) around the time when the pronephros becomes functional, 
and through and beyond maturation (elongation and coiling) of the pronephric 
tubules to stage 42 (Figure 3.7D). Transverse sections of stage 26 embryo 
(figure 3.7F) shows otic vesicle staining (0: otic vesicle), and stage 42 embryo 
(figure 3.7G) revealed specific pronephric tubule staining. A sense Xanx-4 
control probe produced no staining pattern in embryos at any stage (figure 3.7B 
stage 26 and 3.7E stage 42). 
3.2.6 Expression of Xanx4 protein is restricted to the apical surface of 
pronephric tubules in Xenopus laevis embryos 
The distribution of a particular protein, within a given tissue, will often give 
insights as to its function. In an attempt to establish the localisation of Xanx-4 
protein within the developing embryo of Xenopus laevis wholemount anti- 
annexin N antibody staining was carried out using alkaline phosphatase 
conjugated secondary and NBT-BCIP substrate for the colour reaction. For the 
sections FITC conjugated secondary was used. In the absence of a Xenopus 
laevis anti-annexin IV antibody, two antibodies raised against annexin IV in 
other species, and previously published, were used. Firstly, monoclonal antibody 
AS 17, raised in mouse against human annexin IV, has been shown to react 
specifically with human annexin IV (Satoh et al., 1997). AS 17 cross reacts with 
Xanx-4 and was used in wholemount immunohistology on Xenopus laevis 
73 
Figure 3.7 
f-I 
A 
D 
0 
)#A 
c4ýa ', L! 
4 1 l: 
F 
p 
vf, 
G. 
74 
Figure 3.7: Wholemount in situ hybridisation of Xenopus laevis embryos using 
Xanx-4 DIG labelled antisense RNA probe. A: Stage 26 embryo expression of 
Xanx-4 is restricted to the pronephric tubule anlagen (PA) and to the otic vesicle 
(0). B: Sense Xanx-4 probe control, no staining pattern. C: Stage 36 embryo Xanx-4 
expression restricted to the pronephric tubules (P). D: Stage 42 embryo Xanx-4 
transcripts located specifically to the pronephric tubules (P). E: Stage 42 embryo 
sense probe control shows no staining pattern. F: Section of stage 26 embryo shows 
otic vesicle staining (0) and G: Section of stage 42 embryo shows Xanx-4 
transcripts are restricted to the pronephric tubules (P). 
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embryos. The staining pattern shows Xanx-4 localisation to the pronephric 
tubules from stage 38 (figure3.8A) and at stage 40 (figure 3.9B & 3.8C). Some 
staining is also seen in the proctodeum at these stages with the AS 17 antibody. 
Secondly, monoclonal anti-annexin IV antibody BL7B 1, raised in rat against 
rabbit annnexin-4 has been shown to react specifically with rabbit annexin 
IV(Massey et al., 1991a), and cross-reacts with the Xanx-4 protein. The staining 
pattern observed, with BL7B 1 antibody, indicates that Xanx-4 protein is 
specifically localised to the pronephric tubules of Xenopus laevis embryos at 
stage 40 (Figure 3.8D & 3.8E). BL7B 1 staining of transverse sections of stage 40 
embryos reveals Xanx-4 is located on the luminal side of the tubule and is 
probably confined to the apical membrane of the pronephric tubule epithelium 
(Figure 3.8F). 
3.2.7 Expression of Xanx-4 is restricted to specific organs in the adult frog. 
To further investigate the dynamic developmental expression profile of Xanx-4, 
northern blot analysis of RNA isolated from dissected adult organs was carried 
out (Figure 3.9). RNA was isolated from dissected adult organs using Trizol 
reagent. Approximately 30µg of RNA was loaded onto a formamide/agarose gel 
and separated according to manufacturer's recommendations (figure3.9A). The 
RNA was transferred onto nitrocellulose membrane by capillary action in lOx 
SSC buffer over 48 hrs. After baking the membranes were probed using a 
32PaGTP labelled 3' Xanx-4 probe. The membranes were washed and exposed to 
X-ray film. Transcripts of approximately 1600 bases were detected at the highest 
level in the gall bladder, duodenum and ileum. Lower levels were detected in the 
lung, kidney, ovary, testis, stomach, rectum, bladder, spleen and pancreas 
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Figure 3.8: Wholemount anti-annexin IV antibody staining on Xenopus laevis 
embryos. Using anti-annexin IV antibody AS17, Xanx-4 protein is localised to the 
pronephric tubules (P) and the proctodeum at stage 37 (figure 3.8A) and stage 40 
(figure 3.8B & 3.8C). Wholemount immunohistochemistry using anti-annexin IV 
antibody BL7B 1 localises Xanx-4 protein specifically to the pronephric tubules (P) 
at stage 42 (figure 3.8D & 3.8E). Cryostat section of stage 42 Xenopus laevis 
embryo using antibody BL7B 1 and FITC secondary localises Xanx-4 protein to the 
luminal surface of the pronephric tubule epithelium (figure 3.8F). 
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Figure 3.9. Northern blot analysis of RNA isolated from dissected adult 
organs. (A) Using 3' Xanx-4 probe Xanx-4 transcripts were detected at high 
levels in the gall bladder and intestine, at lower levels in tadpole, lung, kidney, 
ovary, testis, stomach, bladder, spleen and pancreas. No transcripts were 
detected in neural tissues, heart, liver, muscle or skin. (B) Ethidium bromide 
stained agarose gel showing RNA loadings for different adult tissue types prior 
to transfer. 
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(figure3.9A). No Xanx-4 transcripts were detected in the brain, spinal chord, 
heart, liver, muscle or skin. All the organs in which transcripts were detected 
contain significant quantities of polarised epithelial tissues, thus correlating with 
the observed polarised expression of the Xanx-4 protein (section 3.2.6). 
3.3 Discussion 
3.3.1 Sequence analysis, protein structure and motifs 
Sequencing of the K2 cDNA clone and comparison to Genbank database 
identified it as the Xenopus laevis orthologue of human annexin IV. The 
predicted amino acid sequence shows that Xanx-4 has 69-74% identity with 
annexin IV sequenced in other vertebrate species. Surprisingly, of those 
vertebrate annexin IV sequenced so far, Xanx-4 has the highest sequence identity 
with bovine annexin IV (74%) and lowest sequence identity with the more 
phylogenically closely related medaka fish (69%). This may be indicative of 
divergent evolution (Morgan and Fernandez., 1997). 
Annexins have a common primary structure constituted of two different regions, 
the unique N-terminal domain and the highly conserved C-terminal domain 
(Raynal & Pollard et al., 1994). Through a motif search on the deduced amino 
acid sequence it was discovered that Xanx-4 contained a four fold repeat of the 
70 amino acid domain signature that identifies it as an annexin family member. 
The annexins possess a novel conserved type II Ca2+ binding motif that contains 
the sequence [(Leu/Met)-Lys-Gly-X-Gly-Thr-40X-acidic residue]. Xanx-4 
contains two of these active calcium-binding sites that are located in the first and 
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forth loops of the annexin core domain. These sites are thought to mediate the 
association of annexins with phospholipid membranes (Raynal and Pollard, 
1994). 
In contrast with the C-terminal domain, the sequence and length of the N- 
terminal domain is extremely variable amongst annexin family members 
(Morgan and Fernandez, 1997). It is this region which is though to confer the 
particular specificity of a given annexin. On examination of the Xanx-4 N- 
terminal domain a number of motifs, common to annexin family members, were 
discovered. Both protein kinase C (PKC) and casein kinase 2 (CK2) sites, which 
suggest that Xanx-4 exsists in activated and deactivated states. Two N- 
myristoylation sites and two ASN-glycosylation sites were also identified in 
Xanx-4. These sites are known to be present in molecules involved in membrane- 
cytoskeletal events including membrane-trafficking (Stryer, 1995). 
3.3.2 Maternal Expression of Xanx-4 
Xanx-4 transcripts are present in the oocyte as a maternal pool that is much 
reduced by 32-cell stage and by stage 9 is barely detectable (figure 3.4). It has 
been shown that these transcripts are present evenly throughout the oocyte (ie. 
not specifically localised) (figure 3.5). Although it is not certain whether these 
transcripts are translated, the result in figure 3.6 shows that injected exogenous 
mRNA is translated. Therefore, Xanx-4 is not specifically localised to one 
region of the oocyte but spread throughout the subcellular compartments in 
approximately equal amounts. 
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Annexins of lower vertebrates cloned thus far display maternal expression. Both 
Xenopus annexin II and annexin VII have two phases of expression one maternal 
and one zygotic (Izant & Bryson 1991, Srivastava et al., 1996). Additionally, the 
maxl-4 medaka annexins are expressed maternally and zygotically (Osterloh et 
al., 1998), as are M. fossilis annexin I-V (Ivanenkov et al., 1994). 
The presence of maternal pool of annexins in the oocyte/egg has suggested their 
involvement in events occurring during fertilisation. It has been suggested that 
annexins may be involved in cortical granule exocytosis (Ivanenkov et al., 1994). 
3.3.3 Zygotic embryonic Expression of Xanx-4 
RT-PCR stage series (figure 3.4) demonstrates that upregulation of zygotic Xanx- 
4 occurs from stage 13 and continues at a similar level through embryonic 
development to stage 41. Stages beyond this point were not analysed. 
By in situ hybridization Xanx-4 transcripts are first detected in the pronephric 
anlagen from stage 26 (figure 3.7). Interestingly, this coincides with the time of 
lumen formation in the pronephric tubules. This may reflect a condensation and 
polarisation of the tubule epithelium. Transcripts are detected in the pronephric 
tubules at all stages of organogenesis. Xanx-4 is specific to the tor-shaped 
pronephric tubules (stages 35-38) and during later stages of elongation and 
coiling (stages 40+). The highly specific expression profile of Xanx-4 during 
embryonic development suggests a role for Xanx-4 in the formation and 
maturation of the pronephric tubules. 
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Xanx-4 protein is detected specifically in the apical domain of the functional 
pronephric tubules, which is in agreement with studies on annexin IV in other 
species (Kaetzel et al., 1989; Kaetzel et al., 1994; Mayran et al., 1996). This may 
reflect a role for Xanx-4 in the function of the pronephros. 
Expression of Xanx-4 transcripts in the otic vesicle is not surprising as almost all 
genes expressed in the pronephros identified so far display otic vesicle staining 
(Brändli, 1999). This may reflect the common anlagen of the two structures. It is 
also interesting to note that a number of human disorders with kidney phenotypes 
also involve ear abnormalities (Abdelhak et al., 1997, Kohlhase et al., 1998, 
Favor et al., 1996). 
The expression pattern of the two other annexin family members characterized in 
Xenopus embryos is less specific. Xenopus annexin 11 is expressed in tailbud 
embryos at low levels in the brain and muscle, at higher levels in the heart, liver 
and kidney and highest in the skin (Izant and Bryson., 1991). Studies conducted 
on Xenopus annexin VII have shown that it is expressed in muscle, heart and 
brain in tailbud stage embryos (Srivastava et al., 1996). 
The expression pattern of annexin IV in a number of fish species is far less 
specific than Xanx-4. Four annexins maxl -4 have been cloned from Oryzias 
latipes Killifish Medaka. Max2 is assumed to be the fish homologue of annexin 
IV (59% identity). The expression pattern of max2 by in situ hybridization 
showed transcripts are present in the primordial stomach and in the floor plate 
during stages 26-28 and from stage 30-33 transcripts were detected in the cloaca 
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and in the floor plate (Osterloh et al., 1998). Five annexins have been cloned 
from Misgurnus fossilis eggs (Ivanenkov et al., 1994). 
Interestingly, the expression pattern of annexin IV mouse and rat embryos is 
restricted to neural tissues. Murine annexin IV is expressed in the notochord 
from E8.5, in the floor plate at E9.5 and in the roof plate at E10.5. Annexin IV is 
detected from caudal spinal cord, through the brain stem up to the diencephalon 
and lamina terminalis, in glial cells, sensory neurons and their axons, and ventral 
motor neurons in the spinal chord (Hamre et al., 1996). The expression pattern 
in rat embryos follows an almost identical pattern (Naciff et al., 1996). 
The expression of Xanx-4 is highly specific to the pronephric tubules during 
organogenesis. The temporal expression pattern of Xanx-4 coincides with the 
specification, development and function of the pronephric tubules during 
embryogenesis of Xenopus laevis. Together, these observations implicate Xanx-4 
in the development of the pronephric tubules. It is expressed in the right place at 
the right time. Expression continues up to and beyond the time when the 
pronephros becomes functional, its location at the luminal surface implies Xanx- 
4 may have a role in the development and also in the function of the pronephric 
tubules. 
3.3.4 Expression of Xanx-4 in the adult frog 
The expression pattern of Xanx-4 in adult tissues by northern blot analysis, using 
a highly specific 3'UTR probe shows Xanx-4 to have tissue specificity. 
Although transcripts are present in the metanephros, the highest level of Xanx-4 
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expression is seen in the gall bladder and intestine. Low level expression is also 
seen in other epithelial tissues. 
In agreement with this result annexin IV has been found in adult epithelial tissues 
of other animal species; lungs (Sohma et al., 1995), intestines and pancreas 
(Massey et al., 1991b), liver (Boustead et al., 1993) and kidney. Interestingly 
Bovine annexin IV is located in the apical membranes of the proximal tubules in 
adult kidney (Kojima et al., 1994), but basolaterally in the rabbit adult kidney 
(Massey-Harroche et al., 1995). The common theme for annexin IV expression 
in adult tissues seems to be that of polarised epithelial tissue (Massey-Harroche 
et al., 1998). In many cases the pattern appears to be apical (Kaetzel et al., 1989, 
Kaetzel et al 1994, Mayran et al 1996). 
3.3.5 In conclusion 
All types of epithelia have one important function in common: they serve as 
selective permeability barriers, separating fluids on each side that have different 
chemical compositions. The fact that Xanx-4 is specifically located to the apical 
membrane of the pronephric tubule epithelia suggests an involvement in 
transcellular transport. This could involve transmembrane or membrane bound 
receptors and/or signalling their pathways; channels or pores and/or their 
regulation; endocytosis or exocytosis; protein chaperoning or cytoskeletal 
architechure. Current literature suggests an annexin family member candidate for 
each of these functions in vitro (Raynal and Pollard, 1994). The results achieved 
in this chapter provided a platform on which to mount the search for a function 
of Xanx-4 in the pronephric tubules in Xenopus laevis. 
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Chapter 4 The effect of overexpression of Xanx-4 on pronephric structure in 
Xenopus laevis. 
4.1 Introduction 
Injection of mRNA into cleavage stage Xenopus embryos (overexpression) is 
often used to assess the developmental consequences of elevation of activity of a 
gene (Kreig and Melton, 1987). Increased activity can be used to determine the 
function of a particular protein during development. If the elevated expression 
causes specific reproducible developmental changes, this may indicate the 
normal function of the gene. The mRNA is translated immediately after its 
injection and depending on the longevity of the mRNA, can continue to exert an 
effect up to swimming tadpole stages. This results in expression, inconsistent 
with the normal timing of expression of the gene. Methods of temporal control 
include injection of inducible plasmid constructs (Kreig and Melton, 1987). 
However, this results in non-uniform expression (mosaicism) throughout a given 
tissue, since the DNA is episomal and the genes are not expressed from a stable 
position. This problem can be avoided by transgenic approaches that integrate 
multiple copies of a given gene into the host genome (Kroll and Amaya, 1996). 
Genes integrated under the control of a tissue specific promoter can allow 
expression of that gene at the right time and place. Constitutive promoters can 
also be used providing elevated expression of a gene in the wrong place at the 
wrong time, or the right place at the wrong time, which can also be extremely 
informative. 
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Overexpression of a number of pronephric genes in Xenopus laevis embryos has 
been used in previous studies to provide information on their function in 
pronephric organogenesis. 
XPax-2/XPax-8 and Xlim-1 
One such study involves the transcription factors XPax-2 and XPax-8 and their 
requirement for a co-factor Xlim-1. Ectopic co-expression of either XPax-2 or 
XPax-8 with Xlim-1 results in a synergistic effect producing increased 
pronephric tubule complexity, enlarged tubules and ectopic tubules while 
expression of either XPax-2 or XPax-8 alone has a moderate effect (Carroll and 
Vize, 1999). 
xWTJ 
In this study the authors showed that ectopic expression of xWT-1 inhibits 
pronephric tubule development, probably by repressing tubule specific gene 
expression in the portion of the pronephros fated to become tubules (Wallingford 
et al., 1998). 
Notch 
Targeted overexpression of notch signalling in the pronephric anlage both 
perturbed the characteristic pattern of the differentiated tubule network and 
increased the expression of early markers of pronephric cells, XPax-2 and xWTJ. 
Inducible constructs of active or dominant negative Su(H) were used to 
misactivate Notch signalling. The authors propose that Notch signalling plays a 
role in the early selection of duct and tubule cell fates as well as functioning 
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subsequently to control tubule patterning and development (McLaughlin et al., 
2000). 
The analysis of perturbed development generally includes inspection of the 
overall anatomy of the embryo and analysis using molecular makers and/or 
histology. Overexpression of some genes can lead to obvious changes in 
morphology that can be scored. Inclusion of a lineage tracer aids analysis of the 
phenotype by marking those cells or tissues carrying the injected protein 
especially in left versus right side comparisons. Persistence of a lineage tracer in 
the embryo also demonstrates how well the injected cells survive and contribute 
to a differentiated organ and controls for any altered fate in injected cells. 
Previous work has demonstrated that the dorsal and ventral C-tier blastomeres of 
a 32-cell stage embryo are fated to become the lateral plate mesoderm and 
pronephric anlagen (figure 4.1) (Dale and Slack, 1987; Moody, 1987). Injecting 
into one of the two C2/C3 blastomeres allows internal control left vs. right. 
The aim of the research contained in this chapter was to perform targeted 
overexpression of Xanx-4 in Xenopus laevis embryos and to analyse any changes 
in morphology of the pronephros, as indicated by wholemount 
immunohistochemical staining with the monoclonal antibodies 3G8 and 4A6. 
87 
Figure 4.1 
AP 
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Figure 4.1: Nomenclature of blastomeres at 32-cell stage Xenopus 
laevis blastula embryo (reproduced from Dale and Slack, 1987). C2 
and C3 blastomeres are fated to become pronephric anlagen (Moody, 
1987). 
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4.2 Injected Xanx-4 mRNA translates into a 34 kDa protein at high level in 
oocytes. 
It was firstly important to ensure that the Xanx-4 mRNA would translate 
efficiently when injected. Xanx-4 mRNA was prepared from the Xanx-41RN3 
construct (appendix 2) linearised with Sf1 and transcribed with T3 RNA 
polymerase using the mMessage mMachine kit (Ambion) and diluted to 
250µg/ml. lOng (36n1) was injected into each oocyte which were cultured 
overnight in BarthX and 35S methionine. The oocytes were homogenised and the 
equivalent of 0.5 of an oocyte was subjected to SDS-PAGE and autoradiography. 
Figure 4.2 shows the Xanx-4 mRNA was successfully translated into a protein of 
approximately 34kDa at a high level (arrow). 
4.3 Targeting of the Xanx-4 mRNA to the presumptive pronephric anlagen. 
To ensure that the mRNA injected was targeted to the right place (i. e. the 
pronephric anlagen), the blastomeres were co-injected with mRNA plus FLDX 
as a lineage label. 18n1 of the Xanx-4/FLDX mixture (0.5ng Xanx-4 
mRNA/lOng FLDX) was injected into the C2 or C3 blastomere of 32-cell stage 
Xenopus laevis embryos, cultured to stage 42 and fixed in MEMFA. After 
fixation, the embryos were immediately sorted for presence of FLDX (Figure 
4.3A). Embryos with expression in the pronephros were sorted into those 
showing fluorescence in either the left or the right sides using an UV filter on a 
Nikon microscope (e. g. figure 4C left side FLDX is present and 4D right side of 
same embryo, no FLDX present). Those without FLDX in the pronephric field 
were discarded. FLDX was also injected into the Al/A2 blastomeres (neural 
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Figure 4.2 : Expression of Xanx-4 in oocytes. Xenopus laevis oocytes were 
injected with Xanx-4 mRNA and cultured overnight at 18°C in BarthX with 35S 
methionine. The oocytes were homogenised and subjected to SDS-PAGE and 
autoradiography. Lanes 2 and 4: Xanx-4 mRNA translates at a high level in 
oocytes, resulting in a protein product of approximately 34kDa. Lanes 1 and 3: 
Uninjected control oocytes. 
Figure 4.3 
Figure 4.3: Targeted injections of Xanx-4 to the pronephros. Embryos were 
injected with FLDX and Xanx-4 mRNA at the 32-cell stage, cultured to stage 42, 
fixed and visualised under a microscope with UV filter. A: C2 blastomere 
injected, FLDX can be seen in the pronephros. B: Control, Al blastomere 
targeted, shows FLDX in the brain and spinal chord. C: C2 blastomere targeted, 
FLDX only seen in the left nephron and D: Right hand view of C, no FLDX 
observed, this provides the uninjected control nephron. 
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Figure 4.4 
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Figure 4.4: Analysis of Xanx-4 overexpression on pronephric phenotype. 
Wholemount double antibody staining of stage 38 Xenopus laevis embryos. The 
wholemount double antibody staining was carried out using the pronephric tubule 
(T) specific monoclonal antibody 3G8, (deep purple stain) and the pronephric duct 
(D) specific monoclonal antibody 4A6, (red stain). A: Uninjected control embryo, 
B: overexpression of Xanx-4 in the left nephron (FLDX observed) and C: 
untargeted right nephron (no FLDX observed) of the same embryo. Although on 
comparison the left and right pronephroi exhibit morphological variation this was 
deemed to be within normal variation. 
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anlagen) as a small control group for the injection targeting (figure 4.3B); these 
were not included in the phenotype analysis. 
4.4 Analysis of the Xanx-4 mRNA injected embryos by wholemount 
antibody 3G8 and 4A6 staining. 
In order to assess if any morphological changes had occurred to the embryos on 
overexpression of Xanx-4, the embryos were subjected to wholemount antibody 
staining using the tubule specific monoclonal antibody 3G8, and the duct specific 
monoclonal antibody 4A6 (figure 4.4). The embryos were scored for differences 
in morphology between the pronephroi on the uninjected side and injected side 
using the following criteria. 
A. Both sides same and normal 
B. Injected side different - small, less tubules 
C. Injected side different - large, more tubules 
D. Injected side different - narrow tubules 
E. Injected side different - wide tubules 
F. Injected side different - no tubules 
G. Gross phenotype abnormal 
H. Injected side: duct phenotype abnormal 
The control injected embryos were scored as left versus right to indicate the level 
of natural variation within an embryo. Two independent experiments were 
carried out to control for individual genetic differences in the frog colony (Figure 
4Ai, ii and 4Bi, ii). The summary of the scoring data for each experiment is 
shown in figures 4.5A and B. Although some pronephroi were considered 
abnormal, the trend (as shown in the graphs 4.5 A and B) is the same between 
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[igure 4.5A: ] 
Experiment 1: Xanx-4 Overexpression 
(i) Table shows phenotype scoring analysis of overexpression of Xanx-4 : Experiment 1 
Scoringcate ories A D E F Total G H 
Xanx-4 side vs uninfected L 31 0 2 4 37 5 6 
Xanx-4 side vs uninjected R 38 
4 
0 0 3 45 6 3 
Total 
No. as a percentage of total 
69 
84% c( 
0 
0% 
2 
2% 
7 
9% 
82 11 
13% 
9 
11% 
Controls 54 2 2 0 3 1 61 8 8 
No. as a percentage of total 88% 3% 3% 0% 4% 2% 13% 13% 
(ii) Graph represents phenotype scoring analysis of overexpression of Xanx-4 : Experiment 1 
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Figure 4.5: Morphogenic analysis of Xanx-4 overexpressing embryos. The C2/C3 
blastomeres of 32-cell stage embryos were co-injected unilaterally with Xanx-4 
mRNA and FLDX, cultured to stage 38 and sorted for the presence of FLDX 
marking left or right nephron. Those with no FLDX or FLDX not in the pronephros 
were discarded. The embryos were fixed and subjected to wholemount double 
antibody staining using 3G8 (tubules) and 4A6 (duct). Two independent 
experiments, using two different frogs were carried out. The embryos were then 
scored according to the categories listed in C, Xanx-4 injected side versus uninjected 
side. The results of the scoring data for experiment 1 is shown in figure 4.5A: table 
(i) and graph (ii). The results of the scoring data for experiment 2 (a repeat 
experiment) is shown in figure 4.5B: table (i) and graph (ii). Small numbers of 
embryos were considered to have abnormal phenotypes, but these also appeared in 
the control category and were accepted as within the normal level of variation. 
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ABCDEF 
Figure 4.5B 
Experiment 2: Xanx-4 Overexpression 
(i) Table shows phenotype scoring analysis of overexpression of Xanx-4 : Experiment 2 
Scoring categories A B C D E F Total G H 
Xanx-4 side vs uninjected L 24 2 1 0 2 4 33 13 3 
Xanx-4 side vs uninfected R 19 2 0 0 5 2 28 4 4 
Total 43 4 1 0 7 6 61 17 7 
No. as a percentage of total 70% 7% 2% 0% 11% 10% 28% 11% 
Controls 31 3 1 07 0 42 5 2 
No. as a percentage of total 74% 17% 5% 0% 17% 0% 12% 5% 
(ii) Graph represents phenotype scoring analysis of overexpression of Xanx-4 : Experiment 2 
Overexpression of Xanx-4: Experiment 2 
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ABCDEF 
Scoring Categories 
QC 
Key 
Scoring Categories 
A. Both sides same & normal E. Injected side different - wide tubules 
B. Injected side different - small, less tubules F. Injected side different - no tubules C. Injected side different - large, more tubules G. Gross phenotype abnormal 
D. Injected side different - narrow tubules H. Injected side duct phenotype abnormal 
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those with elevated Xanx-4 expression and controls. Therefore the aberrant 
phenotypes observed are considered to be within normal range. No gross 
morphological differences were seen between left and right Xanx-4 injected 
versus left and right control embryos. 
4.5 Longevity of injected message 
Injection of synthetic mRNA into Xenopus embryos allows the elevated 
expression of that gene, this will continue until the message is degraded. To test 
the longevity of the injected message and whether FLDX had any effect on this 
longevity, embryos were injected with Xanx-4 mRNA alone or FLDX plus Xanx- 
4 mRNA into C2/C3 of the 32-cell stage blastula. The embryos were cultured to 
stage 9,12.5,20,28 and 38 and at each stage the embryos were inspected under 
UV filtered microscope. For each type three embryos were selected in which 
lineage tracer could be visualised in the pronephric anlagen. At each stage the 
samples were pooled (i. e. 3 embryos per sample) and subjected to RT-PCR using 
Xanx-4 specific primers and EFlcc as a loading control (figure 4.6). Uninjected 
samples were also included as a control for Xanx-4 expression. In the Xanx-4 
mRNA injected embryos, a high level of Xanx-4 transcripts was detected at 
stages 9 and 12.5 but was much reduced by stage 20 and at normal levels 
(endogenous) at stage 28 and 38. This implies that a high level of exogenous 
message was present for translation between 32-cell stage and stage 20. The 
same result was seen in the Xanx-4 mRNA plus FLDX samples, confirming that 
FLDX had no effect on the level or longevity of the injected message. In the 
uninjected samples the endogenous level of Xanx-4 was detected. A phenotype 
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Figure 4.6: RT-PCR stage series showing longevity of injected Xanx-4 mRNA. 
Xenopus laevis embryos were injected with Xanx-4 mRNA alone or in combination 
with FLDX or un-injected as controls and cultured to the appropriate stage. The 
embryos were subjected to RT-PCR. Exogenous Xanx-4 mRNA persists at a high 
level to stage 9 and 12.5 and persists at a lower level until stage 20. The embryos 
coinjected with Xanx-4 mRNA and FLDX show a similar result. It appears that 
FLDX has no effect on the persistence of the message. EFIa was used as a loading 
control. The controls used were, (-RNA) no input of RNA into the reverse 
transcription, no input of reverse transcriptase (-RT) and no input of cDNA into the 
PCR reaction. The 0.2µ1,0.4µl, 0.8µl and 1.6µl input cDNA into the PCR reaction 
were included so as to ensure the PCR was within the linear range. 
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would therefore only be expected to occur if Xanx-4 functions prior to stage 20 in 
the presumptive pronephric anlagen. 
4.6 Discussion 
The exogenous Xanx-4 mRNA injected into the oocyte translated into a 34kDa 
protein the size of which is in agreement with annexin IV proteins in other 
species. 
The exogenous mRNA is not detected by RT-PCR past stage 20, it is possible 
that the mRNA may not persist long enough to have an effect on the pronephric 
tissues. The protein may still be present at much later stages, but due to the lack 
of an effective antibody to analyse this protein persistence, experiments were not 
carried out to analyse this. The Xanx-4 protein may require a binding partner or 
other factors to exert a full overexpression effect, as is the case with other 
Xenopus genes (Carroll and Vize, 1999). It is also possible that an early elevated 
expression (32-cell to stage 20) of Xanx-4 may not yield an aberrant phenotype 
as it is well tolerated at these stages and is not overexpressed at the right time and 
in the right place to have an effect. For example, xWnt-4 dorsally targeted 
overexpression can cause shortened body axis whereas vegetally targeted 
overexpression has no effect (Du et al., 1995, Ungar et al., 1995). 
In summary, overexpression of Xanx-4 mRNA in embryos showed that Xanx-4 
does not affect the phenotype of the embryos. The majority of the pronephroi 
were of normal phenotype and it was concluded that the overexpression of Xanx- 
4 in Xenopus embryos does not cause an aberrant phenotype. As shown by RT- 
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PCR, the use of FLDX as a lineage label did not seem to effect the longevity of 
the Xanx-4 mRNA, although it is possible that FLDX could effect the translation 
of this message. This was not tested but a further experiment could be conducted 
by co-injection of FLDX and Xanx-4 mRNA and western blot analysis using a 
suitable anti-Xanx-4 antibody. Annexins are known to bind with a variety of 
proteins in vitro, for example S 100 family (Raynal and Pollard, 1994), although 
this has not been studied in vivo in the kidney. Overexpression of Xanx-4 in 
conjunction with other pronephric genes may reveal Xanx-4 binding partners or 
synergistic effects. To test whether Xanx-4 is required at a later stage in order to 
exert morphological effects, a hormone inducible Xanx-4 construct could be 
prepared (for review see Mattioni et al., 1994) which would allow expression of 
Xanx-4 to be induced at later stages of development. 
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Chapter 5: Perturbation of Xanx-4 expression in Xenopus Iaevis by double 
stranded RNA. 
5.1 Introduction 
5.1.1 Studying gene activity in Xenopus by loss-of-function experiments. 
As outlined in the previous chapter, successful perturbation of gene expression in 
Xenopus is often carried out using gain-of-function assays. These include 
injection of mRNA, inducible DNA constructs and production of transgenic 
tadpoles and frogs. This type of experiment can demonstrate that a gene is 
sufficient to carry out a particular function but not whether it is required in vivo. 
In contrast, loss-of-function studies can provide evidence for a specific 
requirement in normal development. The classic approach for knockout, 
homologous recombination, is not open to researchers in Xenopus due to its 
pseudo-tetraploid genome and long breeding cycles (Graf and Kobel, 1991). 
However, a number of other approaches have been attempted, and although some 
have proved very informative, in many, the results are often difficult to achieve 
and analyse. Many of these studies often require a good basic knowledge of the 
gene and protein product in question. 
5.1.1.1 The dominant-negative approach 
The use of dominant-negative proteins has been shown to be particularly useful 
in Xenopus. Dominant-negative ligands (Hoppler et al., 1996), receptors 
(Hemmati-Brivanlou and Melton 1992), transcription factors (Mead et al., 1996) 
and signal transduction pathway components (Pierce and Kimelman 1995) have 
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all allowed the elucidation of activity of the particular proteins. Injection of 
specific antibodies, which bind to and block the function of a protein, has also 
been used to assess the requirement of particular proteins (Ruiz I Altaba et al., 
1991). 
5.1.1.2 Antisense DNA and RNA 
The injection of DNA expression constructs producing antisense RNA (Latinkic 
and Smith, 1999) or direct injection of antisense RNA into Xenopus embryos has 
been successful in reducing the amount of native protein synthesised, and led to 
phenotypes consistent with other signal reducing manipulations (Steinbeisser et 
al., 1995). There are, however, limitations to the former strategy due to the 
mosaic pattern of transcript expression obtained from injected plasmid vectors 
(Vize et al., 1991). Current opinion suggests that exogenous antisense RNA acts 
by blocking translation by binding to endogenous mRNA. Unfortunately, it 
seems that the results of antisense experiments in Xenopus can be inconsistent, 
and the outcomes are often difficult to interpret. Rebagliati and Melton, (1987) 
and Bass and Weintraub, (1987), have identified an `unwindase' activity that 
unwinds RNA: RNA duplexes. The activity is present at low levels in oocytes, 
increasing during oocyte maturation, and is present at high levels in early 
embryos, decreasing by late blastula stage. It is thought that this might explain 
why antisense RNA strategies sometimes fail to ablate gene expression in 
embryos. A novel application of antisense RNA technology has used 
hammerhead RNA structures, the authors suggest that both degradation and 
translation arrest of Histone HI RNA occurs in the presence of this specialised 
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RNA. Although this phenomenon has yet to be demonstrated using mRNA other 
than Histone HI (Steinbach et al., 1997). 
The most successful antisense experiments carried out so far are those that 
involve the depletion of maternal mRNAs in oocytes. The technique involves 
injection of short (-17mer) oligodeoxynucleotides (ODN) into oocytes, targeted 
to specific maternal mRNAs. These single stranded DNA molecules hybridise to 
their target mRNA and Ribonuclease H degrades the RNA strand of the 
heteroduplex. The oocytes are allowed to recover, implanted into a primed 
female and are then laid and fertilised in the normal way. Depletion of maternal 
ß-catenin mRNA by sequence-specific ODN resulted in embryos with a loss of 
axial structures, which could be rescued by injection of mRNA (Heasman et al., 
1994). 
5.1.1.3 Rescue of dominant-negative, antisense and antibody induced 
phenotypes 
Probably the most essential feature of analysing the specificity of dominant- 
negative, antisense and antibody experiments is the question of whether rescue of 
a resultant phenotype can be achieved. In the case of dominant-negative 
experiments, rescue may involve titrating in the wild-type gene product or 
activating the pathway downstream as a by-pass to the inhibition being exerted. 
Unless the phenotype observed can be successfully rescued by addition of sense 
mRNA in antisense experiments or protein in antibody depletion experiments, 
the results are difficult to interpret since the specificity of the effect is doubted. 
Until recently a simple method for specific and reproducible interference of gene 
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function was lacking for researchers using Xenopus laevis as a model vertebrate 
organism in developmental biology. 
5.1.2 Transgene induced gene silencing. 
With the widespread use of transgenesis, it was inadvertently discovered in a 
number of organisms that transgenes are able to elicit specific gene-silencing 
effects on the endogenous copies of the gene. This gene silencing has been 
termed co-suppression in plants and quelling in fungi (Napoli et al., 1990; 
Romano and Macino, 1992). 
Epigenic gene silencing has also been observed and is associated with X- 
chromosome inactivation in mammals (Lyon, 1961), the yeast mating locus, 
paramutation (Brink, 1956), Position Effect Variegation and telomeric regions 
(reviewed by Karpen, 1994). 
5.1.3 Transgene silencing in plants (co-suppression). 
Transgene-induced gene silencing, or co-suppression has been well studied in 
plants (for reviews see Vaucheret et al., 1998, Gura, 2000). The silencing can 
occur at the level of DNA as in transcriptional gene silencing (TGS) or at the 
post-transcriptional level (PTGS). In TGS, transcription does not occur, it is 
meiotically heritable (Assaad., 1993) and thus far, it has only been reported in 
plants. TGS occurs when multiple copies of a transgene are inserted into a plant 
genome. Specific DNA methylation and condensation follows, resulting in the 
silencing of the endogenous copies of the gene (Wassenegger et al., 1994). This 
silencing can occur not only locally but can transfer from one locus to another, 
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suggesting that different parts of the genome can communicate. It has been 
suggested that DNA-DNA interactions may be responsible, or that diffusable 
RNA from one locus can result in RNA-DNA interactions at another (Park et al., 
1996). Since epigenetic alterations in DNA methylation and condensation can 
block recombination, it is probable that the function of this phenomenon is a 
genome protection against harmful deletions during recombination events. This 
may also explain TGS in wild-type plants with large numbers of transposable 
elements. 
In contrast to TGS, PTGS involves high levels of transcription although mRNA 
does not accumulate. It is thought that PTGS is a natural post-transcriptional 
antiviral defence mechanism. PTGS generally occurs when a strong promoter of 
either a transgene or virus produces a high level of mRNA (Napoli et al., 1990). 
It appears that the cellular machinery recognises this abnormally high level of 
transcription and triggers a cascade of events resulting in the degradation of both 
the endogenous and transgene or viral RNA (Lindbo & Dougherty 1992). Due to 
the fact that transcriptional activity of the transgene is required, it is suggested 
that a diffusable RNA is the messenger of this silencing action. Grafting 
experiments have shown that silencing factors can spread systemically and can 
trigger silencing in other tissues (Palauqui et al., 1997; Voinnet et al., 1998). 
However, silencing of endogenous genes by PTGS has also been shown to occur 
on insertion of promoterless or weakly transcribed genes (Van Blokland et al 
1994), which may involve a different mechanism. 
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In Arabidopsis, an RNA-dependent RNA polymerase, Silencing Defective-1, 
(SDE1), has been found to be essential for the PTGS mediated by transgenes 
(Dalmay et al., 2000). Mourain et al., (2000) have shown that SGS2, an RNA- 
dependent RNA polymerase, and SGS3 are required for PTGS and natural virus 
resistance in Arabidopsis. It is current opinion that most cases of co-suppression 
in plants are due to genetic interference by double stranded RNA. 
5.1.4 Gene silencing in fungi (Quelling) 
A phenomenon, termed quelling, which is essentially similar to co-suppression in 
plants has been observed in fungi (Cogoni et al., 1996). It involves transgene- 
induced gene silencing. An elegant experiment in Phytophthora showed that on 
introduction of a transgenically silenced nucleus to a normal cell (creating a 
heterokaryon), the silencing was transferred to the wild-type nucleus and the 
endogenous gene was also silenced (van West et al., 1999). In Neurospora 
crassa, qde-1,2 &3 mutants are defective for quelling and are therefore 
implicated in the quelling process (Cogni & Macino, 1997). The QDE-1 protein 
is highly homologous to an RNA-dependent RNA polymerase (Cogoni & 
Macino, 1999) characterised in tomato (Schiebel et al., 1998). QDE-1 also 
shares homology with proteins from several different organisms C. elegans 
(ELEG1), S. pombe (POM) and A. thaliana (ARAB), indicating that gene 
silencing mechanisms may be conserved across species. 
5.1.5 RNA interference (RNAi). 
RNA interference (RNAi) is a recently discovered phenomenon that has been 
shown to actively and specifically silence gene expression in a range of 
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eukaryotic organisms, from trypanosomes to mouse. The silencing occurs in the 
presence of double-stranded RNA (dsRNA) and results in homologous mRNA 
being targeted for degradation. This RNA-triggered genetic-control mechanism 
of RNAi is currently of great interest and is thought to be related mechanistically 
to transgene silencing and transposition (for review see Plasterk and Ketting, 
2000, Bosher and Labouesse, 2000). 
5.1.5.1 Caenorhabditis elegans 
The efficacy of RNAi as a means of interfering with gene expression was 
originally discovered in C. elegans and since then, has become of great interest as 
it provides a potent and specific method of mRNA ablation (Fire et al., 1998. 
Since RNAi can provide a method of interfering with gene expression and 
thereby help elucidate the function of a gene, it has been used to systematically 
examine the function of genes on virtually whole chromosomes of C. elegans. 
Gonczy et al., (2000) synthesised dsRNA for 2232 genes (96%) encoded by 
chromosome III, and injected them into germline of C. elegans worms. Time- 
lapse DIC (differential interference contrast) microscopy was used to score for 
those dsRNAs that caused abnormalities in the first two cell divisions. 133 (6%) 
of the genes test produced such phenotypes. Of the 7 known genes on 
chromosome II with early cell division phenotypes, all showed RNAi phenotypes 
which matched the genuine mutant phenotype. 104 had no previous function 
identified in C. elegans, but have homologies to other species. 11 of the 133 were 
previously identified with a function in C. elegans. 18 of the 133 could not be 
ascribed a function on the basis of sequence homology and therefore this 
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approach has currently provided the best functional data available on these 
C. elegans genes. 
Fraser et al., (2000) constructed a library of bacteria expressing dsRNA for 2416 
of the genes on C. elegans chromosome I (87%); these dsRNAs were fed to the 
worms and RNAi induced phenotypes were scored under a dissecting 
microscope. 13% of the genes tested provided RNAi-induced phenotypes. This 
information increased the number of genes on chromosome I with known 
phenotypes from 70 to 378. Both of these studies validate the use of RNAi as a 
means to functionally analyse genome wide searches. 
Considerable work has been carried out in C. elegans to try to elucidate the 
mechanism by which RNAi works, and the genes involved in the pathway. In 
ego-1 mutants the worms are defective for germline RNAi effects (Smardon et 
al., 2000), ego-1 encodes an RNA dependent RNA polymerase and is the 
homologue of qde-1 in N. crassa. rde-1 and rde-4 mutants are also defective in 
RNAi but display no other aberrant phenotype (Tabara et al., 1999). The 
Drosophila homologues of rde-1 are piwi and sting. piwi is required for 
maintenance of germ cell populations whilst mutations in sting cause de- 
repression of a normally silent repetitive locus (Schmidt et al., 1999). In 
A. thaliana the rde-1 family members zwille and argonaute-1 are required for the 
maintenance of stem cell populations, possibly through repression of transcript 
processing (Lynn et al., 1999). Mutations in rde-2, rde-3, mut-2 and mut-7 
display reduced RNAi response and an increase in transposon mobilisation, 
providing evidence for a connection between transposon silencing and RNAi in 
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C. elegans (Tabara et al., 1999). Mutations in mut-2, mut-7, mut-8 and 'nut-9 are 
defective in transposon silencing, co-suppression and RNAi, suggesting 
mechanistic similarities between these three phenomena (Ketting and Plasterk, 
2000). Mut-7 protein has homology with RNaseD (3'-5' exoribonuclease) and a 
helicase, supporting the theory that RNAi works by dsRNA directed, enzymatic 
RNA degradation (Ketting et al., 1999). 
5.1.5.2 Drosophila melanogaster 
It has been shown that RNAi is a potent and specific inhibitor of gene activity in 
Drosophila melanogaster (Kennerdell & Carthew 1998). The authors injected 
into syncytial blastoderm embryos, dsRNAs designed to seven different genes, 
all of which generated loss-of-function phenotypes. Some generated null- 
phenotypes whereas others produced mosaicism close to the site of injection. In 
Drosophila, as with C. elegans, sub-stoichiometric levels of dsRNA are required 
to cause interference, dsRNA is more potent than ssRNA of either sense or 
antisense strands and a particular dsRNA may interfere with expression of highly 
related gene family members. By co-injection of two specific dsRNAs, this 
study demonstrates the use of RNAi as a method to overcome problems of 
redundancy amongst gene family members. Kennerdell and Carthew (1998) 
showed that Frizzled and Drosophila Frizzled-2 function redundantly upstream 
of zeste-white3 and downstream of wingless in the Wingless pathway. A number 
of other studies have also successfully used RNAi in Drosophila to inhibit gene 
expression and dissect signal transduction pathways (Clemens et al., 2000), 
providing phenotypic information on previously elusive mutants (Misquitta and 
Patternson, 1999). 
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In an attempt to unravel the mechanism underlying the effectiveness of RNAi, a 
cell free system using syncytial blastoderm extracts was developed (Tuscht et at., 
1999). The study demonstrated that RNAi in Drosophila involves the specific 
degradation of target mRNA by dsRNA, and not by ssRNA. The fact that pre- 
incubation of the dsRNA potentiated the interference and that the interference 
could be competed out, [although it did not effect translation of other 
(untargeted) mRNAs so the factors required are not part of the translation 
machinery] suggests that other factors are required to associate with the dsRNA. 
Zamore et at., (2000) used this in vitro system to find that RNAi mediated 
degradation is ATP dependent but uncoupled from mRNA translation. During 
the RNAi reaction the dsRNAs are processed into 21-23 length nucleiotides, a 
process which does not require target mRNA. But when the target is present, it 
too is cleaved into 21-23mers, suggesting that the cleaved dsRNAs are acting as 
templates or guides. 
A tissue culture system set up to test RNAi in the Drosophila Schneider-2 (S2) 
cell line, used transient GFP expression and stable chloramphenicol 
acetyltransferase (CAT) expressing S2 models to show a dose-dependent 
response using a 78bp dsRNA (Caplen et al., 2000). The 78bp dsRNA was a 
chemically synthesised oligomer rather than an in vitro produced gel-purified 
transcript. 
One study was set up to establish a biochemically tractable model in which the 
RNAi mechanism could be investigated. Hammond et al., (2000) showed that a 
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dsRNA-mediated response could interfere with transient lacZ and endogenous 
cyclin E expression. The result was potent and sequence specific, but required the 
dsRNA to be a minimum length of 300bp. Transfection with a 540bp dsRNA to 
cyclin E caused G1-phase cell-cycle arrest, thereby confirming inhibition of 
cyclin E expression and demonstrating a functional effect since cyclin E protein 
is required for cells to progress into S-phase of the cell cycle. dsRNAs of 540bp 
and 400bp were found to be effective whereas 300bp and 200bp were less potent 
and 50bp and 100bp were impotent. Using cell lysates from S2 cells, Hammond 
et al., (2000) identified an RNA-dependent nuclease, RISC (RNA-induced 
silencing complex), that specifically degrades exogenous transcripts homologous 
to the dsRNA into RNAs of approximately 25nt. Partial purification of the 
nuclease fraction of the cell lysates revealed that the lysates contained 25nt 
length RNA oligomers homologous to the target transcript. 
Hammond et al., (2000) suggest that RISC is capable of ablating target mRNAs 
through the generation of sequence-specific nuclease activity. Occasionally 
observing putative intermediates in this process, the absence of stable cleavage 
end-products indicated the activity of an exonuclease (perhaps coupled to an 
endonuclease). Hammond et al., (2000) speculate that the RNA nuclease may 
make an initial endonucleolytic cut and then non-specific exonucleases may 
complete the degradation process (Shuttleworth and Colman, 1988). 
Furthermore, the fact that LacZ and GFP can be successfully targeted 
demonstrates that an endogenous copy of the target gene is not required. 
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Elbashir et al., (2001 a) have demonstrated that 21 and 22nt RNA fragments are 
the sequence specific mediators of RNAi. These duplexes, short interfering 
RNAs (siRNA), are generated by RNase III-like processing from the initial 
dsRNA input. Using chemically synthesised siRNAs with 1-5nt 3' overhangs to 
mimic this process, targeted degradation of the mRNA occurs, at or near the 
centre of the sequence in the mRNA identical to the siRNAs. These results are in 
good agreement with previous studies. Hamilton and Baulcombe (1999) 
observed a population of small 25nt RNAs associated with PTGS in plants. 
Zamore et al., (2000) demonstrated in vitro in Drosophila blastoderm lysates that 
target mRNA is cleaved into 21-23nt by a process that requires ATP. They 
suggest that the cleavage sites are determined by a process that is able to measure 
the 21-23nt intervals. 
Recent studies have shown that the product of the Drosophila Dicer gene is an 
RNase III enzyme and when purified from syncytial blastoderm lysates is 
capable of cleaving dsRNA into 22bp fragments (Bernstein et al., 2001). The 
authors suggest that Dicer protein is involved in the initiation of RNAi. Several 
classes of RNase III enzymes have been identified, the first is the canonical 
RNase III which contains a single RNase III signature motif and a dsRNA 
binding domain. The second class, contains two RNase domains and one dsRNA 
domain with homologues in Drosophila (Drosha), C. elegans (CeDrosha) and 
human (Filippov et al., 2000, Wu et al., 2000). The third class is represented by 
the C. elegans gene K12H4.8, the protein product of which has an amino-terminal 
RNA helicase motif, two RNase II catalytic domains and a dsRNA-binding motif 
(Bass 2000, Cerutti et al., 2000). 
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5.1.5.3 Zebrafish 
Microinjection of RNAi to target specific genes with defined mutant phenotypes 
in zebrafish embryos induced specific embryonic defects that recapitulate those 
mutant phenotypes. The efficiency of producing defects was 20-30% with 
dsRNA compared to 2-3% with antisense RNA. The level of the targeted 
endogenous mRNA was significantly reduced and the effects were dose 
dependent (Wargelius et al., 1999). 
Li et al., (2000) showed that null phenotypes for Zf-1 (no tail) and Pax6.1 
(greatly reduced eye and forebrain development) could be recapitulated by 
injection of dsRNA. These specific phenotypes were the result of a 75% 
reduction in mRNA levels as detected by RT-PCR and the reduction rendered the 
expression of mRNA too low to be detected by in situ hybridization. Co-injection 
of Pax6.1 and Zf-1 dsRNA resulted in a phenotype equivalent to the combination 
null phenotypes. They also showed that transient GFP expression can be 
quenched by dsRNA directed to GFP. In a more recent study, despite the 
findings of Li et al., (2000), Oates et al., (2000) discovered that they were unable 
to reproduce specific effects on endogenous mRNA or to generate mutant 
phenocopies using dsRNA. They showed that injection of dsRNA causes non- 
specific effects on phenotype and non-specific depletion of numerous mRNA 
species, irrespective of the sequence of the dsRNA. This study brings into 
question the validity of the use of RNAi in the zebrafish model and the general 
applicability of this method of mRNA depletion. 
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5.1.5.4 Mouse 
It appears that a pathway, induced by dsRNA, can also specifically cause the 
suppression of gene expression in mammals. Potent and specific RNAi in mouse 
oocytes and embryos has been reported (Wianny and Zernicka-Goetz, 2000; 
Svoboda et at., 2000). Wianny and Zernicka-Goetz (2000) showed that dsRNA is 
a specific inhibitor of maternal c-mos in the oocyte and zygotic E-cadherin and 
GFP (transgenic) in the preimplantation embryo. The phenotypes observed were 
consistent with those reported for the null mutants of the endogenous genes. 
They showed by western blot that the protein levels of the target gene were also 
much reduced. The embryos subjected to RNAi mediated interference of GFP 
developed normally showing that RNAi does not interfere with normal 
development. 
5.1.5.5 Mammalian cell line studies 
Studies on RNAi in mammalian cell culture systems have demonstrated a 
prevalent and non-specific response to dsRNA using 3.8-1.6kb dsRNAs (Caplen 
et al., 2000, Ui-Tei et al., 2000). This result was somewhat surprising as dsRNA 
has been shown to cause PTGS in Rat-1 fibroblasts (Bahramiam and Zarbl, 
1999) and Elbashir et al., (2001b) showed that 21nt siRNA (short interfering 
RNA) duplexes specifically suppress expression of endogenous genes in 
different mammalian cell lines including one derived from human embryonic 
kidney. Current opinion suggests that RNAi involves initial input dsRNA 
(>100bp) being cleaved into siRNAs which are thought to be the mediators for 
targeting mRNA degradation. Therefore, there are currently conflicting views 
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concerning the efficacy or generality of RNAi and/or siRNA; only time and 
carefully controlled experiments will display the true picture. 
A possible explanation for non-specific effects of dsRNA is suggested to involve 
the interferon response. One component of the response to dsRNA in mammalian 
cells is mediated by the dsRNA-dependent protein kinase (PKR) which 
phosphorylates and inactivates the translation factor eIF2a, leading to a 
generalised suppression of protein synthesis and in some cases apoptosis (Meurs 
et al., 1990, Zhou et al., 1999). Additionally, Tuschl et al., (1999) tested dsRNA 
in vitro in rabbit reticulocyte lysate and wheat-germ extract translation system. 
They found that dsRNA caused a profound, rapid and non-specific degradation 
of mRNA when using the rabbit reticulocyte lysate and that this was not apparent 
when using the wheat-germ extract. Furthermore, in Zebrafish, specific RNAi 
interference is probably obscured by the rapid induction of non-specific antiviral 
responses by dsRNA (Zhou et al., 1999). 
5.1.5.6 Xenopus 
In Xenopus it has been reported that dsRNA can cause knock down of specific, 
exogenous and endogenous, gene expression by RNAi. Oelgeschläger et al., 
2000 showed that injection of Xenopus Twisted gastrulation (xTsg) dsRNA into 
Xenopus embryos specifically inhibited expression of secreted xTsg protein. xTsg 
ventralizes embryos by competing with CR1 (a product of chordin cleavage 
generated by Xolloid) for binding to BMP. Microinjection of xTsg dsRNA 
resulted in abnormal development of the postanal region, in particular loss of the 
ventral fin, an identical phenotype to that produced by injection of dominant- 
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negative xTsg (dn-xTsg) mRNA; it was not reported whether this phenotype 
could be rescued by co-injection of xTsg mRNA. Both xTsg RNAi and do-xTsg 
greatly potentiated the dorsalizing effects of injection of CR1; it was reported 
that these effects could be partially rescued by co-injection of xTsg mRNA but 
that the rescue was more efficient for dn-Tsg. 
Nakano et al., (2000) showed in embryos that expression of exogenous luciferase 
reporter under the control of a CMV promoter was reduced by around 40% on 
injection of luciferase specific dsRNA. They also showed that Mim-1 dsRNA 
injected into embryos resulted in embryonic phenotypes which included reduced 
eyes or anterior truncations. Embryos injected with Mim-1 antisense RNA also 
produced very similar phenotypes. Other defects were also seen including 
gastrulation defects, bent body or shortened A-P axis. These phenotypes were 
also present in the embryos injected with control dsRNA; the authors suggest that 
these may be non-specific dsRNA injection phenotypes. The level of endogenous 
Mim-1 mRNA was shown to be reduced by 30-40%, as shown by RT-PCR. 
5.1.5.7 Trypanosoma brucei 
In Trypanosoma brucei, Ngo et al., (1998) found that transient introduction of 
gene-specific dsRNAs resulted in selective degradation of the corresponding 
mRNAs. 
5.1.5.8 Planarians 
RNAi has been shown to have great potential for genetic analysis in organisms 
conventionally difficult to produce knockouts. In metazoan regeneration 
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research, the planarian is a classic model; one group have shown dsRNA 
knockouts for known genes involved in regeneration (Sanchez Alvarado and 
Newmark, 1999). 
5.1.5.9 Hydra magnipapillata 
RNAi has been shown to work well in Hydra magnipapillata and has allowed 
functional genetic tests to decipher known developmental gene functions 
(Lohmann et al., 1999). 
5.1.6 The specificity, length, localisation, delivery and heritability of dsRNA 
for RNAi. 
Evidence from numerous studies demonstrates that RNAi is sequence specific 
and the sequences must be carefully selected to avoid cross-interference (Fire et 
al., 1998). Although there is an example in C. elegans of RNAi induced by 
operon sequences, it is necessary for the sequences of RNAi to be exonic and not 
intronic (Bosher et al., 1999). Generally, the dsRNAs that have been shown to 
potently initiate RNAi are several hundred base pairs (bp) long. 
Work conducted by Parrish et al., (2000) analysed the specificity, length and 
location of dsRNAs required for RNAi in C. elegans. The homology of the 
dsRNA versus the target mRNA was tested; 96% identity sufficed but when the 
identity was less than 80%, the effects were much reduced. The positional 
specificity of dsRNA sequences along the target mRNA was assessed using 5 
non-overlapping dsRNAs and all but one gave the expected phenotype. The 
dsRNA that did not give the expected phenotype may have been directed to an 
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inaccessible region, possibly containing secondary structure in the mRNA. The 
length of dsRNAs required to trigger RNAi was tested. Double stranded RNAs 
between 26bp and 81bp were observed to trigger RNAi and cause the predicted 
phenotype although the 26bp dsRNA was required at 250 fold higher 
concentration than that of 81bp dsRNA (Parrish et al., 2000). 
In contrast, Hydra RNAi requires a minimum length of 100 bp dsRNA, less than 
100bp was ineffective, increasing from 100-450bp significantly increased the 
degradation of the corresponding mRNAs (Ngo et al., 1998). Tuschl et al., 
(1999) demonstrated that in Drosophila lysates, dsRNA of 49bp was ineffective 
whereas 149bp was enhanced and both 505bp and 997bp caused robust mRNA 
degradation. Another study in Drosophila analysed the mRNA substrate 
requirements, they found that substrates of 600bp and lkb were degraded, 
reduced activity was detected with 220 and 300bp, and 100bp was resistant 
(Hammond et al., 2000). 
Evidence from a number of studies suggest that the site of RNAi activity within 
the cell is cytoplasmic (Tuschl et at, 1999) and not nuclear. Work by Ngo et al., 
(1998) showed that levels of pre-mRNA are not affected (Northern blotting), so 
they suggested that either enzymes responsible for RNAi are not present in the 
nucleus or RNAi factors cannot act on pre-mRNA. 
The delivery method of choice for the dsRNA is generally microinjection 
directly into the cell (Trypanosomes, Hydra), syncitial blastoderm (Drosophila), 
blastula stage embryos and oocytes (Zebrafish, Xenopus and mouse) or liposome 
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transfection (cell lines). In C. elegans experiments the dsRNA is delivered by 
injection into the germline, but injection into the intestines is just as potent. It is 
suggested that the dsRNA is transported along with yolk proteins, which are 
made in the gut, to the gonads through pores in the sheath cells surrounding the 
germline. It has been shown that feeding C. elegans with bacteria expressing the 
target gene dsRNA targeting construct (Timmons & Fire, 1998, Kamath et al 
2000) or just soaking the worms in a solution containing dsRNA (Tabara et al., 
1998) is effective. 
Injection of dsRNA into the gonad of C. elegans results in RNAi in 100% of the 
Fl progeny but no inheritance beyond that generation. Methods of penetrance 
have been devised to overcome this problem in C. elegans (Tavernarakis et at., 
2000). 
Plasmids carrying inducible hairpin target gene constructs have been developed. 
The target sequence is organised as an inverted repeat and is injected into the 
gonad. Using a strong heat-shock promoter the RNAi phenotype is produced. 
Transgenic lines are easy to produce and the transgene is inherited by future 
generations. Large numbers of transgenic animals can be produced, and because 
it is inducible it allows stage specific gene analysis. Genes which have essential 
early function, especially those which are early mutant-lethal, can be studied at a 
later time point (Tavernarakis et al., 2000). This method has also been 
successfully applied to Drosophila (Kennerdall and Carthew, 2000). 
5.1.7 The current model of RNAi induced mRNA degradation 
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All studies conducted thus far agree that RNAi is mediated by sequence specific 
dsRNA, which is more potent than antisense or sense strands alone. The response 
to dsRNA is the degradation of it's specfic cognate mRNA which leads to the 
repression of target gene expression. Permanent gene modification or disruption 
of transcription have been experimentally eliminated as the mechanism of RNAi 
(Montgomery et at., 1998). 
The current accepted model of RNAi is as follows (figure 5.1): 
Step 1: Recognition and cleavage of dsRNA 
The process begins with the binding of a dsRNA-processing protein complex to 
the dsRNA (blue, sense and green, antisense ovals). The dsRNA is cleaved into 
21-23nt fragments with staggered 3' ends (siRNA) in a process likely to involve 
RNase III-like activity (Nicholson, 1999; Bass, 2000). Recently, an RNase III 
encoded by Drosophila Dicer, has been shown to be capable of cleaving dsRNA 
into 22bp fragments and is suggested to be involved in the initiation of RNAi 
(Bernstein et al., 2001). Interestingly, the Dicer protein also contains a PAZ 
motif restricted to gene families already known to be involved in RNAi induced 
mRNA degradation (qde-2 and rde-1). 
Step 2: Dissociation 
The resulting short interfering RNAs (siRNAs) remain associated with the RNA- 
specific proteins (blue and green ovals) and is termed the small interfering 
ribonucleo-protein complex (siRNP). The separation of the two strands of the 
dsRNA following cleavage may require an ATP-dependent RNA helicase, the 
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Figure 5.1: A proposed model for RNA interference (RNAi). The first step in 
RNAi is the recognition and processing of the dsRNA into 21-22nt short interfering 
RNAs (siRNA). The process involves the binding of the dsRNA-processing protein 
complex to the dsRNA (represented by the blue, sense and green, antisense ovals). 
This complex mediates the cleavage of the dsRNA into 21-22nt siRNAs with short 
(1-3nt) 3' overhangs. Step 2: The dsRNA-processing complex remains bound and the 
siRNAs are then dissociated by a helicase into ssRNAs forming the siRNPs. Step 3: 
Targeting and degradation of mRNA. Either the edonuclease contained in the siRNP 
or a recruited exonuclease would then cleave the mRNA: siRNA duplex at target sites 
in the centre of the 21nt siRNA, leading to depletion of target mRNA (Adapted from 
Elbashir et al., 2001a). 
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protein encoded by the mut-7 gene may be a candidate for this activity (Ketting, 
1999). 
Step 3: Targeting and cleavage of mRNA 
Each small RNA fragment causes site-specific cleavage of the target mRNA at 
the centre of each 21-23 nt fragment (Elbashir et al., 2001a). The siRNP would 
bind with the mRNA and either recruit a nuclease that cleaves mRNA or the 
endonuclease responsible for the dsRNA cleavage may also cleave the target 
mRNA. Alternatively, strand exchange could occur in siRNP that transiently 
holds a 21-23nt dsRNA fragment close to the mRNA (Zamore et al., 2000). The 
cleavage process may also involve genes such as the C. elegans rde-1 and rde-4. 
The small RNAs may be amplified by an RNA-directed RNA polymerase, for 
example ego-1 identified in C. elegans (Smardon et al., 2000) or qde-1 from 
N. crassa (Cogoni and Macino, 1999). It appears that both antisense and sense 
mRNA can be targeted for degradation by this process (Elbashir et al., 2001 a). 
Ultimately, the target gene expression is silenced. 
5.1.8 Aims 
The following chapter is an account of studies conducted to assess the use of 
dsRNA to perturb the expression of Xanx-4 in Xenopus laevis. 
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5.2 Results 
5.2.1 Production of single stranded and double stranded RNAs. 
In order to test whether RNAi could be used to interfere with Xanx-4 expression 
in Xenopus, a range of Xanx-4 dsRNAs were prepared. The PCR products, Short 
(74bp), Long-1 (367bp) and Long-2 (367bp) were generated using the primers 
shown in figure 5.2 and table 2.3. The Xanx-4 specific primers incorporated 
RNA polymerase binding sequences at their 5' ends, allowing for RNA synthesis 
from the PCR products generated. 
The Short and Long-1 PCR products were used as templates to generate the 
dsRNAs double stranded RNA-Short (dsRNA-S) and double stranded RNA- 
Long-1 (dsRNA-L1) respectively (figure 5.3). To generate control RNAs, Long- 
2 PCR product was used to synthesise the single stranded RNA sense strand 
(ssRNA-Sense) and antisense strand (ssRNA-Asense) (figure 5.4, i and ii). Equi- 
molar amounts of these two strands (ssRNA-Sense and ssRNA-Asense) were 
combined to produce the single stranded RNAs-not annealed sample (ssRNAs- 
Nann) (Fig 5.4, iii) and were also combined and annealed to produce the double 
stranded RNA-annealed sample (dsRNA-Ann) (figure 5.4, iv). 
All RNAs were visualised on an agarose gel (figure 5.5A), quantitated by UV 
absorbance and diluted to 500µg/ml. Xanx-4 mRNA was transcribed from Sf1 
linearised Xanx-41RN3 construct (appendix 2) using T3 polymerase and diluted 
to 250µg/ml. For a specificity control, XEZ (Barnett et al., 2001) dsRNA was 
transcribed using T7 polymerase from XEZ PCR product previously amplified 
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Figure 5.2 
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Figure 5.2: PCR products amplified from Xanx-4 cDNA used to generate 
dsRNA templates. The position of the primers L1(T7), L2(T7), L2(T3), 
S1(T7) and S2(T7) on the Xanx-4 cDNA template coding region is shown in 
the box. Below shows the combinations of primers used in the PCR to 
generate the individual PCR products Short, Long-1 and Long-2. 
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Figure 5.3 
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Figure 5.3: Generation of dsRNAs from PCR templates for use in RNAi 
experiments. The flow diagram demonstrates the process of generating the dsRNA- 
Long-1 and dsRNA-Short. To synthesise dsRNA-Long-1, Long-1 PCR product is 
amplified from Xanx-4 cDNA coding region template using primers L1(T7) and 
L2(T7) and transcribed using T7 RNA polymerase. To synthesise dsRNA-Short, Short 
PCR product is amplified from Xanx-4 cDNA coding region template using primers 
S 1(T7) and S2(T7) and transcribed using T7 RNA polymerase. 
123 
LI (T7) 
Xanx-4 5' 3 
template cDNA 
3' 117 
- coding region ý 
L5 (T3) 
PCR 
Figure 5.4 
1(T7) 
ti 
L2 T3 
Transcription Transcription 
using T7 RNA using T3 RNA 
polymerase polymerase 
Imo. 1(T7) 
L2(T3 
Mix 
L1(T7) 
L2(T3) 
Annealing reaction 
1(T 7) 
L2(T3),. - 
Treat with RNaseA 
Control RNA 
produced 
(i) 
ssRNA-Sense 
(ii) 
ssRNA-Antisense 
(iii) 
ssRNA-Not Annealed 
(iv) 
dsRNA-Annealed 
Figure 5.4: Generation of control ssRNAs and dsRNAs. The flow diagram 
demonstrates the process of generating the control ssRNA-Sense and ssRNA- 
Antisense, the ssRNA-Not annealed and the dsRNA-Annealed. To synthesise 
ssRNA-Sense and ssRNA-Antisense, Long-2 PCR product is amplified from Xanx-4 
cDNA coding region template using primers L1(T7) and L2(T3). A transcription 
reaction using Long-2 PCR product as template and T7 RNA polymerase results in 
the production of ssRNA-Sense, and using T3 RNA polymerase produces ssRNA- 
Antisense. Mixing of equal amounts of ssRNA-Sense and ssRNA-Antisense allows 
the production of ssRNA-Not annealed. The dsRNA-Annealed is prepared by mixing 
equal amounts of ssRNA-Sense and ssRNA-Antisense and performing an annealing 
reaction. The dsRNA-Annealed is purified by treatment with RNase A to degrade 
any contaminating ssRNAs. 
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Figure 5.5: The mRNAs, ssRNAs and dsRNAs used in RNAi experiments. 
An agarose gel showing all the ssRNAs and dsRNAs used in the RNAi 
experiments, including Xunx-4 mRNA, dsRNA-Short, dsRNA-Long and control 
RNAs (A). XEZ mRNA and XEZ dsRNA which, were used as controls (B). 
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with primers XEZR1 and XEZR2 (table 2.3), visualised on an agarose gel (figure 
5.5B) and diluted to 500µg/ml. 
5.2.2 RNAi prevents translation of exogenous mRNA in Xenopus oocytes. 
In order to determine whether dsRNA would effect the translation of exogenous 
Xanx-4 mRNA, Xenopus oocytes were injected with 2.5ng, 1. Ong or 0.5ng Xanx- 
4 mRNA alone or in combination with 5ng Xanx-4 dsRNA-L1 (transcribed from 
PCR product Long-1) or 5ng XEZ dsRNA. The oocytes were incubated 
overnight in 35S methionine and subjected to SDS-PAGE and autoradiography 
(figure 5.6Ai). Reduction of translation of Xanx-4 protein by dsRNA is seen in 
oocytes injected with l. Ong Xanx-4 mRNA and is greatly reduced in oocytes 
injected with 0.5ng Xanx-4 mRNA. Translation of Xanx-4 protein in oocytes 
injected with 2.5ng Xanx-4 mRNA is unaffected by Xanx-4 dsRNA. Therefore 
5ng of dsRNA is able to significantly reduce translation of Xanx-4 protein when 
0.5ng mRNA is injected. XEZ dsRNA had no effect on the translation of Xanx-4 
mRNA and the interference by Xanx-4 dsRNA is therefore specific. Figure 
5.6Aii shows a repeat of this experiment, the result is identical and therefore the 
effect of Xanx-4 dsRNA on Xanx-4 mRNA is reproducible. A further 
experiment that includes interference by dsRNA-S (transcribed from 74bp PCR 
product Short) is shown in figure 5.6B; Xanx-4 protein translation is perturbed 
by both of the dsRNAs, showing that in oocytes dsRNA from 74bp to 367bp can 
be effective in preventing Xanx-4 translation. 
To assess the effect of ssRNAs compared to dsRNAs, on the translation of 
exogenous Xanx-4 mRNA, oocytes were injected with 0.5ng Xanx-4 mRNA 
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Figure 5.6: Xanx-4 dsRNA-Long-1 and dsRNA-Short prevents translation of 
exogenous Xanx-4 mRNA in Xenopus oocytes. Xenopus oocytes were injected with 
2.5ng, 1. Ong or 0.5ng Xanx-4 mRNA alone or in combination with 5ng Xanx-4 
dsRNA-L l or 5ng XEZ dsRNA. The oocytes were incubated overnight in ; 'S 
methionine and subjected to SDS-PAGE and autoradiography. The results show that 
dsRNA-Long-1 is able to deplete Xunx-4 mRNA translation (At). It appears that Sng 
of Xanx-4 dsRNA is able to deplete 0.5ng of Xunx-4 mRNA. XEZ dsRNA no effect 
on translation of Xanx-4 mRNA. In a repeat of the experiment (Ai) similar results 
were observed. The results shown in B, demonstrate that Xanx-4 dsRNA-Short is also 
capable of depleting Xanx-4 mRNA translation to a similar extent to that of Xanx-4 
dsRNA-Long- 1. 
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alone or in combination with 5ng dsRNA-L1, dsRNA-S, ssRNA-Asense, 
ssRNA-Sense, dsRNA-Ann or ssRNAs-NAnn. The oocytes were incubated 
overnight in 35S methionine and subjected to SDS-PAGE and autoradiography 
(figure 5.7i). Reduction of Xanx-4 translation is observed when Xanx-4 mRNA is 
co-injected with dsRNAs, ssRNA-Asense and ssRNAs-NAnn. No reduction in 
Xanx-4 translation was seen when Xanx-4 mRNA is co-injected with ssRNA- 
Sense. Figure 5.7ii shows a repeat of this experiment and provides a similar 
result, although translation of Xanx-4 is slightly reduced by ssRNA-Sense. 
Therefore, both Xanx-4 dsRNA and ssRNA-Asense prevent translation of Xanx-4 
with a similar efficiency. 
5.2.3 Interference of endogenous Xanx-4 expression by RNA! in Xellopus 
oocytes. 
In order to determine whether the effect on protein expression in oocytes was due 
to interference by the RNAs at the level of mRNA, RT-PCR was carried out on 
Xenopus oocytes injected with the ssRNAs and dsRNAs. Oocytes were injected 
with 5ng of dsRNA-L1, dsRNA-S, ssRNA-Asense, ssRNA-Sense, dsRNA-Ann 
or ssRNAs-NAnn and incubated overnight in BarthX. Two groups of five 
oocytes injected with the RNAs and two groups of uninjected controls were 
selected at random and subjected to RT-PCR using Xanx-4 specific primers 
(Figure 5.8i). Xanx-4 expression is much reduced by ssRNA-Asense and 
ssRNAs-NAnn in one of the two duplicates and slightly reduced in dsRNA-L1 
and dsRNA-Ann. However, figure 5.8ii shows a repeat of this experiment where 
Xanx-4 expression is slightly reduced only in the dsRNA-S and dsRNA-L1 
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Figure 5.7: The effect of control Xanx-4 ssRNAs and dsRNAs compared to 
Xanx-4 dsRNA-Short and dsRNA-Long-1 on the translation of exogenous 
Xanx-4 mRNA in oocytes. Xenopus oocytes were injected with 0.5ng Xanx-4 
mRNA alone or in combination with 5ng dsRNA-L1, dsRNA-S, ssRNA-Asense, 
ssRNA-Sense, dsRNA-Ann or ssRNAs-Nann. The oocytes were incubated 
overnight in 35S methionine and subjected to SDS-PAGE and autoradiography (i). 
Reduction of Xanx-4 protein translation is observed when Xunx-4 mRNA is co- 
injected with the three dsRNAs, ssRNA-Asense and ssRNAs-Nann. No reduction 
in Xanx-4 protein translation is seen when Xanx-4 mRNA is co-injected with 
ssRNA-Sense. (ii) shows a repeat of this experiment and provides a similar result, 
although translation of Xanx-4 protein is slightly reduced by ssRNA-Sense. 
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Figure 5.8: Interference of endogenous Xanx-4 expression by Xanx-4 
dsRNA and ssRNA in Xenopus oocytes determined by RT-PCR. Oocytes 
were injected with 5ng of dsRNA-Ll, dsRNA-S, ssRNA-Asense, ssRNA- 
Sense, dsRNA-Ann or ssRNAs-Nann and incubated overnight in BarthX. 
Two groups of five oocytes injected with the RNAs and two groups of 
uninjected controls were selected at random and subjected to RT-PCR using 
Xunr-4 specific primers (i). Xanx-4 expression is much reduced by ssRNA- 
Asense and ssRNAs-Nann in one of the two duplicates and slightly reduced 
in dsRNA-Ll and dsRNA-Ann. However, a repeat of this experiment shows 
Xunx-4 expression is slightly reduced only in the dsRNA-S and dsRNA-Ll 
groups and no reduction was seen in ssRNA-Asense or ssRNAs-Nann (ii). 
EFI a was used as a loading control. 
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groups and no reduction was seen in ssRNA-Asense or ssRNAs-NAnn. 
Therefore it appears any reduction in Xanx-4 expression seen in the endogenous 
mRNA level is very small and not reproducible using oocytes from different 
frogs. 
5.2.4 Effect of RNAI on exogenous Xanx-4 mRNA in Xenopus oocytes. 
To test whether the reduction in Xanx-4 protein expression seen in the oocyte 
experiments (Figure 5.6 and 5.7) was due to an effect of the dsRNA on injected 
(in vitro synthesised) mRNA alone, with no detectable activity against 
endogenous mRNA, RT-PCR was carried out on oocytes co-injected with Xanx- 
4 mRNA and ssRNA or dsRNA. Xenopus oocytes were injected with 0.5ng 
Xanx-4 mRNA alone or in combination with 5ng of dsRNA-S, dsRNA-L1, 
ssRNA-Asense, ssRNA-Sense, dsRNA-Ann or ssRNAs-NAnn and incubated 
overnight in BarthX. Two groups of five oocytes injected with mRNA alone and 
in combination with each RNA together with two groups of uninjected controls, 
were selected at random and subjected to RT-PCR (Figure 5.9i). A slight 
reduction of Xanx-4 expression was seen in the groups injected with dsRNA-S, 
dsRNA-L1 and ssRNAs-NAnn. However, in a repeat experiment (figure 5.9ii) 
all RNAs lowered the level of mRNA detectable when compared to mRNA 
alone. It appears that the different RNA samples may indeed have an effect on 
the Xanx-4 mRNA level that is detectable, but in a non-reproducible manner. 
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Figure 5.9: The effect of Xanx-4 dsRNA and ssRNA on exogenous Xanx-4 
mRNA in Xenopus oocytes as determined by RT-PCR. Xenopus oocytes were 
injected with 0.5ng Xunx-4 mRNA alone or in combination with 5ng of Xunx-4 
dsRNA-S, dsRNA-L1, ssRNA-Asense, ssRNA-Sense, dsRNA-Ann or ssRNAs-Nann 
and incubated overnight in BarthX. Two groups of five oocytes injected with 
mRNA alone and in combination with each RNA together with two groups of 
uninjected controls, were selected at random and subjected to RT-PCR (i). A slight 
reduction of Xanx-4 expression was seen in the groups injected with dsRNA-S, 
dsRNA-Ll and ssRNAs-Nann. However, in a repeat experiment (ii) all RNAs 
lowered the level of mRNA detectable when compared to mRNA alone. EFIa was 
used as a loading control. 
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5.2.5 Interference of endogenous Xanx-4 expression by RNAi in Xenopus 
embryos. 
To investigate whether dsRNA would have an effect on endogenous Xanx-4 
mRNA expression in embryos, a pilot experiment was carried out. 1-cell 
Xenopus embryos were injected with 5ng dsRNA-L1 and cultured to stage 13. 
Six groups of two embryos injected with dsRNA and six groups of uninjected 
controls were selected at random and subjected to RT-PCR. Figure 5.10 shows 
that Xanx-4 expression is much reduced in the presence of dsRNA-L1 when 
compared to control embryos. However sample 5 did not show reduction of 
expression of Xanx-4 as a result of the injection of dsRNA. 
To further analyse the effect of dsRNA on Xanx-4 expression, 1-cell Xenopus 
embryos were injected with dsRNA-S, dsRNA-L1, ssRNA-Asense, ssRNA- 
Sense, dsRNA-Ann or ssRNAs-NAnn and cultured to stage 20. Two groups of 
five embryos injected with each of the ssRNAs or dsRNAs and two groups of 
uninjected controls were selected at random and subjected to RT-PCR. In direct 
contrast to the previous experiment (figure 5.10) figure 5.111 shows that Xanx-4 
expression is unaffected by the different dsRNAs and the ssRNAs. Similarly a 
repeat experiment (figure 5.11ii), using embryos from different frogs yielded the 
same result. These experiments suggests that dsRNA may indeed be able to 
affect levels of gene expression at certain embryonic stages, but in an unreliable 
and non-reproducible manner. 
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Figure 5.10: The interference of endogenous Xanx-4 expression by Xanx-4 
dsRNA-Long-1 in stage 13 Xenopus embryos determined by RT-PCR. 1-cell 
Xenopus embryos were injected with 5ng Xunx-4 dsRNA-Ll and cultured to 
stage 13. Six groups of two embryos injected with Xanx-4 dsRNA and six 
groups of uninjected controls were selected at random and subjected to RT-PCR. 
Xanx-4 expression is much reduced in the presence of dsRNA-L 1 when 
compared to control. embryos. However sample 5 did not show reduction of 
expression of Xanx-4 as a result of the injection of dsRNA. EFI a was used as a 
loading control. 
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Figure 5.11: The interference of endogenous Xanx-4 expression by Xanx-4 
dsRNAs and ssRNAs in stage 20 Xenopus embryos determined by RT- 
PCR. I-cell Xenopus embryos were injected with dsRNA-S, dsRNA-LI, 
ssRNA-Asense, ssRNA-Sense, dsRNA-Ann or ssRNAs-Nann and cultured to 
stage 20. Two groups of five embryos injected with each ssRNA, ssRNAs or 
dsRNA and two groups of uninjected controls were selected at random and 
subjected to RT-PCR (i). In direct contrast to the previous experiment (figure 
5.10) this result shows that Xanx-4 expression is unaffected by the three 
different dsRNAs, the two ssRNAs and ssRNAs Nann. Similarly a repeat 
experiment (ii), using embryos from different frogs yielded the same result. 
EF1 a was used as a loading control. 
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5.2.6 Persistence of dsRNA in Xenopus embryos 
Due to the interference of Xanx-4 expression by dsRNA observed in embryos 
harvested at stage 13 (Figure 5.10) and the lack of interference observed in 
embryos harvested at stage 20 (Figure 5.11), the persistence of dsRNA in 
Xenopus embryos was analysed in embryos at different stages of development. 1- 
cell Xenopus embryos were injected with dsRNA-S, dsRNA-L1, ssRNA-Asense, 
ssRNA-Sense, dsRNA-Ann or ssRNAs-NAnn and cultured to stage 12.5, stage 
25 and stage 35. Two groups of five embryos injected with each dsRNA and 
ssRNA and two groups of uninjected controls were selected at random at each 
stage and subjected to RT-PCR. PCR primers AN4-S and AN4-A (table 2.1) 
were used to detect the endogenous mRNA. AN4-A lies outside the dsRNA 
region (figure 5.12A) and so would fail to amplify the injected dsRNAs or 
ssRNAs. PCR primers within the region of dsRNA (figure 5.12A) were used to 
detect the endogenous mRNA and all injected RNAs except for dsRNA-S. No 
interference with Xanx-4 expression was seen in the presence of the dsRNAs or 
the ssRNAs at all three stages (figure 5.12B). Furthermore, all of the injected 
RNAs persisted until the latest stage harvested (stage 35). It therefore seems 
unlikely that the discrepancy between the two previous experiments (Figure 5.10 
and 5.11) was due to a lack of persistence of injected dsRNA. 
5.2.7 Effect of RNAi on exogenous Xanx-4 mRNA in Xenopus embryos. 
Due to the effect of injected dsRNA on exogenous Xanx-4 mRNA in Xenopus 
oocytes (Figures 5.6 and 5.7), an experiment was performed to ascertain whether 
dsRNA has an effect on exogenous injected Xanx-4 mRNA in Xenopus embryos. 
1-cell Xenopus embryos were injected with 0.5ng Xanx-4 mRNA alone or in 
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Figure 5.12: Longevity of Xanx-4 dsRNAs in Xenopus embryos determined by a 
stage series and RT-PCR. 1-cell Xenopus embryos were injected with dsRNA-S, 
dsRNA-L1, ssRNA-Asense, ssRNA-Sense, dsRNA-Ann or ssRNAs-Nann and 
cultured to stage 12.5, stage 25 and stage 35. Two groups of five embryos injected 
with each Xanx-4 dsRNAs or ssRNAs and two groups of uninjected controls were 
selected at random at each stage and subjected to RT-PCR. PCR primers AN4-S and 
AN4-A (table 2.1) were used to detect the endogenous mRNA (27 cycles) and not 
the injected ssRNAs and dsRNAs (A). AN4-A lies outside the dsRNA region and so 
would fail to amplify the injected dsRNAs and ssRNAs. PCR primers AN4-S and 
AN4-U were used to detect the injected dsRNAs and ssRNAs (25 cycles) but not the 
dsRNA-S. These primers would also detect the endogenous mRNA. No interference 
with Xanx-4 expression was seen in the presence of the dsRNAs or ssRNAs at all 
three stages analysed (B). Furthermore all of the injected RNAs persisted until the 
latest stage harvested (stage 35). It therefore seems unlikely that the discrepancy 
between the two previous experiments is due to a lack of persistence of injected 
dsRNA. EF1 a was used as a loading control. 
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combination with 5ng of dsRNA-S, dsRNA-L1, ssRNA-Asense, ssRNA-Sense, 
dsRNA-Ann or ssRNAs-NAnn and cultured to stage 20. Two groups of five 
embryos injected with each RNA sample and two groups of uninjected controls 
were selected at random and subjected to RT-PCR. The level of exogenous 
Xanx-4 mRNA was reduced slightly in the presence of all dsRNAs and ssRNAs 
(figure 5.13i). Similarly a repeat experiment (figure 5.13ii), using embryos from 
different frogs, yields the same result. 
5.3 The use of synthetic short interfering RNA (siRNA) to perturb Xanx-4 
expression in Xenopus laevis 
5.3.1 The advent of synthetic siRNA 
During the course of the dsRNA analyses just described (Section 5.2), work 
carried out by other groups demonstrated that the RNAi pathway in Drosophila 
involved the cleavage of dsRNAs into 21nt fragments which were then used as 
templates for the degradation of the target mRNA (Zamore et al., 2000). Due to 
the apparent lack of success with long dsRNAs in vertebrate species, Elbashir et 
al., (2001b) used synthetic 21nt dsRNA to specifically induce RNAi in 
mammalian cell lines. Their success in a number of cell lines (including a 
human kidney cell line) suggested the possibility of using 21nt dsRNA oligos 
which may be more potent and specific for vertebrate systems than the longer 
dsRNAs previously used. To test this in Xenopus laevis, siRNA were designed 
to Xanx-4 and tested in the following series of experiments. 
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Figure 5.13: The effect of Xanx-4 dsRNAs and ssRNAs on exogenous Xanx-4 
mRNA in Xenopus embryos. 1-cell Xenopus embryos were injected with 0.5ng 
Xanx-4 mRNA alone or in combination with 5ng of dsRNA-S, dsRNA-L I, ssRNA- 
Asense, ssRNA-Sense, dsRNA-Ann or ssRNAs-Nann and cultured to stage 20. Two 
groups of five embryos injected with each RNA sample and two groups of uninjected 
controls were selected at random and subjected to RT-PCR. The level of exogenous 
Xunx-4 mRNA was reduced slightly in the presence of all the three dsRNAs, two 
ssRNAs and dsRNA-NAnn (i). Similarly a repeat experiment (ii), using embryos 
from different frogs, yields the same result. EFI a was used as a loading control. 
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5.3.2 The design and preparation of the Xanx-4 siRNA 
The siRNA sequence was designed against the Xanx-4 5' coding region, which is 
the least conserved between annexin family members. This provided gene 
specificity and reduced the risk of cross-targeting with other annexins in Xenopus 
(figure 5.14). A 23nt region was chosen that contained the sequence 5'-AA- 
19N-TT-3' in the sense strand, 3'-TT-19N-AA-5' in the antisense strand, thus 
allowing the design of complemetary sense and antisense RNA oligos with two 
thymine deoxyribose overhangs. These overhangs have been shown to provide 
stability and assist in targeting (Elbashir et al., 2001b). The 19 nucleotide 
stretches were then converted to the corresponding RNA and ordered for 
synthesis (figure 5.13B). The usual considerations were applied as for primer 
design, less than 50% CG content and checking for possible hairpin loop 
formation. The oligos were deprotected, quantitated by UV absorption and the 
double stranded oligo prepared by annealing equi-molar amounts of the antisense 
and sense strands (see methods 2.10.2). The antisense, sense and double 
stranded siRNAs were diluted to 250mg/ml for the in vitro assay and 250gg/ml 
for the in vivo assays. 
5.3.3 Testing the effect of Xanx-4 siRNA in vitro 
It has been suggested that the reason for the lack of specificity of dsRNA in 
vertebrate systems may be due to the effect of dsRNA activating PKR and 
inducing the interferon response (Tuschl et al., 1999) (see section 5.1 . 5.8). To 
assess whether the Xanx-4 siRNA would induce non-specific blocking of 
translation in vitro the rabbit reticulocyte lysate systems was employed. 
Reactions containing 100ng Xanx-4 mRNA alone or in combination with 1µg 
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Figure 5.14: The sequence and position of Xanx-4 siRNA. The siRNA 
sequence was designed against the Xanx-4 5' coding region, which is the 
least conserved between annexin family members (A). A 23nt region was 
chosen that contained the sequence 5'-AA-19N-TT-3' in the sense strand, 3'- 
TT-19N-AA-5' in the antisense strand, thus allowing the design of 
complementary sense and antisense oligos with two thymine deoxyribose 
overhangs (red in B). The 19 nucleotide stretches were then converted to the 
corresponding RNA and ordered for synthesis (B). 
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Xanx-4 siRNA antisense, sense or double stranded and 10µg Xanx-4 siRNA 
double stranded, were incubated and labelled with 35S-methionine according to 
manufacturer's recommendations. Samples were subjected to SDS-PAGE and 
autoradiography. Xsox17ß mRNA was used as a specificity control for the action 
of siRNA (figure 5.15). The experiment shows that the 1µg siRNA (antisense, 
sense or double stranded) had no effect on translation of Xanx-4 mRNA. Even 
10µg siRNA did not effect translation of Xanx-4 mRNA. The translation of Xsox- 
17ß mRNA was also not affected by Xanx-4 siRNA. 
5.3.4 Xanx-4 siRNA does not have a marked effect on the level of Xanx-4 
mRNA in Xenopus laevis embryos. 
In order to test whether Xanx-4 siRNA effects the level of Xanx-4 mRNA in vivo, 
the following assay was conducted. Groups of 1-cell stage embryos were injected 
with 3.5ng (13.8n1) or 7ng (27.6n1) of siRNA antisense, sense or double stranded 
oligonucleotides and cultured to stage 13. Two groups of five embryos were 
selected at random from each sample set, together with two groups of five 
uninjected control embryos. Total RNA and cDNA were prepared and the 
samples subjected to RT-PCR, using gene-specific primers, and autoradiography 
(figure 5.16i). The Xanx-4 siRNA oligos had no marked effect on the level of 
Xanx-4 mRNA detected in any sample tested. The same result was observed in a 
repeat of the experiment (figure 5.16ii). ODC was used as a loading control. 
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Figure 5.15 The testing of Xanx-4 siRNA in vitro using rabbit 
reticulocyte lysate system. Reactions containing 100ng Xanx-4 
mRNA alone or in combination with 1µg Xanx-4 siRNA antisense, 
sense or double stranded or 10µg Xanx-4 siRNA double stranded, were 
incubated and labelled with 35S-methionine according to 
manufacturer's recommendations. The samples were subjected to SDS- 
PAGE and autoradiography. Xsoxl7, ß mRNA was used as a specificity 
control for any effect of siRNA. The result shows that the I ltg siRNA 
(antisense, sense or double stranded) had no effect on translation of 
Xanx-4 mRNA. Even 10 pg siRNA did not effect translation of Xanx-4 
mRNA. No effect on translation of Xsoxl7ß mRNA was observed. 
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Figure 5.16: The effect of Xanx-4 siRNA on Xanx-4 mRNA in Xenopus 
laevis embryos by RT-PCR. Groups of 1-cell stage Xenopus embryos were 
injected with 3.5ng or 7ng of siRNA antisense, sense or double stranded 
oligonucleotides and cultured to stage 13. Two groups of five embryos 
were selected at random from each sample set, together with two groups of 
five uninjected control embryos and subjected to RT-PCR (i). The result 
shows that Xanx-4 siRNA oligos had no marked effect on the level of Xanx- 
4 mRNA detected in any sample tested. The same result was observed in a 
repeat of the experiment (ii). ODC was used as a loading control. 
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5.3.5 Xanx-4 siRNA double stranded produces a reduced tubule phenotype 
in Xenopus laevis embryos. 
The remainder of embryos from the experiment described in section 5.3.4 were 
allowed to develop in order to test whether Xanx-4 siRNA produces 
morphological changes in Xenopus embryos. The groups of embryos were 
cultured to stage 40 and subjected to wholemount antibody staining using the 
monoclonal antibodies 3G8 (pronephric tubule specific) and 4A6 (duct specific) 
(figure 5.17). The embryos were inspected and scored for gross morphological 
changes, as compared to the uninjected control group, particular attention was 
paid to the pronephric phenotype. 
On wholemount inspection of the embryos, except in a small number of cases, no 
obvious gross phenotype alteration was noted. However, a large number of the 
embryos injected with siRNA double stranded (A) had pronephroi with reduced 
pronephric tubules but appeared normal in other respects, when compared to 
embryos injected with siRNA antisense (B) or sense (C) and uninjected controls 
(D) (Figure 5.17). The scoring categories decided upon were "normal", "reduced 
tubules" and "other". Each pronephros on either side of the embryo was scored 
as individual and the results for all pronephroi are shown in Figure 5.18. 
In the "reduced tubule" category, the tubules appear to be normal in most 
respects; they are of similar diameter to normal, they are coiled and appear in the 
normal position but are shorter. Therefore it appears that the pronephroi contain 
less tubules. An example phenotype associated with the "reduced tubule" 
category can be seen in figure 5.17A. Most of the embryos injected with siRNA 
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Figure 5.17: Xanx-4 siRNA produces a reduced tubule phenotype in 
Xenopus embryos. Groups of 1-cell stage embryos were injected with 3. Sng 
or 7ng of siRNA antisense, sense or double stranded oligonucleotides, cultured 
to stage 40 and subjected to wholemount 3G8 antibody (pronephric tubules, 
purple) and 4A6 (duct, red) staining. Embryos injected with siRNA double 
stranded had pronephroi with reduced pronephric tubules (A) when compared 
to embryos injected with siRNA sense (B), siRNA antisense (C) or uninjected 
controls (D). In some cases the reduced tubule phenotype appears to be 
associated with an increase in pronephric duct in embryos injected with siRNA 
double stranded. It seems that the staining of the duct with the duct-specific 
4A6 antibody recognises what would normally be pronephric tubule tissue (A, 
arrowed). 
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antisense (B) and sense (C) displayed normal morphology. The "reduced tubule" 
phenotype is mainly associated with the siRNA double stranded (3.5ng injections 
= 33.3%, 7ng injections = 37.5%), although small numbers are also seen in the 
antisense group [3.5ng injections: 5.6% (n=3/54), 7ng injections: 3.7% 
(n=2/54)], in the sense group [3.5ng injections: 7.1% (n=7/98), 7ng injections: 
2.5% (n=2/81)] and the control group [2.9% (n=2/68)]. In some cases the 
reduced tubule phenotype appears to associated with an increase in pronephric 
duct in embryos injected with siRNA double stranded [3.5ng injections: 4.5% 
(n=1/22), 7ng injections: 9.5% (n=2/21)]. It seems that the staining of the duct 
with the duct-specific 4A6 antibody recognises what would normally be 
pronephric tubule tissue (figure 5.16A arrowed). 
The "other" scoring category included small numbers of embryos with common 
aberrant phenotypes (4.5% - 16% across the sample groups), which were also 
seen in the control group (7.4%). The embryos placed in the normal category 
were considered to have phenotypes within the normal range. In a repeat of the 
experiment similar results were obtained. 
5.4 Discussion 
Loss-of-function analyses can provide evidence for the requirement of a 
particular gene during the epigenesis of an organism. A number of strategies 
have been adopted in attempts to interfere with gene expression in Xenopus 
laevis, including antisense RNA, antisense DNA, expression of dominant- 
negative proteins and the use of antibodies to perturb protein function. These 
methods have all been used to produce loss-of-function results with varying 
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degrees of success, none of which is the method of choice for ablating protein 
expression in Xenopus or any other model organism. The recent discovery of 
RNAi as a potent method of inhibiting the expression of specific genes in various 
species, in particular in Drosophila and C. elegans, has provided an opportunity 
to test a new sequence specific method in Xenopus laevis at a time when RNA 
technologies required credence in vertebrate systems. 
5.4.1 RNAi effects on Xanx-4 mRNA translation in Xenopus oocytes 
It has been shown that dsRNA of 78bp and 367bp is effective in blocking 
translation of injected Xanx-4 mRNA in oocytes (Section 5.2.2; Figure 5.6). The 
effect of dsRNA in blocking translation of injected Xanx-4 mRNA in oocytes 
appears to be specific, since XEZ (Barnett et al., 2001) dsRNA does not effect 
translation of injected Xanx-4 mRNA. Furthermore, the inhibition of Xanx-4 
translation by both Xanx-4 dsRNA-S and dsRNA-L1 is highly reproducible. This 
implies that RNAi can be used for specific interference of protein expression in 
the Xenopus oocyte. Complete block of translation by the interferon response 
leading to PKR activation, can be ruled out as the mode of blocking Xanx-4 
translation in oocytes since the interferon response is zygotic and other maternal 
messages are translated at a normal level. 
The size of the interfering dsRNAs found to be effective in this study is in good 
agreement with studies conducted in C. elegans (Fire et al., 1998; Parrish et al., 
2000), however studies in Drosophila show that dsRNAs of less than 100bp 
often do not activate RNAi (Hammond et al., 2000, Tuschl et al., 1999). The 
concentration of dsRNA used in this study was 5ng/embryo, this is equal to 
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0.2µM dsRNA-S and 0.04µM dsRNA-L1. In the zebrafish assays 15- 
60pg/embryo (0.04nM) no tail (ntl) dsRNA was found to be effective (Wargelius 
et al., 1999). In the mouse c-mos dsRNA at 20pg/embryo (12nM) gave the 
expected phenotype (Wianny and Zernicka-Goetz, 2000). In C. elegans 
6x104molecules/embryo, which calculates as just a few molecules per cell (Fire 
et al., 1998) and Drosophila 25nM (Tuschl et al., 1999). 
The ssRNAs, ssRNA-Antisense and ssRNAs-Not Annealed caused suppression 
of translation of Xanx-4 mRNA in oocytes (figure 5.7i and 5.7ii). This is 
probably due to antisense blocking of translation by RNA: DNA hybridisation. 
Antisense Xanx-4 was as effective as dsRNA in inhibiting translation of Xanx-4 
protein; this is not observed in C. elegans or Drosophila where much lower 
concentrations of dsRNA result in more efficient reduction in protein expression 
than antisense strategies (Fire et al., 1998; Kennerdell and Carthew, 1998). This 
would suggest that RNAi is less efficient in Xenopus oocytes than in less 
complex organisms. 
The effect observed on Xanx-4 translation may be due to a mechanism similar to 
antisense, which might explain why the dsRNAs appear to function with a 
similar efficiency to the ssRNA antisense. Since dsRNA sometimes led to the 
detection of a reduction in the level of endogenous and exogenous mRNA, this 
may reflect a fluctuation in the level of mRNA in response to RNAi. Perhaps the 
interference occurs at particular levels of intracellular mRNA concentrations or 
during particular phases of development. The response to RNAi over a specific 
period of time could be investigated by following the fate of injected GFP 
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labelled Xanx-4 mRNA. To look at the effect of RNAi on endogenous Xanx-4 
mRNA over a time course, a transgenic Xenopus line expressing Xanx-4 linked 
to GFP would need to be constructed. 
5.4.2 RNAi effects on Xanx-4 mRNA translation in embryos 
In Xenopus embryos specific depletion of endogenous target mRNA by dsRNA 
occurred in one experiment (figure 5.10) but was not reproducible in two others 
(5.11i and 5. llii). In a third experiment (figure 5.12B), no depletion of 
endogenous Xanx-4 expression was detected at any stage. It also appears that the 
ssRNA and dsRNAs persist well beyond stage 35 (figure 5.12B), suggesting that 
RNAi is not operating in Xenopus laevis since interfering dsRNAs are reported to 
be degraded to 21 nt as the first step of the RNAi response. dsRNA does not 
therefore act reproducibly as a means of specific endogenous mRNA depletion in 
both oocytes and embryos. 
Exogenous Xanx-4 mRNA is not degraded by RNAi in response to dsRNA 
(figure 5.13). Since levels of Xanx-4 protein are reduced in oocytes injected with 
Xanx-4 mRNA by dsRNA, it would be interesting to find out whether levels of 
Xanx-4 protein are affected by dsRNA in embryos. This could be achieved by 
injecting embryos with myc-Xanx-4 mRNA alone or in combination with Xanx-4 
dsRNA and quantifying the Xanx-4 protein expression by western blotting using 
an anti-myc antibody. Additionally, in a similar experiment to analyse the effect 
of RNAi on endogenous protein levels, an antibody would need to be raised to 
Xanx-4 protein. During this project, two commercially available antibodies (sc- 
1930, Santa Cruz and 0590-5096 Biogenesis) and two gifted antibodies (AS 17, 
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Satoh et al., 1997 and BL7B1, Massey et al., 1991a) were extensively tested in 
western blotting and immunoprecipitation. Although all of these antibodies could 
detect Xanx-4 in wholemount, none of these could successfully detect Xanx-4 in 
western blotting or function in immunoprecipitation. Positive control antibodies 
demonstrated that the techniques used were working effectively. 
5.4.3 The effects of Xanx-4 siRNA in Xenopus laevis 
It is current opinion that the first step of RNAi involves longer dsRNAs being 
cleaved into 21nt fragments (siRNA) by RNase III (Elbashir et al., 2001a). 
These short RNA fragments are able to specifically interfere with gene 
expression in mammalian cell lines where longer dsRNAs have failed (Elbashir 
et al., 2001b). It has been shown that viral dsRNA of greater than 30bp induces 
the interferon response which can lead to blocking of viral and cellular protein 
synthesis, cell growth is impeded and apoptosis results (Meurs et al., 1990). 
Tuschl et al., (1999) reported rapid non-specific degradation of mRNA when 
dsRNA of 505bp was incubated with rabbit reticulocyte lysates; this was 
suggested to be an interferon response to the longer dsRNA. 
The Xanx-4 siRNA (21nt) did not cause specific or non-specific degradation of 
mRNA (Xanx-4 or Xsox17) in rabbit reticulocyte lysate, at any concentration 
tested (figure 5.15). The Xanx-4 siRNA does not therefore induce RNAi or an 
interferon response in vitro. Similarly, the siRNA did not cause detectable potent 
and reproducible degradation of Xanx-4 mRNA in embryos (figure 5.161 and 
5.16ii). It seems that siRNA does not invoke the RNAi pathway or the RNAi 
pathway is not functional in Xenopus. It was therefore surprising that injection 
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of siRNA into embryos resulted in a reduction in pronephric tubules in 31-37% 
of embryos. It seems likely that this phenotype is caused by a reduction in Xanx- 
4 protein synthesis by siRNA. It is possible that the injection of siRNAs resulted 
in a slight reduction in Xanx-4 mRNA levels and Xanx-4 protein expression, not 
detectable by the methods employed or at specific stages not analysed by RT- 
PCR. Further experiments will determine whether Xanx-4 protein levels are 
depleted in response to siRNA. Northern blot analysis of RNA extracted from 
embryos injected with siRNA could allow the detection of cleavage products of 
RNAi. In addition, similar experiments to those of Zamore et al., (2000) could 
be conducted whereby labelled mRNA is coinjected with siRNA and cleavage 
products are visualised on an acrylamide gel. The indicator of functional RNAi 
in this system would be the detection of Xanx-4 mRNA products of 21nt and/or 
multiples thereof. 
5.4.4 Conclusion 
Attempts by two other groups (Nakano et al., 2000; Oelgeschläger et al., 2000) to 
use RNAi in Xenopus resulted in gene specific suppression and aberrant 
phenotypes, previously associated with the function of the gene in question. It 
has been shown in this chapter that dsRNA can specifically reduce levels of 
Xanx-4 protein, and Xanx-4 siRNA causes a reduced pronephric tubule 
phenotype. However analysis of the effects of dsRNA and siRNA on mRNA 
levels have proved inconclusive and cast doubt on the mechanism by which the 
dsRNAs are working. Further studies on RNAi in Xenopus will be required 
before it can be judged a reliable method for interfering with gene expression. 
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Chapter 6: Perturbation of the expression of Xanx-4 using morpholino 
technology 
6.1 Introduction 
Recently, antisense morpholino technology has been used to deplete endogenous 
gene expression in a number of organisms by blocking translation of specific 
genes in early stages of development (for review see Corey and Abrams, 2001; 
Ekker and Larson, 2001). This contrasts with the previously described RNAi 
technologies which interfere with transcription (Chapter 5). Morpholino (MO) 
oligonucleotides possess a non-ionic morpholine backbone rather than a standard 
ribose sugar backbone of DNA/RNA (figure 6.1). These phosphorodiamidate 
antisense oligos bind to target mRNA with high affinity and are not recognized 
by any known cellular binding protein or nuclease (Summerton, 1999). Although 
MOs bind to complementary RNA sequences by Watson-Crick base-pairing, 
unlike traditional antisense technology they are not susceptible to degradation by 
RNaseH. Greater efficacy is thus achieved by a nonclassical antisense approach. 
These oligos present a non-toxic, relatively inexpensive and reliable method of 
gene product depletion (Summerton and Weller, 1997). To date, two methods of 
gene targeting using MOs have been utilised. Firstly, a recent study 
demonstrated a method of gene knockdown using MOs to inhibit pre-mRNA 
splicing (Giles et al., 1999). Using this method Draper et al., (2001) 
demonstrated depletion of FGF8 using a MO that spans an intron/exon boundary; 
this resulted in the blocking of zygotic, but not maternal, mRNA translation. This 
method of targetting MO to intron/exon boundaries also allows for the selective 
depletion of alternative splice variants. The analysis of the effects of MO blocked 
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Figure 6.1: The structure of DNA and morpholino oligonucleotides. A 
morpholino oligo is composed of a series of 6-membered morpholine rings which are 
joined by non-ionic phosphorodiamidate linkages compared to the 5-membered 
deoxyribose backbone joined by ionic linkages in DNA. Base refers to adenine, 
cytosine, guanine or thymine. R and R' denotes continuation of the oligomer chain in 
the 5' or 3' direction respectively. 
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splicing has the advantage of not requiring an antibody, it can be detected semi- 
quantifiably by RT-PCR. The second method involves steric blocking of 
translation and is at present the most commonly used technique for in vivo 
experiments. The MO is designed to the leader sequence of the mRNA, 
generally including the start codon. The double stranded RNA: MO complex 
inhibits scanning of the mRNA by the 40s ribosomal subunit of the ribosome 
thereby inhibiting translation. This type of approach targets maternal and zygotic 
mRNA (Summerton, 1999). 
6.1.1 The use of morpholinos in Xenopus 
The first study of the use of morpholinos in Xenopus was reported by Heasman et 
al., (2000). Maternal depletion of /-catenin, a molecule involved in the Wnt 
pathway, was previously shown to cause embryos to develop without dorsal 
structures (notochord, somites, neural tube, heads and tails). A similar depletion 
had been carried out by antisense knockdown in the oocytes that were then 
subjected to the host-transfer technique (Heasman et al., 1994). This is a very 
difficult, complex and time consuming process (see previous chapter, section 
5.1). Unfortunately, these same antisense oligos could not be used to study 
zygotic function of /j catenin, as the oligonucleotides were toxic in fertilised 
eggs. Additionally they are unstable and do not deplete zygotic protein or 
membrane-associated maternal protein. 
In the study of Heasman et al., (2000) the authors injected a morpholino 
complementary to ß-catenin into blastomeres of early Xenopus embryos, and 
demonstrated the depletion of ß-catenin protein through neurula stages. The 
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depletion of both maternal and zygotic gene products occurred. They used 
targeted injection to show depletion of gene products in different regions of the 
embryo at different stages. Injection of the MO into dorsal vegetal region of 
embryos at the 2-cell and 4-cell stage blocks dorsal axis formation and at the 8- 
cell stage blocks head formation. An injection of MO into A-tier blastomeres at 
the 32-cell stage causes aberrant cement gland formation. This study showed the 
use of MO in specific targeting of maternal and zygotic messages allowing the 
analysis of regionalised, complex pathways. Comparatively, 6-20ng of MO 
caused the same ventralised phenotype as seen previously with Ing of 
phosphorothioate oligo injected into oocytes. The depleted phenotype could be 
rescued by co-injection with ß-catenin mRNA (Heasman et al., 2000), a 
fundamental control for these experiments. 
A number of recent studies on wnt signalling pathways using MO have allowed 
loss-of-function studies to be carried out for previously intractable systems. 
The study used a combination of MOs designed to the 5'UTR of two orthologs of 
Xfz7 (frizzled genes encode receptors for wnts) and utilised a rescue mRNA 
without the 5'UTR. The depletion of maternal Xfz7 (Sumanas & Ekker, 2001) 
resulted in loss or reduction of anterior structures, confirming a previously 
suggested role for Xfz7 in the wnt/(3-catenin dorsoventral axis formation 
pathway. Later stage Xfz7-depleted embryos displayed gastrulation defects, 
caused by inhibition of convergent extension movements, therefore probably 
zygotic, as demonstrated by an animal cap cell motility assay (Smith et al., 
1990). Both aberrant phenotypes could be rescued by co-injection of Xfz7 
mRNA. Demonstration of a zygotic-only depletion phenotype by injecting MO 
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into 1-cell stage embryos, probably failed due to a maternal pool of Xfz7 protein 
already present in the embryo. This study provides the first evidence for a 
vertebrate Frizzled involvement in both canonical and non-canonical wnt- 
signalling pathways. 
Other studies on the Wnt pathway using the MO technology include that of 
Deardorff et al., (2001) who showed that Xfz3 is required for Xwntl signalling 
in the formation of the neural crest in Xenopus laevis embryos. Tan et al., (2001) 
have shown that depletion of Kermit using a specific morpholino, blocks neural 
crest induction by Xfz3 in Xenopus laevis; an effect which can be rescued by co- 
injection with Kennit mRNA. The authors suggest that Kermit interacts directly 
with the cytoplasmic portion of frizzled proteins to modulate their signalling and 
is required for wnt/frizzled signalling in neural crest development in Xenopus 
laevis. 
A number of additional studies have been conducted in Xenopus laevis, using 
MOs as a method to elucidate the function of cloned genes. Schweickert et al., 
(2001) demonstrated for the first time the requirement of Pitxl and Pitx2 genes 
for cement gland formation by loss-of-function experiments. In Drosophila and 
C. elegans loss-of-function assays have shown that cyclin E, which binds to cdk2 
and initiates DNA replication and histone biosynthesis, is responsible for 
underproliferation in the developing embryo. There are currently no reports of 
loss-of-function mutations for cyclin E in vertebrates. Audic et al., (2001) 
demonstrated that cyclin E depletion using cyclin E MO designed to target all 
three cyclin E forms previously cloned, causes a delay in embryogenesis in 
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Xenopus laevis embryos. The study demonstrates that an injection of 24ng 
provides a delay of around 1 stage, 48ng and 96ng around 2-3 stages, at tailbud 
stage (27) embryos. Injection of control MO at the same level caused no obvious 
delay. When the uninjected embryos reached stage 39, the MO injected embryos 
were delayed to stage 35/36 and the control MO injected embryos were delayed 
one stage. This demonstrates an effect of control MO on the general timing of 
development of the Xenopus embryos at high levels of MO (96ng). This amount 
of MO is however approximately 24 times higher than the amount routinely used 
to be effective in Xenopus. 
Other Xenopus studies include functional studies on genes with previously 
known effects. Retinoic acid receptors (RAR) are able to activate and repress 
transcription of target genes on recruitment of coactivators and corepressors, 
depending on the presence of retinoic acid (RA). RAR-mediated signalling is 
known to be required for patterning along the anterioposterior axis. RARs and 
corepressors are present in regions where RA is absent (anterior), suggesting 
unliganded-RARs are acting as repressors in anterior patterning (Koide et al., 
2001). Derepression of RARs by injection of a dominant-negative corepressor 
leads to posteriorisation, as does treatment with RA; an effect which was 
phenocopied by injection of RARa morpholino. Injection of wild-type or 
dominant-negative RARa rescued the MO phenotype, confirming that RAR 
functions anteriorly as a transcriptional repressor (Koide et al., 2001). In Dibner 
et al., (2001) Xmeis3 was suggested to be involved in the transformation step in 
neural patterning. It has been suggested that it overcomes anterior neural 
signalling to enable proper hindbrain cell fate identity. Injection of MO or 
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Xmeis3-antimorph mRNA, coding for a fusion protein containing Xmeis3 linked 
to the Engrailed transcriptional repressor domain, both caused loss of hindbrain 
marker expression and an expansion of forebrain markers. 
In a comparative study conducted by Nutt et at., (2001) between Xenopus laevis 
and Xenopus tropicalis the authors discovered that the inhibitory effect of MO in 
both Xenopus species is long-lived (well into tadpole stages) when using in 
excess of ing MO. The inhibitory effect on translation was also tested and 
demonstrated to be highly specific. CMV-GFP transgenic lines were used to 
demonstrate the usefulness of MO in Xenopus laevis and tropicalis. A GFP-MO 
was injected into CMV-GFP transgenic 1-cell stage X laevis embryos; 0. ing- 
0.4ng did not appreciably deplete GFP, ing depleted GFP protein to 
approximately half at stage 20 but the protein accumulated to virtually normal 
levels by stage 30.4ng-40ng of GFP-MO completely knocked down the GFP 
protein level until reappearance at around stage 40-43. No gross morphological 
abnormalities were noted in injections of less than or equal to lOng, however, 
injections at 20ng resulted in approximately 20% abnormalities and injections at 
40ng, 45% abnormalities were observed. In general, the abnormalities seen were 
anterio-posterior truncations and/or microcephaly. A X. tropicalis egg is 
approximately 10-fold smaller then a X. laevis egg. Correspondingly a 
proportionally less quantity of MO provided a similar result in X. tropicalis as in 
X. laevis. ing injected into X. tropicalis blocked translation of crystallin-GFP to 
stage 43 but by stage 47 the GFP fluorescence was indistinguishable from the 
control. To test the rapidity of dispersal of the oligonucleotide after injection, 
FITC labelled control MO was injected into the animal pole of one of a 2-cell 
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stage Xenopus embryo and the spread of fluorescence monitored throughout 
development. The fluorescence was present evenly throughout the injected side 
of the embryo and so was inherited by daughter cells equally and persisted until 
stage 43. This suggests that longevity of MO treatment is sufficient to interfere 
with specific translation well into organogenesis 
In a cross-species study Ross et al., (2001) demonstrated that Twisted 
gastrulation (Tsg) is a conserved extracellular antagonist of BMP signalling. 
Overexpression of chordin mRNA in Xenopus embryos causes axis duplication 
(dorsalisation) by inhibition of BMP signalling. MO depletion of Tsg in zebrafish 
causes ventralisation, similar to that produced by chordin mutants. Sub-inhibitory 
levels of chordin MO and Tsg MOs were co-injected into zebrafish embryos, the 
resultant phenotype demonstrated that they synergistically enhanced blood island 
expansion (ventralisation). 
6.1.2 Zebrafish 
Nasevicius and Ekker (2000) reported the first example of MO translational 
inhibition in zebrafish. They blocked expression from a ubiquitous GFP- 
transgene, demonstrating that all cells could respond to the MO. The study also 
involved the targeted depletion of a number of endogenous genes in zebrafish, 
the resultant morphology of which phenocopied known mutations (no tail, nacre 
and sparce). The one-eyed-pinhead MO demonstrates a limitation in the use of 
MOs as half of the embryos injected with this MO failed to elicit the loss-of- 
function phenotype. The authors suggest this could be attributed to 
polymorphisms in the leader sequence. The authors developed zebrafish models 
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of human disease targeting the uroporphyrinogen decarboxylase gene with a 
specific MO and produced embryos with hepatoerythropoietic porphyria. 
Finally, embryos with reduced sonic hedgehog (shh) and tiggy-winkle hedgehog 
(twhh) displayed partial cyclopia and other specific midline abnormalities, 
providing a zebrafish genetic model for the common human disorder 
holoprosencephaly. These studies indicated that the MO could indeed 
specifically deplete maternal and zygotic gene function in zebrafish by 
interfering specifically with translation and that the aberrant phenotypes could be 
rescued by coinjection with the appropriate mRNA. During the course of their 
extensive study, Nasevicius and Ekker (2000) noted an 18% mistargeting rate. 
This is defined as the fraction of repeated unexpected phenotypes particular to 
MOs. For example, a phenotype common to the shh and pax-2.1 MOs was that of 
neural death. Due to the large number of genes required for neural cell survival, 
it was suggested that this is due to serendipitous homology (Ekker and Larson 
2001). As with other types of loss-of-function studies, controls are essential, 
especially a specific rescue, to allow correct interpretation of any aberrant 
phenotype observed. 
More recently, a host of studies have been reported using MO depletion in 
zebrafish. These studies have included dissection of induction signalling 
pathways (Yang et al., 2001; Furthauer et al., 2001; Bauer et al., 2001; Agathon 
et al., 2001; Erter et al., 2001; Huang et al., 2001), phenocopies of known mutant 
phenotypes (Kawahara and Dawid, 2001; Yee et al., 2001; Topzewska et al., 
2001), confirmation of suggested redundancy (Imai et al., 2001) and differential 
requirements of specific gene products (Muller et al., 2001). These studies show 
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that MOs provide a potent, sequence specific depletion of the targeted gene 
function; they are non-toxic (when used at <30ng/embryo), produce phenocopies 
of known mutations in a dose-dependent manner and can be successfully rescued 
using co-injection of mRNA in zebrafish. 
Of particular interest, work carried out by Shepherd et at., (2001) demonstrates 
that Zebrafish GDNF and GFRoc expression is consistent with it playing a role in 
enteric nervous system, motor neuron and kidney development. In mouse and 
salamander GDNF is suggested to have a role in kidney organogenesis (Durbec 
et at., 1996; Drawbridge et al., 2000). Interestingly, overexpression of neither 
GDNF nor GDNF MO had any effect on motor neuron or pronephric 
development. In contrast, overexpression of GDNF, targeted to somitic tissues, 
altered the normal axonal guidance, suggesting a role as a chemo attractant. MO 
knockdown of GDNF caused a 95% reduction in the number of enteric neurons. 
This effect was not due to apoptosis as using TUNEL labelling, no difference in 
the number of apoptotic cells was observed in MO injected embryos, at different 
stages, compared to controls. 
6.1.3 Mouse 
The only example of MO used in mouse so far is a phenocopy of the mouse mos 
mutation, which has been characterised in null mutants and by RNAi (see chapter 
5). In mouse mos mutants, the oocytes fail to arrest at metaphase II and undergo 
parthenogenetic activation. The phenotype of parthenogenetic activation was 
observed, by injecting the mos MO into oocytes to give a frequency of 56% of 
cases using 340pg MO, 23% of cases using 17pg of mos MO and none in control 
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MO samples. This study demonstrates that the mos MO successfully 
recapitulates the mos genetic mutation in mouse (Coonrod et al., 2001). 
6.1.4 Chick 
Two recent studies have shown that MOs can produce specific depletions of gene 
expression in the chick. This was achieved by electroporation or microinjection 
of the MOs in vivo. The introduction of an MO specific to FoxD3 resulted in 
defects in neural crest segregation and differentiation (Kos et al., 2001) and 
introduction of an MO specific to tenascin-C resulted in defects of neural crest 
migration (Tucker, 2001). 
6.1.5 Sea urchin 
Specific MOs have been shown to block translation of target genes in sea urchin. 
One study suggests a function for SpKrl in patterning the vegetal domain by 
suppressing animal regulatory activities (Howard et al., 2001). 
6.1.6 Morpholinos in cell lines and in vivo) in vitro for therapeutics 
Morpholino-modified antisense oligomers were first tried and tested in cell 
culture with the intention of designing human therapeutics. Many studies were 
conducted comparing different types of oligomers for their efficacy (Taylor et 
al., 1996; Summerton et al., 1997; Stein et al., 1997; Taylor et al., 1998), some 
time before they were utilised in vivo. The success of these initial studies 
demonstrated a scope in therapeutics for such molecules with specific and 
predictable effects (Summerton and Weller, 1997). Aberrant splicing of the ß- 
globin gene is the most common mutation causing ß-thalassemia in humans. 
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Lacerra et al., (2000) have shown that aberrant splicing could be corrected by 
using MOs in ß-thalassemic blood cells, and thus expression of defective ß- 
globin genes was repaired and a significant level of Hb A was restored. Arora 
and Iverson (2001) reported another potential use of MOs in therapeutics. 
Inhibition of CYP enzymes (enzymes involved in drug metabolism in humans) 
by MOs could result in safer and more uniform metabolism of clinically relevant 
drugs. In another study of restenosis (an aberrant proliferative disorder which 
often follows cardiac surgery), in vivo delivery of c-myc MO to four different 
animal models of restenosis resulted in reduction of the myointimal response 
(Hudziak et al., 2000; Kiphidze et al., 2001). 
6.1.7 Caged RNA/DNA 
Ando et al., (2001) have recently reported a new technique for photo-mediated 
gene activation using another modified nucleic acid analog in zebrafish embryos. 
The authors demonstrate that a synthetic compound, 6-bromo-4-diazomethyl-7- 
hydroxycoumarin (Bhc-diazo), can form a covalent bond with the phosphates of 
the sugar-phosphate backbone of RNA, blocking translation. This process, 
known as "caging", is released when the covalently bound RNA is exposed to 
UV light and results in a partial recovery of translational activity. The protected 
mRNAs injected are resistant to enzymatic degradation and are therefore more 
stable than non-caged mRNAs. Since the caged mRNA is highly stable, this 
technique allows temporal release of injected caged mRNAs at a much later stage 
than would normally be possible. This conditional expression system allows the 
induction of dominant-negative mRNAs and simultaneous induction of genes 
that may act synergistically. This technique, if combined with the MO to produce 
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caged MOs, could provide a very useful tool to activate the MO at a specific 
time-point in development. 
6.1.8 Summary 
In summary, it appears that morpholinos can provide a reliable method of gene 
knockdown in a number of vertebrate species. They have been show to 
phenocopy known mutations and provided answers where conventional antisense 
or RNAi have failed. Morpholinos show few non-specific effects, although a 
number of workers have reported increases in toxicity on long term storage of 
MO. They can be used at a range of concentrations to provide a graded response 
and can be rescued using mRNA. The following chapter describes the analysis 
of the results obtained using Xanx-4 morpholinos to deplete Xanx-4 protein in 
Xenopus laevis. 
6.2 Results 
6.2.1 Xanx-4 MO1 blocks translation of Xanx-4 mRNA 
A morpholino oligonucleotide, termed MO1, was designed to be complementary 
to Xanx-4 and tested in vitro and in vivo for its ability to specifically perturb 
Xanx-4 translation (Figure 6.2). Due to the lack of anti-annexin IV antibody, that 
could detect Xanx-4 by western analysis, an Xanx-4-myc-tagged expression 
construct was prepared (section 2.4.5, Table 2.2), the protein product of which 
could then be detected by western blotting using an anti-myc antibody. The 
Xanx-4 cDNA was cloned in frame and upstream of the myc-tag in vector 
pCS2+MT3 (appendix 3). The myc-tagged Xanx-4 construct (myc-Xanx-4) was 
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Figure 6.2 
5' MO1 g tac cgt cgt gag cct tga ttc cca 
Xanx-4 
... cag ttg gtg gac atc atg gca gca ctc gga act aag aca ... 
M02 C cac ctg tag tac cgt cgt gag cct 3+ 
Figure 6.2: The position and sequence of the Xanx-4 morpholinos MOl 
and M02 in relation to Xanx-4 coding region. The translation start site 
(methionine, atg) is in bold type. 
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linearised with EcoRI and transcribed with SP6 RNA polymerase. myc-Xanx-4 
mRNA was diluted to 500gg/ml and used in the following assays to demonstrate 
the effectiveness and specificity of the Xanx-4 morpholino (Xanx-4 MO I) for 
Xanx-4 mRNA. 
Xanx-4 morpholino specificity in vitro 
Initially the specificity of the Xanx-4 morpholino was established in vitro. Myc- 
tagged Soxl7ß mRNA (myc-Xsoxl7ß, a kind gift of D. Clements, Warwick) was 
used as a control to test for the Xanx-4 MO1 specificity. A combination of 100ng 
of myc-Xsox17ß mRNA and IOOng of myc-Xanx-4 mRNA was incubated either 
alone or in combination with 1µg, 5µg or1Oµg of Xanx-4 MO1 in the reticulocyte 
lysate system. The lysates were subjected to SDS-PAGE and western blotting 
using anti-myc antibody (Figure 6.3). Both myc-Xsoxl7ß mRNA and myc-Xanx- 
4 mRNA were successfully translated at similar levels (lanes 1,3,5) but when 
incubated with 1µg, 5µg orlOgg Xanx-4 MOI, myc-Xanx-4 mRNA translation 
was blocked whereas myc-Xsoxl7ß mRNA translation was not (lanes 2,4,6 
respectively). Lane 7 was no input control sample. The result demonstrates that 
Xanx-4 MO1 specifically blocks translation of Xanx-4 mRNA in vitro. 
Xanx-4 MO! specificity in vivo. 
To test the efficacy of Xanx-4 MO1 in vivo the follow experiment was 
conducted. Embryos were injected at the 1-cell stage with 0.5ng myc-Xanx4 
mRNA alone or in combination with 5ng, lOng or 20ng Xanx-4 MO1 and 
cultured to stage 9,13 or 21. The embryos were homogenised, fractionated, and 
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Figure 6.3 
mvc-Xanx-4 mRNA 
Xanx-4 morpholino 
mvc-Xsox17ß mRN A++++- 
Figure 6.3: Xanx-4 MO1 specificity in vitro. Western blot showing Xw, x-4 
MOI interferes with in vitro translation of myc-tagged Xanx-4 mRNA (myc- 
Xanx-4) and not of myc-tagged Xsoxl7ß mRNA (myc-Xsox17/. The 
translations were performed in the rabbit reticulocyte lysate system. Lane I: 
100ng myc-Xanx-4 and 100ng myc-Xsoxl7,6 mRNA. Lane 2: I OOng myc-Xwix-4 
and 100ng myc-Xsoxl7ß mRNA and lpg Xanx-4 MO1. Lane 3: 100ng myc- 
Xanx-4 and I OOng myc-Xsoxl7ß mRNA. Lane 4: 100ng myc-Xanx-4 and 100ng 
myc-Xsox17/3 mRNA and 5µg Xanx-4 MO1. Lane 5: 100ng myc-Xanx-4 and 
myc-Xsoxl713 mRNA. Lane 6: 100ng myc-Xanx-4 and 100ng myc-Xsox1713 
mRNA and 10µg Xanx-4 MO1. Lane 7: No input rnRNA or MO 1. 
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the cytosolic fraction subjected to SDS-PAGE and western blotting using anti- 
myc antibody. As specificity controls, 0.5ng myc-Xsoxl7ß mRNA was also 
injected alone or in combination with Xsox17ß MO or Xanx-4 MO1. The results 
(Figure 6.4) show that myc-Xanx-4 is translated in vivo (lanel) and that 
translation is blocked by 5ng (lane 2), lOng (lane 3) or 20ng (lane 4) Xanx-4 
MO1 at all stages examined (stage 9,13,21). For the specificity control, injected 
myc-Xsoxl7ß mRNA alone is translated (lane 6) and its translation is knocked 
down by Xsoxl7ß MO (lane 7). However, the expression of myc-Xsox17ß 
mRNA is not affected by the Xanx-4 MO1 (lane 8). Uninjected, control embryos 
do not react with the anti-myc antibody at any of the stages tested (lane 5). 
Therefore, we show that the Xanx-4 MO1 is specific for myc-Xanx-4 mRNA in 
vivo. Myc-Xsox17ß mRNA injected embryos could not be analyzed at later 
stages, due to lethality at late gastrula/early neurula stages of this level of 
message. 
6.2.2 Xanx-4 depletion using MO1 produces pronephric tubules with an 
enlarged diameter. 
In order to examine the activity of Xanx-4 in vivo, MO1 was used to perturb 
endogenous expression of Xanx-4. Embryos were injected at the 1-cell stage with 
lOng control MO, lOng Xanx-4 MO1 or 0.5ng Xanx-4 mRNA. The injected 
embryos were cultured to stage 40 and wholemount antibody stained with 3G8 
and 4A6, which are tubule and duct specific monoclonal antibodies, respectively. 
The wholemount phenotype of each sample group was scored relative to controls 
(Figure 6.5). Although no obvious effect on pronephric tubule or duct 
morphology following overexpression of Xanx-4 mRNA or on injection of 
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Fi`7ure 6.4 
mvc-Xanx-4 mRNA 
Xanx-4 morpholino 
invc-Xsoxl7ß rnRNA 
Xsox17ß morpholino 
+ + + - 
- + ++ +++ - - - ++ 
+ + + 
- - - - - ++ - 
1234 
Stage 9 .. 
Stage 13 , ý..,.,. 
Stage 21 
5678 
Figure 6.4: Xanx-4 MO1 specificity in vivo. Western blot using anti-myc 
antibody showing Xanx-4 MO I interferes with in vivo translation in Xenopu. y 
embryos of myc-tagged Xanx-4 mRNA (myc-Xanx-4) and not of myc-tagged 
Xsoxl7ßmRNA (myc-Xsoxl7/1). I cell stage Xenopus embryos were injected 
with myc-Xanx-4 mRNA alone or in combination with Xunx-4 Mo l and 
myc-Xsox17/ mRNA alone or in combination with Xsox17/1 MO and 
cultured to stage 9,13 and 21. The embryos were homogenised and samples 
equal to half of an embryo were subjected to SDS-PAGE and western 
blotting using anti-myc antibody. Lane 1: O. Sng myc-Xanx-4 mRNA. Lane 2: 
0.5ng myc-Xanx-4 mRNA and 5ng Xanx-4 MO. Lane 3: O. Sng myc-Xanx-4 
mRNA and lOng Xanx-4 MO. Lane 4: O. Sng myc-Xanx-4 inRNA and ? Ong 
Xanx-4 MO. Lane 5: Uninjected control. Lane 6: 0.5ng myc-Xsox1713 mRNA. 
Lane 7: 0.5ng myc-Xsoxl713 mRNA and IOng Xsoxl713 MO. Lane 8: 0.5ng 
myc-Xsoxl7ß mRNA and l Ong Xanx-4 MO. 
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Figure 6.5 
AB 
Figure 6.5: Depletion of Xanx-4 in embryos by injection of Xanx-4 
MO1 results in pronephric tubules with an enlarged diameter: 
Wholemount antibody 3G8 staining of stage 411 Xanx-4 MOl injected 
embryos. 1 cell stage Xenopus embryos were injected with long o1' Xw,. r-4 
MO I, cultured to stage 40 and subjected to wholemount antibody staining 
with pronephric tubule specific antibody 3G8. A: Normal uninjected 
control embryo. B: Embryo injected with Xanx-4 MO shows the shortened, 
enlarged diameter tubule phenotype. 
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control MO was observed (116 embryos, 232 pronephroi, figure 6.6), a clear 
effect on pronephric tubule morphology was observed following Xanx-4 MO1 
injection. The normal, coiled, tubular structure of the pronephric tubules 
appeared completely disrupted in Xanx-4 MO1 injected embryos. The effect of 
the Xanx-4 MOl led to the formation of shortened, enlarged and less coiled 
tubules, figure 6.5B, compared to control figure 6.5A. In some embryos the 
tubules were reduced in overall size and in some cases missing completely 
(8/232). A repeat of the experiment yielded a similar result. 
In order to investigate the phenotype, a random sample of six immunostained 
embryos from each treatment group were acrylamide embedded, frozen and 
cryostat-sectioned at 12µm thickness. The slides were counterstained stained 
with Hoescht 33258, mounted and compared to un-injected controls. Analysis of 
the sections revealed that Xanx-4 MO1 treated embryos (figure 6.7G-I) had 
tubules that were substantially wider than control un-injected (figure 6.7A-C), 
control MO injected (figure 6.7D-F), or Xanx-4 mRNA injected embryos (figure 
6.7J-L). 
In order to quantify the extent of the Xanx-4 MO1 phenotype, complete serial 
sections of the pronephroi from each of the six samples for each treatment were 
inspected. Approximately 24 sections were counted from each pronephros 
scored. Tubules were positively identified by the light microscopic identification 
of 3G8 positive immunostaining and nuclei counted under UV illumination to 
identify Hoescht staining (figure 6.7). Due to the coiled nature of the pronephric 
tubules many of the tubule sections could be seen as elongated or oval shaped 
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Figure 6.7 
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Figure 6.7: Cryostat transverse sections of stage 44) Xenupus 
pronephroi from Xanx-4 depleted embryos and embryos over- 
expressing Xanx-4. I cell stage embryos were injected with lung Xanx-4 
MO, lung Xanx-4 MO and O. 5ng Xunx-4 mRNA, cultured to stage 40 and 
subjected to wholemount antibody 3G8 staining. The embryos were 
acrylamide embedded, cryostat sectioned at 12µm and lifted on to subbed 
slides. The slides were counterstained with Hoescht, inspected under 
light, UV illumination and both light and UV. The figure shows examples 
of the sections inspected under each light condition. A-C: Un-injected 
normal controls, D-F sections ul embryos injected with long control MO, 
G-I: sections of embryos injected with long Xan. r-4 MOI, J-L: sections 
of embryos injected with O. 5ng Xanx-4 mRNA. The enlarged lumen can 
clearly he seen in the Xanx-4 depleted embryos G-1, all other samples 
appear normal. 
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cross-sections. A schematic representation of an example section with true 
transverse (shaded, counted) and a partial longitudinal section (unshaded and 
arrowed, not counted) is shown in figure 6.8A along with the actual section in 
6.8B. Any section of a pronephric tubule that was considered not being a true 
transverse section, on the basis of such cross-sectional shape, was discounted. 
All cells of each sectioned pronephric tubule, on both sides of the embryo and in 
each section were counted and the mean cell count was calculated (Figure 6.9). 
The number of cells contributing to normal control tubules was remarkably 
consistent, averaging 9 cells and with a range from 6-15 cells. Inspection of the 
sections of the Xanx-4 MO1 injected embryos for the number of cells making up 
a tubule section, however, revealed that the pronephric tubules had an enlarged 
lumen, but appeared normal in all other respects. The cells of the tubules retained 
normal cell integrity and shape, the organisation of the tubule epithelium was one 
cell in diameter as in normal controls (Figure 6.7). In the Xanx-4 MO1 injected 
embryos the average number of cells contributing to the tubule section, however, 
was 25 and the range was 6-48 (Figure 6.9). The wide range observed reflects the 
observation that the tubule width at the start and the finish of each tubule domain 
was of normal size; where the tubules connect with nephrostomes (dorsal) and 
pronephric duct (ventral). This represents a significant difference from either 
uninjected control values (mean =9 and range 5-15), control MO injected values 
(mean =9 and range 6-15) or values obtained from Xanx-4 mRNA injected 
embryos (mean =9 and range 6-14). Representative results are presented in 
figure 6.7 and the mean and standard deviation of the cell counts per tubule 
section for each sample group are shown in figure 6.9. Duct staining was also 
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Figure 6.8 
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Figure 6.8: A pronephric tubule section and a schematic 
representation of the same section. The figure illustrates those tubule 
sections which were included in the analysis and those which were 
rejected. A: A schematic representation of the sample section in B 
indicating pronephric tubule section glancing blows (arrowed), unfilled 
(not counted) and true transverse sections, filled (counted). B: The 
actual tubule section viewed under a combination of UV and white 
light, the UV illuminates the Hoescht staining (nuclear DNA) allowing 
cell count and the white light allows the identification of those cells 
contributing to the pronephric tubules. 
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Figure 6.9 
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Figure 6.9: Graphical representation of data collected from cell counts 
of complete serial sections of pronephric tubules from embryos with 
depleted Xanx-4 expression or over-expressing Xanx-4. I cell stage 
embryos were injected with lOng control MO (control MO), IOng Xun_r--l 
MO (IOMO), 0.5ng Xanx-4 mRNA (mRNA), cultured to stage 40 and 
subjected to wholemount antibody 3G8 staining. The embryos were 
acrylamide embedded, cryostat sectioned at I2 tm and lifted on to subbed 
slides. The slides were counterstained with Hoescht, inspected under light 
and UV illumination and cell counts per pronephric tubule weir ohtaincd. 
The mean number of cells per tubules section in the control, control MO 
and Xanx-4 mRNA injected embryos were not significantly diflercnt, 
whereas those embryos injected with 10ng Xwix-4 MO displayed an 
enlarged pronephric tubule phenotype. The error Kars show I "tandard 
deviation from the mean. 
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carried out using specific monoclonal antibody 4A6, no effect on duct 
morphology was observed. 
6.2.3 Xanx-4 MO1 phenotype can be rescued by co-injection with Xanx-4 
mRNA. 
In order to rescue the phenotype caused by injection of the Xanx-4 MO I, Xanx-4 
mRNA was co-injected with Xanx-4 MO1. Embryos were injected at 1-cell stage 
with 5ng, lOng or 20ng of Xanx-4 MOl alone or in combination with 0.5ng 
Xanx-4 mRNA. Equal volumes were injected into all embryos. The embryos 
were cultured to stage 40 and wholemount antibody immunostained with tubule 
specific 3G8. Embryos injected with Xanx-4 MO1 were compared to the co- 
injected and to the un-injected controls. The embryos were examined initially as 
wholemount specimens (figure 6.10). 
As previously described, pronephric tubules of the embryos injected with the 
Xanx-4 MO1 (Figure 6.1OA, C, E) appeared in general to be wider, shorter and 
less coiled than those of the normal control embryos (Figure 6.10G), with the 
most severe aberrant phenotype observed in those embryos injected with the 
higher concentration of MO I. Those embryos co-injected with 5ng Xanx-4 MO1 
and 0.5ng Xanx-4 mRNA appeared completely rescued. The pronephric tubules 
appeared almost normal, (Figure 6.10B). The embryos co-injected with lOng and 
20ng MO1 and 0.5ng Xanx-4 mRNA showed significant, although incomplete, 
rescue with the tubules being somewhat less normal and displaying some larger 
and less coiled tubules (figure 6.1OD, F respectively). Seemingly the rescue was 
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Figure 6.10 
5ng MOl 
A 
LB 
lOng MOl 
D 
20ng MOl 
Un-injected 
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Figure 6.10: The enlarged pronephric tubule phenotype produced by 
injection of Xanx-4 MO can be rescued by co-injection with Xanx-4 mRNA. 
1 cell stage embryos were injected with 5ng (A), lOng (C) or 20ng (E) Xanx-4 
MO1 alone or in combination with 0.5ng Xanx-4 mRNA (B, D, F respectively) 
and cultured to stage 40. The embryos were subjected to wholemount antibody 
3G8 staining and were scored for phenotypic aberrations. It was seen that those 
embryos depleted in Xanx-4 display a shortened, widened and less coiled 
pronephric phenotype when compared to controls. Those embryos injected with 
20ng MO1 display a more severe phenotype than those injected with lOng MO1 
and the least severe phenotype is associated with 5ng MO1 injection. It appears 
that injection of Xanx-4 mRNA is able to rescue the enlarged tubule phenotype 
observed, where co-injection of 0.5ng Xanx-4 mRNA and Xan_x-4 MOl (B, D, 
F) leads to pronephric tubules with a more normal phenotype compared to those 
injected with MOI alone (A, C, E). 
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not complete at the higher concentrations of MO1. Other than the pronephric 
tubule phenotype described above, the gross phenotype of the embryos in all 
groups appeared normal. 
In order to quantify this phenotype, a random sample of six embryos from each 
group were acrylamide embedded, frozen, cryostat-sectioned and analysed as 
described previously. Examples of the sections analysed are shown in Figure 
6.11A-U. The complete data collected from the serial sections of each of six 
randomly chosen embryos from each group is shown in graphical representation 
in Figure 6.12. The pronephric tubules of the embryos co-injected with 5ng 
Xanx-4 MO1 and 0.5ng Xanx-4 mRNA were not significantly different from 
normal control embryos (Figure 6.12, mean =9 and the range 5-21). It appears, 
therefore, that 0.5ng Xanx-4 mRNA was able to rescue 5ng Xanx-4 MO! 
completely (Figure 6.11G-I). Those injected with lOng or 20ng of MOl were 
partially rescued by 0.5ng Xanx-4 mRNA (Figure 6.12, mean lOng = 12,20ng = 
14 and the ranges both 6-38). Embryos injected with lOng MOl and 0.5ng 
mRNA were rescued to a 5ng MO1 phenotype (compare Figure 6.11 M-0 to 
6.11D-F) and 20ng MO1 and 0.5ng mRNA were rescued to an intermediate 
phenotype between lOng and 20ng (Figure 6.11S-U). Similar results were 
obtained from a repeat experiment. 
6.2.4 Analysis of the expression of pronephric molecular markers in Xanx-4 
overexpression and Xanx-4 morpholino treated embryos. 
In order to assess whether overexpression or suppression of Xanx-4 has an effect 
on the expression of genes that have been shown to play a role in early kidney 
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Figure 6.121 
Figure 6.12: Graphical representation of data collected from cell counts of' 
complete serial sections of pronephric tubules from embryos with depleted 
Xanx-4 expression or rescued by co-injection of Xanx-4 mRNA. 1 cell stage 
embryos were injected with 5ng (5MO), lOng (IOMO) or 20ng (20MO) of 
Xanx-4 MO1 alone or in combination with 0.5ng Xanx-4 niRNA (5MR, IOMR 
and 20MR respectively), cultured to stage 40 and subjected to whole mount 3G8 
antibody staining. The embryos were acrylamide embedded, cryostat sectioned 
at 12µm and lifted on to subbed slides. The slides were countcrstained with 
Hoescht, inspected under light and UV illumination and cell counts per 
pronephric tubule were obtained. The mean number of cells per tubule section 
in each of the sample groups was calculated and is presented in the graph. It 
appears that Xanx-4 mRNA is able to rescue the enlarged tubule phenotype. 
0.5ng of Xanx-4 mRNA is able to completely rescue the phenotype induced by 
5ng MOl back to normal and partially rescue IOng and 20ng MOl phenotypes. 
The error bars show 1 standard deviation from the mean. 
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development, semi-quantitative RT-PCR and in situ hybridisation was performed 
using a range of pronephric marker genes. Embryos were injected at the 1-cell 
stage with 0.5ng Xanx-4 mRNA or lOng Xanx-4 MO1 and cultured to stage 25. 
Two groups of five embryos from each treatment and two groups of five controls 
were selected at random and subjected to RT-PCR using primers designed 
against Mim-1, XPax-2, XPax-8, Xwnt-4, Xwnt-11 and xWT-1 (Table 2.1). EFI a 
is used as a loading control. No obvious effect on RNA expression of any of the 
marker genes was observed (figure 6.13). 
The remaining embryos from the previous experiment, were fixed at stage 27 and 
subjected to in situ hybridisation using RNA probes prepared from cDNA clones 
of pronephric marker genes XPax-8, Xlim-1 and xWT-1. The expression pattern 
of each marker gene RNA in the embryos injected with Xanx-4 mRNA and 
Xanx-4 MO1 were compared to uninjected control embryos (figure 6.14). No 
apparent change in XPax-8 or Mim-1 expression pattern was observed in either 
group with perturbed Xanx-4 expression, compared to uninjected control. 
However, a reduced field of xWT-1 expression was observed in 12/44 of the 
embryos over-expressing Xanx-4 compared to controls. This suggests a reduction 
of glomus tissue. No altered xWT-1 field of expression was seen in the embryos 
injected with Xanx-4 MO1. It seems perturbation of expression of Xanx-4 is not 
linked to any of the tubule markers analysed. We also assume from these results 
that the Xanx-4 knockout phenotype is not associated with more or less tissue 
being specified to become pronephric tubule in character. 
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Figure 6.13 
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Figure 13: Analysis of the effects of Xanx-4 depletion or over-expression 
on the expression of pronephric marker genes by RT-PCR. Embryos wcIV 
injected at 1 cell stage with O. Sng Xans-4 mRNA or IOng Xuwi. 1-4 MO and 
cultured to stage 27. Groups of five embryos were then subjected to R'I -PCR 
using primers designed against a range of pronephric molecular markers. Noy 
effect on expression of any of the markers was observed. I: FI a was used as a 
loading control. 
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6.2.5 The issue of a true rescue. 
Due to the fact that Xanx-4 MO1 was positioned mainly in the coding region of 
Xanx-4 (figure 6.2) it was suggested that the rescue may not be a true rescue. It 
was proposed that the action of the injected Xanx-4 mRNA was of "mopping-up" 
the MO1. In this way, MOl would not be available to bind to and block 
translation of the endogenous message. Concurrently, the injected mRNA would 
not be available for translation and therefore to rescue the phenotype. A true 
rescue would involve the MO directed to the endogenous message and the rescue 
being performed by the protein product of the exogenous mRNA. This type of 
true rescue requires the MO to be effective against the endogenous message but 
ineffective against the injected message. 
To overcome this issue, two possible approaches were available. Firstly, the MO 
is designed to the 5'UTR of the target gene mRNA and the 5'UTR is removed 
from the injected message template prior to in vitro transcription. Alternatively, 
third-base modifications must be made in the exogenous mRNA, so that it is no 
longer recognised by the MO, but which do not effect its function in vivo. A 
second Xanx-4 MO (M02) was ordered against the 5'UTR of the Xanx-4 cDNA 
clone. Unfortunately, it was not possible to place an MO in the 5'UTR region, 
the manufacturer recommended that a MO designed to this region would be 
ineffective. The next best position (as opposed to MO1) would span the ATG but 
would contain only 15 complementary nucleotides in the coding region as 
opposed to 24 in MO! (figure 6.2). A morpholino is proposed to be ineffective if 
it contains 6 or less contiguous complementary residues (P. Morcos Gene-tools, 
pers. comm. ). Therefore, in order for M02 not to recognise the injected Xanx-4 
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mRNA it was necessary to create Xanx-4 mRNA lacking the 5'UTR and 
containing two third-base changes in the first 15 nucleotides of the coding 
region, no more than 6 nucleotides apart. This was carried out using PCR site- 
directed mutagenesis. 
6.2.6 Design and preparation of mutant Xanx-4 mRNA. 
On inspection of the Xanx-4 cDNA sequence, two third-base modifications were 
chosen and the corresponding upstream primer (AN4-MUT) designed including 
an EcoRI restriction site 5' of the ATG which would allow removal of the 5'UTR 
and aid cloning (Figure 6.15, Table 2.2). The Xanx-4-MUT cDNA was amplified 
by PCR (see methods 2.4.5), cloned into expression vector RN3 (appendix 4) and 
the modifications checked by automated sequencing. Xanx-4-MUT mRNA was 
transcribed using T3 RNA polymerase from Sf1 linearised Xanx-4-MUTIRN3 
construct (appendix 4). The mRNA was diluted to 500ug/ml and used in the 
following assays. 
6.2.7 The effectiveness of Xanx-4 M02 with Xanx-4 mRNA and Xanx-4- 
MUT mRNA in vitro. 
6.2.7.1 Xanx-4 M02 blocks translation of Xanx-4 mRNA in vitro. 
Firstly, it was necessary to check that the new MO (Xanx-4 M02) could block 
translation of normal Xanx-4 mRNA. As a simulation of endogenous mRNA in 
vivo, the effectiveness of the Xanx-4 M02 was established in vitro, using Xanx-4 
MO1 as a positive control for the experiment. 100ng of Xanx-4 mRNA was 
incubated either alone or in combination with 1µg of Xanx-4 MO1 or 1µg, 5µg 
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Figure 6.15 
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Figure 6.15: The preparation of Xanx-4-MUT mRNA template. A: The AN4- 
MUT1 upstream primer was designed to the translation start site, incorporating a 
EcoRI restriction enzyme site upstream of the ATG and two third-base changes 
down-stream of the ATG (CHANGE 1 and CHANGE 2). AN4-MUTZ and T7 
primers were used to amplify the Xanx-4 coding region, allowing the 
incorporation of the engineered EcoRI site and the EcoRI site already in Xanx- 
4/pGEM-T Easy construct for cloning into the RN3 vector. The third-base 
changes achieved are shown in B. 
190 
or1Oµg of Xanx-4 M02 in the reticulocyte lysate system. The lysates were 
subjected to SDS-PAGE and autoradiography (Figure 6.16). The Xanx-4 mRNA 
alone was successfully translated (lane 1) but when incubated with I µg of Xanx- 
4 MO1 (lane 2, positive control) or 1µg, 5µg orlOµg Xanx-4 M02, translation 
was almost completely blocked (lanes 3,4 & 5). To test the specificity of the 
Xanx-4 M02,100ng of Xsoxl7ß mRNA was incubated alone or in combination 
with 10µg of Xanx-4 M02. No effect of Xanx-4 M02 on translation of Xsoxl7ß 
mRNA was observed (compare lane 7 to lane 8). Lane 6 was no input control 
sample. This experiment demonstrated that Xanx-4 M02 can block translation of 
Xanx-4 mRNA but not of Xsoxl7ß mRNA in vitro. 
6.2.7.2 Xanx-4 M02 can not block translation of Xanx-4-MUT mRNA in 
vitro. 
Secondly, it was necessary to check that Xanx-4 M02 could not recognise and 
therefore block the translation of Xanx-4-MUT mRNA. The test was carried out 
in vitro using the rabbit reticulocyte lysate system. 100ng of Xanx-4-MUT 
mRNA was incubated either alone or in combination with 1µg, 5µg or 10µg of 
Xanx-4 M02 and subjected to SDS-PAGE and autoradiography (Figure 6.17). 
The Xanx-4 MUT mRNA alone was successfully translated into a protein of 
34kDa, which is in good agreement with Xanx-4 mRNA (lane 1). When 
incubated with 1µg, 5µg orl0µg Xanx-4 M02, no change in the level of 
translation of Xanx-4 MUT mRNA was observed, at any concentration of Xanx-4 
M02 tested (lanes 4,5 & 6). This demonstrated that Xanx-4 M02 cannot 
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Figure 6.16 
Xanx-4 mRNA 
Xanx-4 MO 11 µg 
Xanx-4 M02 1µg 
Xanx-4 M02 5µg 
Xanx-4 M02 10µg 
Xsox17ß mRNA 
+ + + + + - - - 
- + - - - - - - 
- - + - - - - - 
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Figure 6.16: Xanx-4 M02 blocks translation of Xanx-4 mRNA in vitro. 
The rabbit reticulocyte lysate system was used to test whether Xanx-4 M02 
could block translation of Xunx-4 mRNA. 100ng of Xanx-4 mRNA was 
incubated either alone (lane 1) or in combination with Iµg (lane 3), 5pg (lane 
4) or lOpg (lane 5) Xanx-4 M02. It was observed that the Xan. i-4 M02 could 
block translation of Xanx-4 mRNA at any concentration tested. Xan. v-4 MOI 
(lane 2) was used as a positive control. Xsox17/3 was used as a specificity 
control. Lane 6 was no input RNA control. 
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Figure 6.17 
Xanx-4 rRNA 
Xanx-4 M02 1µg 
Xanx-4-MUT mRNA 
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Figure 6.17: Xanx-4 M02 does not block translation of Xanx-4-MUT 
mRNA in vitro. The rabbit reticulocyte lysate system was used to test 
whether Xanx-4 M02 could block translation of' Xanx-4-MUT mRNA. 
100ng of Xanx-4 mRNA was incubated alone (lane 1) or in combination 
with lpg of Xanx-4 M02 (lane 2). The M02 was able to deplete the 
translation of Xanx-4 mRNA. 100ng of Xanx-4-MUT mRNA was incubated 
either alone (lane 3) or in combination with lµ,, (lane 4), 5µg (lane 5) or 
10µg (lane 6) Xanx-4 M02. It was observed that the Xw, x-4 M02 could not 
block translation of Xunx-4-MUT mRNA at any concentration tested. Lane 
7 was no input RNA control. 
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recognise, and is therefore ineffective at blocking translation of Xanx-4-MUT 
mRNA in vitro. Lane 7 was no mRNA input control. 
6.2.8 Xanx-4 M02 produces the same aberrant pronephric tubule 
phenotype, observed using Xanx-4 MO1, which can be rescued by Xanx-4- 
MUT mRNA. 
In order to test the Xanx-4 M02 in vivo, embryos were injected at the 1 cell stage 
with 5ng, lOng or 20ng of Xanx-4 M02 alone or in combination with 0.5ng 
Xanx-4-MUT mRNA. Equal volumes were injected into all embryos. The 
embryos were cultured to stage 40 and wholemount antibody immunostained 
with tubule specific antibody 3G8. Embryos injected with Xanx-4 M02 were 
compared to the embryos co-injected with Xanx-4 M02 plus Xanx-4-MUT 
mRNA and to the un-injected controls. The embryos were examined as 
wholemount specimens (figure 6.18). 
The pronephric tubules of the embryos injected with the Xanx-4 M02 appeared 
in general to be wider, shorter and less coiled than those of the normal control 
embryos, with the most severe aberrant phenotype observed in those embryos 
injected with the higher concentration of M02 (compare Figure 6.18A, C and E 
with G). Those embryos co-injected with 5ng Xanx-4 M02 and 0.5ng Xanx-4- 
MUT mRNA appeared completely rescued. The pronephric tubules appeared 
almost normal (figure 6.18B). The embryos co-injected with lOng and 20ng 
M02 and 0.5ng Xanx-4-MUT mRNA showed partial rescue with the tubules 
being somewhat less normal and displaying some larger and less coiled tubules 
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Figure 6.18 
5ng I Ong 
C 
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Un-injected 
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5ng + Rescue I Ong + Rescue 20ng + Rescue 
Figure 6.18: Xanx-4 M02 produces the same aberrant pronephric tubule 
phenotype as MO1, which can be rescued by co-injection with Xanx-4- 
MUT, analysed by wholemount antibody 3G8 staining of stage 40 injected 
embryos. 1-cell stage Xenopus embryos were injected with 5ng (A), lOng (C) 
or 20ng (E) Xanx-4 M02, alone or in combination with Xanx-4-MUT mRNA 
(B, D, F), cultured to stage 40 and subjected to wholemount 3G8 antibody 
staining. The embryos were compared to normal uninjected control embryos. 
Embryos injected with Xanx-4 M02 show shortened, enlarged diameter tubule 
phenotype, very similar to the Xanx-4 MO1 phenotype previously observed. 
The phenotype appears to become more severe as the concentration of Xanx-4 
M02 injected increases. Xanx-4-MUT mRNA is able to rescue the enlarged 
tubule phenotype (B, D, F). 
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(Figure 6.18D and F). In general the results phenocopied the experiment carried 
out using Xanx-4 MO1 and Xanx-4 mRNA. Other than the pronephric tubule 
phenotype described above, the gross phenotype of the embryos in control and 
rescue groups appeared normal. Occasionally, embryos injected with Xanx-4 
M02 alone appeared to be slightly growth retarded, in some cases being around 
one to two stages behind the control and rescue groups. This was also shown to 
be the case in a small number of embryos in the Xanx-4 MO1 injected embryos, 
but it appeared as a more pronounced effect with M02. A summary of the 
scoring is shown together with a graphical representation Figure 6.19. In a repeat 
of the experiment the same trend was observed. 
6.2.9 Summary 
These experiments demonstrate that injection of M02 produces the same 
aberrant phenotype as MO1. It also confirms that blocking transcription of 
Xanx-4 mRNA using morpholinos directed to Xanx-4 causes a change in the 
morphology of the pronephric tubules in Xenopus laevis. In some cases the 
embryos are retarded in stage and in others the pronephros is completely missing. 
Apart from these observations the embryos appear to be normal in all other 
respects. The aberrant pronephric tubule phenotype observed is one of shortened, 
widened and less coiled tubules, the cells appear to be of normal integrity though 
more cells contribute to a cross-section of the tubule. Either Xanx-4 or Xanx-4- 
MUT mRNA can rescue the aberrant pronephric tubule phenotype. 
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6.3 Discussion 
Morpholinos are a novel antisense strategy for the perturbation of gene 
expression. During the course of this work they have been used successfully to 
specifically interfere with gene expression in a number of model organisms 
including cell lines, zebrafish, Xenopus and chick (Ekker and Larson, 2001). The 
action of the morpholino is to block translation of the target message and is 
unlike conventional antisense strategy that targets the message for degradation 
(Corey and Abrams, 2001). Although, other antisense techniques have worked 
well in less complex organisms, for example C. elegans and Drosphila (eg. 
RNAi), they have proven to be unreliable in vertebrate systems. In contrast, 
morpholinos seem to be the first successful potent and specific antisense strategy 
employed in more complex organisms. Their success has led to speculation for 
their use as novel therapeutics in medicine. 
6.3.1 Xanx-4 morpholinos are specific and potent inhibitors of Xanx-4 gene 
expression in Xenopus laevis. 
Specific inhibition of Xanx-4 mRNA translation in vitro using the rabbit 
reticulocyte lysate system has been shown with the Xanx-4 morpholinos (Figure 
6.3). At the time of writing and to the best of our knowledge this is the first 
example of the testing of morpholino function in vitro in the scientific literature. 
1-10µg of Xanx-4 MO was able to potently and specifically deplete translation of 
100ng of Xanx-4 mRNA. This system could be routinely used to test the function 
and specificity of MO before in vivo experimentation. 
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Specific inhibition of myc-Xanx-4 mRNA translation was observed in embryos 
using the Xanx-4 MO, at all concentrations and stages tested (Figure 6.4). It was 
found that 5-20ng of Xanx-4 MO1 was able to deplete translation of 0.5ng of 
myc-Xanx-4 mRNA in vivo until at least stage 21. This persistence is in 
agreement with the findings of Nutt et al., (2001) who showed that 4ng of GFP 
MO was able to deplete expression of transgenic GFP in Xenopus until around 
stage 38. The highly efficient depletion observed in the in vitro and in vivo tests 
systems suggests that lower amounts of MO would also be effective. 
6.3.2 Xanx-4 depletion in Xenopus laevis results in enlarged and shortened 
pronephric tubules. 
Depletion of Xanx-4 protein in Xenopus laevis leads to the formation of 
shortened, less coiled pronephric tubules with an enlarged diameter (Figure 6.5, 
7,11). The severity of the phenotype increases with the amount of Xanx-4 MO 
injected (5-20ng). The pronephric duct appears to be of normal size and shape 
and connects with the posterior common tubule in the normal way. The highly 
specific effect of Xanx-4 MOs is evident from observations that apart from the 
pronephric phenotype embryos appear morphologically normal and that the 
control MO results in no apparent phenotype. Overexpression of Mim-1 in 
combination with XPax-2 or XPax-8 results in an enlarged pronephric tubule 
phenotype but also results in an increased amount of tubules (Carroll and Vize, 
1999). This similarity in phenotypes implies that Xanx-4 acts downstream of 
XPax-2, XPax-8 and Mim-1, especially as Carroll and Vize report the formation 
of ectopic tubules. 
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6.3.3 A novel strategy for quantitation of pronephric tubule phenotype 
reveals an increased number of cells in the circumference of the pronephric 
tubules. 
Sectioning of MO injected embryos revealed the tubules were of increased 
diameter, had a larger lumen but retained a single layer of epithelial cells of 
normal morphology (Figure 6.7 and 6.11). The novel method of random selection 
of true transverse sections facilitated the quantitation and comparison of the 
average number of cells comprising a tubule circumference in normal and 
effected pronephroi. The average number of cells contributing to a true 
transverse section of a normal pronephric tubule was found to be 9 with a range 
of 6-15 and in the Xanx-4 depleted embryos the average was found to be 25 with 
a range of 6-48. Detailed inspection of numerous sections of pronephroi revealed 
that the nephrostomes and duct of depleted embryos were of normal morphology. 
The wide range of cells contributing to the tubule circumference in depleted 
embryos reflects that the enlarged tubules were connecting to nephrostomes 
anteriorly and duct posteriorly, in a normal manner although this has not been 
fully investigated. An alternative approach to quantifying the phenotype might 
have measured the circumference of the depleted tubules, however this approach 
would have been much less informative. Inspection of sections of embryos 
overexpressing Xanx-4 revealed that overexpression of Xanx-4 had no effect on 
the morphology of the pronephros or the number of cells comprising the tubule 
circumference. This is in good agreement with the results of chapter 4. 
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6.3.4 Xanx-4 depleted tubule phenotype can be rescued by Xanx-4 mRNA. 
Co-injection of Xanx-4 mRNA and MO1 resulted in the rescue of the aberrant 
tubule phenotype, with 0.5ng of Xanx-4 mRNA completely rescuing 5ng of MO 1 
(Figure 6.10). Co-injection of higher amounts of MO resulted in partial rescue of 
the enlarged tubule phenotype. Complete rescue of the embryos injected with 
higher amounts of MO (10,20ng) might have been achieved using increased 
amounts of mRNA. The rescue of MO1 phenotype with mRNA was deemed to 
be not a true rescue because the function of the injected mRNA may have been to 
"mop-up" MO1. It was therefore important to separate the effect of depletion of 
endogenous message from the effect of rescue by introduction of injected 
mRNA. This was achieved by designing a second morpholino, M02 positioned 
9bp 5' of MO1 and also by engineering an mRNA mutated by third base wobble 
to rescue the phenotype. It was found that in the in vitro test system, M02 could 
block the translation of normal Xanx-4 mRNA but was impotent in blocking the 
translation of the mutated mRNA (MUT-mRNA). Injecting M02 into embryos 
resulted in an identical phenotype to that produced with MO1 (Figure 6.18), 
demonstrating that M02 was as effective in depleting Xanx-4 mRNA translation 
as MO1. It also demonstrates that the location chosen for the morpholino to be 
positioned can be moved without diminishing efficacy. It seems likely that 
multiple positions proximal to the ATG would be similarly effective. Co- 
injecting MUT-mRNA and M02 resulted in a true rescue of the pronephric 
phenotype (Figure 6.18). This clearly demonstrates that the aberrant phenotype is 
the result of specific depletion of Xanx-4 protein. Assuming that the alterations 
to MUT-mRNA did not significantly increase its stability, the ability of MUT- 
mRNA to rescue the phenotype clearly demonstrates that Xanx-4 protein 
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translated from injected mRNA persists long enough to exert its function. This 
represents strong evidence that the lack of Xanx-4 over-expression phenotype 
(chapter 4) is not due to lack of persistence of injected Xanx-4 mRNA or its 
protein product. The lack of a phenotype associated with over-expression of 
Xanx-4 is the result of increased levels of Xanx-4 protein not having an 
observable morphological effect. One explanation for this result is that Xanx-4 
may need to interact with other factors to perform its function. Annexins have 
been shown to have binding partners, in particular members of the S 100 family 
(Garbuglia et al., 2000) and annexin IV has been shown to bind to surfactant 
protein A in lung epithelia (Sohma et al., 1995). 
6.3.5 Pronephric tubule phenotype is a result of morphological perturbation. 
The effect of perturbation of Xanx-4 expression by morpholino injection and 
Xanx-4 mRNA over-expression on pronephric marker genes has been analysed. 
By RT-PCR (Figure 6.12) it has been shown that there is no effect on expression 
of Mim-1, XPax-2, XPax-8, xWnt-4, xWnt-11 and xWT1 by either depletion or 
over-expression of Xanx-4. It therefore seems that perturbation of Xanx-4 
expression by morpholino does not result in a difference in the amount of 
pronephric tissue specified. With the exception of xWT1 all other markers used 
are also expressed in other tissues, it could not be ruled out that overexpression 
or depletion of Xanx-4 was effecting non-pronephric domains of expression. For 
example it is possible that pronephric expression was reduced concurrent with an 
increase of expression in another domain, the total expression thereby remaining 
unchanged. 
202 
To investigate this possibility wholemount in situ hybridisation using Mim-1, 
XPax-8 and xWTJ specific probes was performed on control, Xanx-4 depleted 
and Xanx-4 over-expressing embryos (Figure 6.13). No effect was observed on 
the pronephric domains of Mim-1 and XPax-8, although the expression of the 
glomus specific gene xWT1 was reduced by over-expression of Xanx-4. Due to 
the similarity of phenotype between Xanx-4 depletion and Xlim-1/XPax-2/8 
overexpression (Carroll and Vize, 1999), the observation that Xanx-4 depletion 
does not effect the amount of pronephric tubule tissue specified provides further 
evidence that Xanx-4 is downstream of Xlim-1/XPax-2/8 in a molecular pathway 
of tubule specification. Further experiments will examine the effect of over- 
expression of Xlim-1 and XPax-2/8, alone or in combination, on Xanx-4 
expression. 
The effect of Xanx-4 over-expression on xWT1 was unexpected as no Xanx-4 
over-expression phenotype was previously observed (chapter 4). The fact that 
RT-PCR analysis gave similar levels of xWT1 expression in controls and Xanx-4 
over-expressing embryos suggests that the effect of Xanx-4 over-expression 
results in more diffuse expression of xWTl. This is consistent with the results 
observed in the xWT1 in situ hybridisation of embryos over-expressing Xanx-4, 
where in some embryos xWT1 expression was not seen. Further experiments will 
examine the effect of Xanx-4 expression on the glomus. 
6.3.6 Possible explanations for enlarged tubule phenotype. 
It seems unlikely that the enlarged pronephric tubule phenotype seen in embryos 
injected with Xanx-4 morpholinos is the result of a defect in the osmotic function 
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or electrolyte transport of the kidney. A number of mutants identified in the 
zebrafish genetic screen (Driever et al., 1996) display a pronephric phenotype. 
Analysis of the mutants (Drummond et al., 1998) revealed that the visible 
unifying phenotype of all the mutants was the appearance of fluid-filled cysts in 
the region of the pronephros. These included cyst formation in the glomerulus, 
duct and tubules. It was suggested that these phenotypes were the result of 
defects in osmoregulation and electrolyte transport. In mutants displaying cystic 
tubules the tubule epithelial cells were flattened and distorted by the pressure of 
fluid in the lumen. These defects were also accompanied by severe axis 
curvature and general oedema. Since the enlarged pronephric tubule phenotype 
observed in Xanx-4 depleted embryos displayed normal tubule epithelial cell 
morphology, no general oedema or axis curvature, it is unlikely that this 
phenotype is the result of defective electrolyte transport or osmosis. 
Annexins have been shown to bind actin in various systems (Raynal and Pollard, 
1994). In an epithelial sheet, each cell has a contractile bundle of actin filaments 
forming a belt-like structure around the circumference of the cell at the level of 
the adherens junctions. The tightening of these adhesion belts is known to be 
involved in the formation of the neural tube in early vertebrate development 
(Schoenwolf and Smith, 1990). Although tubulogenesis in the formation of the 
pronephros may be formed by an alternative mechanism, it presumably involves 
remodelling of the actin cytoskeleton. The enlarged tubules phenotype observed 
might be the result of failure to mediate actin dependent morphological changes 
in tubulogenesis. Although annexin IV has not been shown to directly interact 
with actin in any developmental system, it might be that it exerts its effect 
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indirectly. The effect of Xanx-4 depletion on remodelling of the actin 
cytoskeleton during the formation of the pronephric tubules could be tested by 
detecting localisation of actin filaments in wholemount with anti-actin antibodies 
and confocal microscopy. 
In normal development, embryos at stage 35 the pronephric tubules formed and 
appear as the characteristic Tor shape. Further development of the pronephric 
tubules involves their extension to form the mature highly coiled structure. At 
stage 35, the embryos depleted in Xanx-4 expression appear morphologically 
normal as to their pronephric structure. It therefore seems likely that the enlarged 
tubule phenotype, with a greater circumference of morphologically normal cells, 
is the result of a defect in tubule extension between stages 35 and 42. The 
process of nephrogenesis in the mouse metanephros does not appear to involve 
active movement of epithelial cells. Although the process of tubulogenesis in the 
pronephros is not known, the involvement of Xanx-4 in pronephric tubule 
extension would probably not be in mediating changes in cell adhesion at 
adherens junctions if it is assumed that tubule extension does not involve active 
cell movement. The relationship of calcium in annexin re-localisation could 
conceivably be involved in the depletion of calcium required to slacken the cell- 
cell adhesion between cadherins at adherens junctions (De Simone, 1994). A far 
more likely hypothesis is that depletion of Xanx-4 expression in pronephric 
tubules results in defects in direction of epithelial cell division during the 
extension phase of tubulogenesis. If the extension of pronephric tubules is 
mediated by directed cell division then a defect causing randomisation of cell 
division would result in shortened tubules enlarged by a greater number of cells 
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in the circumference, especially if we assume that cells do not divide to produce 
a multi-layered epithelium. The aberrant pronephric tubule phenotype observed 
in embryos depleted of Xanx-4 expression would fit this hypothesis well. This 
hypothesis could be tested by analysing direction of cell division in wholemount 
control and Xanx-4 depleted embryos using anti-a tubulin antibodies and 
confocal microscopy. It seems likely that the role of Xanx-4 in the extension 
phase of pronephric tubules may be an involvement in the orientation of directed 
cell division and not in osmotic and/or electrolyte transport, actin re-modelling 
(Xanx-4 seems to be required after the tube is formed) or calcium-dependent 
changes in cell adhesion. Further experiments will help to elucidate this 
mechanism. 
7 Discussion - Annexins and their biological roles and the potential role of 
Xanx-4 in pronephric development. 
7.1 The annexin family 
Annexins are a family of calcium-dependent phospholipid and carbohydrate 
binding proteins. There are currently 13 annexin family members that have been 
discovered in vertebrates, invertebrates, fungi and plants (European Annexin 
Homepage). They share common properties due to their homologous core 
domain, with approximately 50% amino acid identity in this region between 
family members. The C-terminal annexin core domain is a 33kDa region 
composed of four (or eight in respect to annexin VI) highly conserved 70 amino 
acid repeats (Figure 7.1), including Ca2' and phospolipid binding sites 
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Figure 7.1 
Annexin I 
N Ii 2C 
" Annexin VI 
Nj 1234567RC 
Annexin VII 
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ýC Actin " PKC 
SIOOC 
Figure 7.1: Annexin family members share a highly conserved domain 
structure. A schematic diagram comparing the domain structure of three annexin 
family members; annexin I, VI and VII. Annexin VI contains six of the highly 
conserved core domain repeats, whereas annexin I and VII contain four. Ca2/PL: 
Calcium and phospholipid binding domains. actin: Actin binding motif, SIOOC: 
S-1000 binding motif, ATP/GTP: hypothetical binding sites, PKC: Protein 
kinase C phosphorylation site (Redrawn based on Bandorowicz-Pikula et al., 
2001). 
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(Seaton, 1996). X-ray crystallography studies have revealed that each of the four 
repeats in the core domain contains five a-helices connected by short loops, in 
the centre of which is a hydrophilic pore (Figure 7.2). Two loops together form 
each of the type-II Ca2+ binding sites. The core has a globular doughnut shape 
with the Ca2+ binding sites grouped on the convex face. In the presence of 
calcium, annexins are found in close association with plasma membranes. This 
high affinity membrane association is mediated, in the presence of Cat+, by the 
type-II binding sites and the polar head group of the acidic phospholipids on the 
surface of the membrane (Liemann and Huber, 1997). In the membrane-bound 
state, the N-terminal region faces away from the membrane surface (intracellular 
or extracellular environment) and contains phosphorylation sites and 
protein: protein interaction sites. The N-terminal region is highly variable 
amongst annexin family members and is thought to confer their specificity 
(Morgan et al., 1999). 
In chemical cross-linking (Kirsch et al., 1997) and cryoelectron microscopic 
studies (Pigault et al., 1994) annexins have been shown to bind phospholipid 
membranes in ordered arrays, and it has been suggested that annexin complexes 
may function to modify membrane structure. The current excepted model of the 
mechanism of action of many of the annexins is as follows (Figure 7.3). When 
intracellular free calcium is low, the annexins are in their soluble and 
unaggregated resting state. A rise in calcium, subjacent to the membrane, triggers 
the annexins to rapidly bind to the membrane surface and self-associate. These 
annexin ordered arrays cause changes in the membrane fluidity, segregation of 
phospholipids and in the properties of other membrane-bound proteins and 
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Figure 7.2 
Figure 7.2: Ribbon diagram of the membrane bound form of 
annexin protein. The four repeats in the core domain are shown in 
yellow, dark blue, pale blue and green. The red spheres indicate 
calcium bound to the loop regions. The grey floor shows the plane 
of the membrane. The N-terminal domain is depicted by the red 
ribbon (selected from the European Homepage, structure database). 
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Figure 7.3 
Figure 7.3: Annexins bind to phospholipid membranes in ordered 
arrays. The model depicts a proposed mechanism of annexin IV inhibition 
of CaM KII-mediated ion channel activation. In the presence of calcium 
annexin forms Submembrane scaffolding which prevents chloride ion 
channel phosphorylation and channel opening. In the absence of annexin 
(shown here competed away using anti-annexin antibody) no aggragates 
form and the channel is activated. ANX: annexin IV molecules, Ab: 
antibody (Reproduced from Chen et al., 1994). 
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enzymes (Oling et al., 2000). This activity may be general enough to account for 
the many apparent functions of annexins. The mechanism of extracellular 
annexin action is thought to be similar but that acidic phospholipids would 
trigger the response rather than a rise in free calcium (Seaton and Dedman, 
1998). 
Although annexins have been extensively studied their exact biological function 
remains to be elucidated. Annexins have been well characterised with regard to 
their tissue localisation and their binding activities and have been shown to 
participate in a broad range of physiological processes including calcium 
homeostasis, regulation of ion channel activities, inflammation, anticoagulation 
and membrane traffic events. 
Annexins translocate in response to changes in intracellular calcium. 
It is believed that the ability of annexins to shift from a soluble to a membrane 
bound state upon a rise in free calcium, forms the basis of annexin cellular 
function. Barwise and Walker (1996) demonstrated that annexins I, II, IV, V and 
VI are present in human foreskin fibroblasts in distinctive subcellular locations 
with I, II and VI being cytoplasmic and IV and V being nuclear. On elevation of 
intracellular calcium the annexins relocate to the plasma (I, II, VI) or nuclear (IV, 
V) membrane. The authors suggest a role for these annexins in calcium handling, 
signal transduction and membrane cytoskeletal interactions. Massey-Harroche et 
al. (1995) demonstrated polarised expression of annexin IV in renal proximal 
tubules in the rabbit. The localisation of annexin IV was investigated in cultured 
proximal tubule cells. They found that when the cells were attached to the base 
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of the culture dish, annexin IV was localised around the nucleus. On further 
culturing the cells formed domes. Analysis of cells derived from the domes 
revealed that annexin IV was localised to the basolateral membrane. Eventually 
when the domes burst and the cells returned to be attached to the dish, annexin 
IV localisation returned to the nuclear membrane. It is suggested, therefore, that 
there is a correlation between annexin IV localisation and the organisation of the 
cytoskeleton and /or cell junctions. 
Ion channel activities of the annexins. 
A number of annexins have been shown to play a part in intracellular Ca2' 
signalling by acting as atypical ions channels (Pollard et al., 1992; Burger et al., 
1996) and as modulators of ion channel activity (for review see Hawkins et al., 
2000). In one particular study Isas et al., (2000) demonstrated that both annexin 
V and XII are able to reversibly insert into lipid bilayers and form ion channels. 
The model presented involves the Ca2+ and H+ switching of annexin membrane 
association. The annexin is a monomer in solution and on presence of free 
calcium the annexin assembles into trimers on the surface of the membrane. In 
conditions of low pH major structural reorganisation occurs and the protein 
inserts into the lipid bilayer. The annexin can be reversibly converted between 
the three states and the equilibrium is controlled by the concentration of 
hydrogen and calcium ions. An in vitro study using large unilamellar vesicles, 
the authors demonstrated that annexins I, II, V and VI display, to varying 
degrees, calcium ion transport activity (Matsuda et al., 1997). Characterisation of 
the human annexin V ion channel using mutantional analysis demonstrated that 
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the hydrophilic pore, in the centre of the helical bundles, is the ion-conducting 
pathway (Liemann et al., 1996). 
Annexin N has been shown to have an inhibitory role in the regulation of 
epithelial calcium-activated chloride ion conductance channel activity. Kaetzel et 
al., (1994) introduced exogenous annexin IV protein into a human colon cell line 
T84 which resulted in the prevention of Cat+-dependent Cl' current activation; 
introduction of anti-annexin IV antibody or oligonucleotides antisense to annexin 
IV resulted in the enhancement of activation of this current. The authors suggest 
that the annexin N plays a role in the modulation of membrane ion channel 
activity. A further study using the same system, the authors demonstrated that in 
the presence of free calcium aggregates of annexin IV form a submembrane 
scaffold, preventing Cl- channel phosphorylation by Ca2+/calmodulin kinase II 
(CaM KII) and therefore a reduction in channel open state. This study 
demonstrates that annexins, cytoplasmic kinases and ion channels can interact to 
modulate membrane conductance (Chan et at., 1994). 
Annexins in membrane fusion events. 
Many cellular events are dependent upon membrane fusion mechanisms 
including fertilisation, cell division and exocytosis and endocytosis. It has been 
demonstrated that a number of annexins, including I, II, IV and VII, can promote 
membrane aggregation (Creutz, 1992). Recent studies suggest that annexin I has 
two separate interaction sites that are involved in membrane binding and 
aggregation respectively. It has been proposed that annexin I binds to the 
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phospholipid membrane and forms a laterally aggregated monolayer which 
directly interacts with a second membrane via its induced hydrophobic 
interaction site (Bitto et al., 2000). Annexin II has been shown to be essential for 
exocytosis of lamellar bodies from alveolar epithelial cells of rat lungs which, 
implicates annexin II in lung surfactant secretion (Liu et al., 1996). Annexin 
XIIIb has also been implicated in exocytosis in the kidney and lungs (Lafont et 
al., 1998). Sohma et al., (1995) demonstrated that annexin IV was the major 
protein bound to the surfactant protein A and lamellar bodies in alveolar type II 
cells in rat lungs. In a further study in the same system, annexin IV was 
implicated in exocytosis (Sohma et al., 2001). A medaka annexin, max 3, is 
present as a maternal pool in unfertilised eggs and has been shown to be able to 
bind phospholipids and aggregate membrane vesicles. The authors suggest max 3 
plays a role in cortical granule exocytosis (Spenneberg et al., 1998). 
Annexin II and VI have been implicated in endocytosis. Inhibition of annexin VI 
by immunodepletion or application of a dominant-negative form of annexin VI 
blocks endocytosis in an in vitro assay using purified fibroblast plasma 
membranes (Lin et al., 1992). A number of in vitro assays have suggested a role 
for annexin II in the fusion event of endocytosis. One current hypothesis suggests 
that on binding to protein p 11, annexin II can bridge endosomes to the cortex of 
the cell, through interactions between rafts and the actin cytoskeleton, thus 
leading to endocytosis (Lecat and Lafont, 1999). Merrifield et al., (2001) have 
used evanescent-field microscopy to study annexin II-GFP in cells performing 
pinocytosis. Although no evidence was seen for a role of annexin II in 
exocytosis, annexin II-GFP was seen to be associated with actin tails propelling 
214 
macropinosomes. It was shown by introducing a dominant-negative annexin 11 
construct that annexin II is required for the formation of these macropinocytic 
rockets. Other annexins have been shown to be associated with the actin 
cytoskeleton. Tzima et al., (2000) have shown that annexin V binds preferentially 
to y-actin but not (3-actin in activated platelets. Filipenko and Waisman (2001) 
have shown by site-directed mutagenesis, that the C-terminus is required for 
annexin II to bind to F-actin. 
Apoptosis and annexin V 
Annexin V is routinely used as a marker of apoptosis (van Engeland et al., 1998). 
Loss of plasma membrane asymmetry, exposing phosphaditylserine (PS) 
residues on the outer membrane is an early event in apoptosis. Annexin V can 
strongly and specifically bind PS thus allowing the detection of apoptotic cells 
with labelled protein or protein plus antibody. 
Annexins as nucleiotide binding proteins 
Annexin V, VI and VII have been shown to bind GTP (Arispe et al., 1996; 
Bandorowicz-Pikula and Awasthi, 1997; Caohuy et al., 1996). Annexin I has 
been shown to bind ATP (Han et al., 1998) and cAMP but not GTP or cGMP 
(Cohen et al., 1995). Cat+-homeostasis, vesicular transport and signal 
transduction pathways could be regulated by nucleotide binding to annexins, 
thereby linking them to cellular energy metabolism. Annexins do not contain the 
Walker consensus motifs for ATP/GTP binding and are thought to contain a 
novel ATP/GTP binding fold (review by Bandorowicz-Pikula et al., 2001). 
215 
Nucleotide binding domains are thought to be within the repeated domains 
known to mediate Ca2+ and phospholipid binding, ATP/GTP binding to annexins 
might therefore be regulated by membrane binding (review by Bandorowicz- 
Pikula et al., 2001). Annexins are thought to undergo conformational changes 
upon nucleotide binding akin to other ATP-binding proteins (Bandorowicz- 
Pikula et al., 1997). It is possible that annexins function to modulate activity of 
other GTP-binding proteins. Annexin VI has been shown to interact with 
p120GAp, a GTP-binding protein that regulates p21r` by direct interaction (Davis 
et al., 1996); interestingly p120GAP becomes associated with membranes in 
response to elevated intracellular Ca2+ levels. Annexins have also been found to 
interact with dynamin (a GTPase involved in endocytosis) (Turpin et al., 1998), 
synapsin I (an ATP-binding protein in synaptic vesicles) (Inui et al., 1994) and 
ATP-binding cytoskeletal proteins (Jones et al., 1992; Babiychuk et al., 1999). It 
has been postulated that annexins might be a new class of GEFs (guanine- 
nucleotide-exchange factors) or GAPs (GTPase-activating proteins), however 
annexins probably do not interact with G proteins very specifically and instead 
regulate interaction of GAPs and/or GEFs with membranes (reviewed by 
Bandorowicz-Pikula et at., 2001). Additionally, annexin VII has Cat+-stimulated 
GTPase activity (Caohuy et al., 1996; Pollard et at., 1998). The intracellular 
localization of annexin VII is important in exocytotic membrane fusion and 
secretion in chromaffin cells, it has been proposed that annexin VII is an atypical 
G protein that is responsible for detecting the Cat+/GTP signal for exocytosis 
(Pollard et at., 1998). 
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In addition to effects on G proteins conferred by GTP binding, annexins are 
implicated in the G protein mediated phosphoinositide (PI) cascade. This cascade 
is initiated by the activation of phospholipase C and results in the cleavage of the 
membrane bound phospholipid PIP2 into IP3 (opens calcium channels) and DAG 
(activates protein kinase C, PKC). PKC phosphorylates many target proteins and 
is only active in the presence of calcium and phosphotidylserine (reviewed by 
Nishizuka, 1992). Most annexins are substrates for PKCs with the exception of 
annexin V (reviewed by Dubois et at., 1996). Mutational analysis of annexin IV 
has revealed that although phosphorylation by PKC is not required for annexin 
IV membrane localisation, it is required for vesicle aggregation in vitro (Kaetzel 
et al., 2001). 
Anti-inflammatory and anticoagulant activities of annexins. 
Annexin I has been shown to function as an anti-inflammatory protein and is 
upregulated by glucocorticoids (reviewed by Adcock and Ito, 2000). 
Glucocorticoids are used in the treatment of inflammatory diseases (eg. asthma). 
Binding of glucocorticoids to a cytosolic glucocorticoid receptor (GR) facilitates 
translocation to the nucleus resulting in regulation of transcription of target 
genes. Glucocorticoids have detrimental side-effects that are thought to be 
caused by undesirable effects on transcription and there is much interest in 
identifying novel glucocorticoids that induce anti-inflammatory effects without 
side-effects. A study by Antonicelli et al. (2001) has shown in vitro that 
treatment with dibutyryl cAMP or the glucocorticoid, dexamethasone, results in 
activation and binding of CREB (CRE-binding protein) to a cAMP response 
element (CRE) identified in the annexin I promoter. 
217 
Annexin II has been shown to act as an anticoagulant by increasing activation of 
plasmin via interaction directly with plasminogen (inactive plasmin precursor) 
and with tissue plasminogen activator (activates plasminogen by proteolytic 
cleavage) (Hajjar et al., 1994; Cesarman et al., 1994). It has been suggested that 
annexin II forms a platform on the surface of endothelial cells to facilitate 
binding of plasminogen and tissue plasminogen activator. Patients with acute 
promyelocytic leukemia (APL) exhibit increased fibrinolysis correlated with 
increased levels of annexin II expression (Menell et al., 1999). It has also been 
reported that annexin II tetramers (AIIt) can inhibit fibrinolysis by stimulation of 
plasmin autodegradation suggesting that Alit is involved in regulation of plasmin 
activity on the fibrin clot surface (Kang et al., 1999; Choi et al., 2001). 
Annexins in the extracellular matrix 
The extracellular matrix contains various proteoglycans and fibrous proteins of 
two functional types; mainly structural (eg. collagen) and mainly adhesive (eg. 
fibronectin and laminin). Glycosaminoglycans (GAGs) are usually attached to 
protein cores forming proteoglycans. Proteoglycans display distinct spatio- 
temporal expression patterns during development and their GAG side chains 
interact with a large number of proteins facilitating function in matrix 
organisation, proliferation, cell adhesion and differentiation. Annexins have been 
shown to have different GAG binding properties (Ishitsuka et al., 1998) 
suggesting that annexins may be involved in extracellular processes. A number 
of annexins have been found in the extracellular milieu. In one particular study it 
was discovered that annexin I is exported from prostate cells where it was found 
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to associate with the surface of the cells in a Ca2+ dependent manner (Christmas 
et al., 1991). Although they have been shown to bind to, and insert into 
phospholipid membranes, secretion of annexins as free molecules seems unlikely 
as they lack a hydrophobic signal sequence that is normally required for targeting 
the protein to the endoplasmic reticulum. Interestingly, there are a number of 
molecules which have been shown to be secreted from cells through a leaderless 
pathway (Rubartelli et al., 1992). Some annexins (I, II) have been shown to be 
expressed on the surface of tumor cell lines, suggesting a role for annexins in 
cell-cell adhesion processes in metastasis (Yeatman et al., 1993; Pencil et al., 
1993). Annexins II, V and VI have been shown to bind collagen and have been 
identified as major components of matrix vesicles (von der Mark and 
Mollenhauer 1997). Matrix vesicles have a critical role of initiating the 
mineralisation process during ossification,., Types II and X collagen were found to 
bind to liposomes in the presence of annexin V which stimulated the influx of 
Ca2' into the liposome. The authors suggest that the role of annexin V is to 
provide a conductivity pathway for the loading of Ca2+ in to matrix vesicles 
(Kirsch et al., 2000). 
7.2 Summary and final discussion 
The review of the annexin literature presented in section 8.1 shows that annexins 
appear to be involved in a wide range of cellular processes. The majority of 
studies on annexin function have been performed in vitro and in order to 
determine whether these in vitro studies are relevant in vivo, it will be of great 
benefit to analyse the function of annexins in developmental systems. To date, 
two annexin-null mutant mice have been reported. Hawkins et al., (1999) found 
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that a null mutant mouse for annexin VI had no definable phenotype. Although it 
was suspected that disruption of annexin VI would effect cardiovascular function 
the mice had normal heart rate blood pressure and displayed normal 
cardiovascular responses to septic shock. Therefore the annexin VI gene is not 
essential for mouse viability and there is probably redundancy between annexins. 
Interestingly, overexpression of annexin VI with a heart specific promoter results 
in mice with congestive heart failure (Gunteski-Hamblin et al., 1996). Calcium is 
a primary regulator of cardiac function, the authors suggested that annexin VI is 
involved in regulation of calcium homeostasis in the heart. Srivastava et al., 
(1999) found that generation of a null mutant for annexin VII resulted in 
embryonic death at day 10 as a result of cerebral hemorrhage. Heterozygous 
annexin VII (+/-) mice were found to be deficient in circulating insulin although 
insulin was present at 8-10 fold higher concentration in the pancreatic islets. It 
has long been thought that annexin VII has a role in Cat+-dependent exocytotic 
secretion events. The authors showed that lowering the level of annexin VII 
causes defects in Ca2+ signal transduction and insulin secretion. The mechanism 
of the defect is suggested to be one of depletion of expression of (inositol 1,4,5- 
triphosphate) IP3 receptors resulting in reduced release of intracellular calcium 
and reduced insulin secretion. 
It appears therefore that disruption of annexin expression in developmental 
systems can yield important functional data, although this has not yet been 
accumulated for annexin IV. 
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The aim of the subtractive hybridisation screen performed in this laboratory was 
to identify novel genes involved in pronephric development. The isolation and 
characterisation of Xanx-4 has resulted in the identification of a useful marker of 
pronephric tubules. The only other specific markers for pronephric tubules are 
XSMP-30 (Sato et al., 2000) and monoclonal antibody 3G8 (Vize et al., 1995). 
However, Xanx-4 is detectable at stage 26 by in situ, much earlier than XSMP-30 
and 3G8 and therefore is a more useful marker for the analysis of early 
pronephric development and presumably has an important functional role. It 
would be interesting to isolate the zebrafish homologue of Xanx-4 and ascertain 
whether it displays pronephric tubule-specific expression. Adult expression of 
Xanx-4 is less restricted and is found in many epithelial tissues with particularly 
high expression in the gall bladder which, may indicate a role in the secretion of 
bile. The wider expression of Xanx-4 in adult frogs is in good agreement with 
expression of annexin IV in higher vertebrates. Characterisation of other 
annexins in developmental model organisms may reveal similarly highly 
restricted expression profiles during embryogenesis as Xanx-4. In common with 
Xenopus annexin II and VII and fish annexins maxl-5, Xanx-4 is expressed 
maternally. This may reflect a role for annexins in the earliest stages of 
fertilisation and/or development driven by maternal transcripts in lower 
vertebrates. 
In order to determine the function of Xanx-4 in pronephric tubule development, 
overexpression and perturbation of gene expression analyses have been 
performed. Xanx-4 overexpression results in no mutant phenotype and it has been 
argued that this is not due to a lack of persistence of exogenous mRNA since the 
221 
phenotype induced by injection of Xanx-4 morpholino can be rescued by Xanx-4 
mRNA. Interestingly, this is opposite to the results of annexin VI knockout and 
overexpression in the mouse, where knockout results in no phenotype and 
overexpression does. However, expression driven specifically in the pronephros 
(transgenic) was not carried and might result in a pronephric phenotype. The 
phenotype observed in Xenopus embryos, injected with Xanx-4 morpholino, is 
evidence for the requirement of Xanx-4 during morphogenesis of pronephric 
tubules. It has been argued that the enlarged tubule phenotype is not the result of 
osmotic dysfunction. This is supported by the observation that tadpoles do not 
display general oedema or cystic pronephric components, but this has not been 
tested directly by physiological measurements. In fact apart from the enlarged 
tubules tadpoles are otherwise normal; it would be interesting to ascertain 
whether they are equally viable at later stages of development that is post onset 
of feeding and into metamorphosis. A number of annexins have been shown to 
be capable of inserting into membranes, acting as functional ion channels and are 
also thought to be involved the modulation of ion channel activity. It is therefore 
possible that the depletion of Xanx-4 results in defects in ion transport, although 
this does not seem to effect the function of the pronephros in maintaining water 
balance. The formation of larger tubules in Xanx-4 depleted embryos might 
reflect a defect in rearrangement of the actin cytoskeleton during tubulogenesis. 
It has been argued that this seems unlikely as the phenotype observed is not 
manifested until after the tubules are formed, they appear normal at stage 35. The 
effects of depletion of Xanx-4 appear during the maturation of the pronephros 
when the tubules elongate and coil. A further experiment conducted in a stepwise 
fashion during the stages of pronephric tubule elongation (stages 35-40) could be 
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conducted to analyse the effect of Xanx-4 depletion during pronephric 
maturation. 
It has been argued that a defect in the direction of cell division during tubule 
extension would explain the phenotype seen in Xanx-4 depleted embryos. The 
increased number of cells in a tubule circumference being generated by cell 
division orientated perpendicular to the direction of tubule extension. Consistent 
with a role for annexins in proliferation, annexin II has been shown to be 
regulated during cell cycle of CHO and HeLa cells (Chiang et al., 1993) and has 
also been shown to be required for DNA replication in Xenopus egg extracts 
(Vishwanatha and Kumble, 1993). Additionally, extracellular annexin II has been 
shown to stimulate proliferation of osteoclast precursors in human marrow 
cultures (Menaa et al., 1999). Furthermore, phosphorylation of annexin I has 
been linked to HGF induced proliferation in the A549 lung carcinoma cell line 
(Skouteris and Schroder, 1996). 
Regulation of direction of cell division occurs in the mouse embryo when the 
morula undergoes the 8-16 cell and 16-32 cell divisions. The morula consists of 
peripheral polar cells (polarised by microvilli on external surface) and internal 
apolar cells, dividing polar cells divide conservatively (symmetric) or 
differentiatively (asymmetric) to compensate for inequalities in the ratio between 
the two types of cells (Fleming, 1987). During murine cortical neurogenesis in 
the ventricular zone, proliferating neural progenitors can divide symmetrically to 
generate two new progenitors or asymmetrically to generate one new progenitor 
and one neuronal precursor (Price and Willshaw, 2000). Direction of cell 
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division is thought to be important in this process and pax6 null mutant mice 
have been shown to display altered ratios of symmetric to asymmetric division 
(D Price, University of Edinburgh pers. comm. ). It is therefore possible that 
direction of cell division is tightly regulated during extension of pronephric 
tubules. Although a defect in direction of cell division would seem to account for 
the enlarged tubule phenotype observed in Xanx-4 depleted embryos, it is 
difficult to envisage how Xanx-4 might be involved in such a process. It would 
seem that a cell division that generated a two-cell thick tubule wall is not 
normally seen in tubule epithelia. There is a clear polarity in the apical and basal 
surfaces of the epithelial cells. However, there is currently no evidence 
suggesting polarity in cells contributing to the length of the tube, rather than the 
circumference. It could be hypothesised that the lateral junctions of cells 
contributing to the circumference of the tubule are subjected to different pressure 
or have differential adhesive properties to the lateral junctions of the same cells 
that contribute to tubule length. This would introduce an asymmetry or cell shape 
necessary to control direction of cell division, Xanx-4 might be implicated in the 
regulation of this process. Since Xanx-4 is localised on the apical surface of 
epithelial tubule cells it seems difficult to envisage how it would contribute to 
such an asymmetry. It is currently not known whether Xanx-4 protein is located 
on the extracellular or intracellular side of the apical membrane, or indeed 
whether it is a transmembrane protein. There is evidence in the literature for 
multiple sub-cellular locations for annexin family members. The exact sub- 
cellular location could be identified by step-wise extraction of Xanx-4 from 
pronephric tubule epithelia using calcium chelators and detergents and immuno- 
gold electron microscopy. Factors that control the asymmetric expression of 
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annexin IV are unknown. It would be interesting to analyse the control of the 
apical localisation of Xanx-4, possibly by site directed-mutagenesis or GFP- 
labelled truncation mutatants. To ascertain whether there is an alteration of cell 
division in the pronephric tubules of Xanx-4 depleted embryos it will be 
necessary to analyse direction of cell division using anti-a tubulin antibodies and 
confocal microscopy. Initial attempts at anti-a tubulin staining were too non- 
specific to interpret. It would also be interesting to analyse proliferation during 
tubule extension to ascertain whether this occurs in discrete regions or 
throughout the tubule length. If Xanx-4 is implicated in direction of cell division, 
it could be used to screen for other factors involved in this process. Initial 
analysis of cell division within the pronephros suggested that low levels of 
division were occuring in tailbud stages. However, a more complete study needs 
to be performed. 
It has been found that antisense morpholino oligonucleotides are a very efficient 
and reliable method of interfering with gene expression. This observation is 
confirmed by the success of other researchers that have reported the use of 
morpholinos in a number of developmental systems. The use of mutant mRNA in 
the rescue experiment allowed the depletion of endogenous Xanx-4 to be 
uncoupled functionally from the rescue event. It is therefore certain that Xanx-4 
M02 interferes with the expression of Xanx-4 and not with any non-specific 
targets. 
The efficacy of RNAi has been tested in Xenopus oocytes and embryos. 
Evidence has been presented that RNAi specifically depletes Xanx-4 protein 
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levels in oocytes. However, due to seemingly inconsistent results on depletion of 
Xanx-4 mRNA in both oocytes and embryos, further experimentation would be 
required to ascertain whether this method of interfering with gene expression can 
be used routinely. RNAi was tested at a time when no reliable, sequence-specific 
method of depletion of gene expression was available to developmental 
biologists working in Xenopus and zebrafish. The results presented in this thesis 
and by other researchers clearly show that antisense morpholino oligonucleotides 
present a far more reliable method for the interference of gene expression than 
RNA1. Due to the ability to uncouple the rescue event and the interference event, 
morpholinos have the advantage of confirming the specific nature of the 
phenotype observed. The observation that siRNA resulted in a reduced tubule 
phenotype was unexpected since no reduction in mRNA levels was detected in 
embryos. Whether this phenotype represents a specific reduction of Xanx-4 
protein remains to be determined. This could be performed by co-injection of 
siRNA and myc-Xanx4 mRNA in Xenopus embryos to ascertain whether Xanx-4 
protein levels are reduced. If this phenotype is the result of specific depletion of 
Xanx-4 it might be that it represents a milder phenotype to that observed by 
injection of morpholino. It is worthy of note that Xanx-4 morpholino injection 
occasionally results in reduced or missing tubules. Therefore the reduced tubule 
phenotype induced by siRNA and occasionally by morpholino injection might be 
the result of increased apoptosis or reduced proliferation in the pronephric 
tubules. Further experiments will determine whether this is the case. 
Further experiments could include overexpression (injection of mRNA) and 
depletion (morpholino) of other pronephric genes and analysis of their effect on 
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Xanx-4. This may lead to insights concerning the molecular regulatory cascade of 
pronephric development. Isolation and characterisation of the Xanx-4 promoter 
would allow specific overexpression of genes in the pronephros using transgenic 
technology. It would also allow creation of Xanx-4-GFP transgenic Xenopus in 
which to study the events of pronephrogenesis and would allow imaging of 
Xanx-4 protein localisation in vivo. Recently, myself and Dr K Masse, have 
isolated two genomic clones (approximately 18Kb and 15Kb) containing Xanx-4 
coding sequence which are currently being analysed. In order to study the effect 
of Xanz-4 on signal transduction pathways (eg. PKC, MAPK) it would be useful 
to develop a system for pronephros organ culture. 
Despite 24 years of intensive research, the precise function of annexins remains 
enigmatic. Annexins are implicated in human diseases eg. asthma, thrombosis, it 
is therefore important to elucidate their functions. This study represents the first 
developmental study on annexin N. Furthermore, the enlarged tubule phenotype 
generated by depletion of Xanx-4 by morpholino injection provides some clues 
that might guide experimentation to elucidate the function of annexin N in vivo. 
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Abstract 
We have identified the Xenopus homologue of Drosophila Enhancer of Zeste using a differential display strategy designed to identify 
genes involved in early anterior neural differentiation. XEZ codes for a protein of 748 amino acids that is very highly conserved in evolution 
and is 96% identical to both human and mouse EZ(H)2. In common with most other Xenopus Pc-G genes and unlike mammalian Pc-G genes, 
XEZ is anteriorly restricted. Zygotic expression of XEZ commences during gastrulation, much earlier than other anteriorly localized Pc-G 
genes; expression is restricted to the anterior neural plate and is confined later to the forebrain, eyes and branchial arches. XEZ is induced in 
animal caps overexpressing noggin; up-regulation of XEZ therefore represents a response to inhibition of BMP signalling in ectodermal cells. 
We show that the midbrain/hindbrain junction marker En-2, and hindbrain marker Krox-20, are target genes of XEZ and that XEZ functions to 
repress these anteroposterior marker genes. Conversely, XEZ does not repress the forebrain marker Otx-2. XEZ overexpression results in a 
greatly thickened floor of the forebrain. These results implicate an important role for XEZ in the patterning of the nervous system. ® 2001 
Elsevier Science Ireland Ltd. All rights reserved. 
Keywords: Enhancer of zeste; EZ(H)2; enx-1; Xenopus; Anterior neural plate; Repression; Polycomb-group; Neural induction; Anteroposterior patterning 
1. Introduction 
The temporal and spatial regulation of homeobox genes 
during the development of Drosophila melanogaster is 
thought to take place via a two step mechanism. Firstly, 
expression is initiated by transiently acting transcriptional 
activators and repressors (gap and segmentation genes) and 
secondly, maintenance of expression is achieved by protein 
products of the trithorax group (trx-G) and the polycomb 
group (Pc-G) genes. These two families act antagonisti- 
cally; the trx-G proteins maintain the transcriptional status 
of activated homeobox genes and the Pc-G proteins main- 
tain inactivated genes in a silent state (reviewed in Orlando 
and Paro, 1995). Pc-G proteins form multimeric protein 
complexes at transcriptionally inactive chromatin sites and 
are believed to be responsible for maintaining target genes 
in a silent state (Franke et al., 1992; DeCamillis et al., 1992; 
reviewed by Pirrotta, 1997). The mechanism underlying this 
silencing is unknown although it has been suggested that it 
could involve the formation of highly condensed chromatin 
domains similar to heterochromatin (Paro and Hogness, 
1991). 
Corresponding author. 
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Enhancer of zeste [E(z)] was first identified as a dominant 
gain-of-function modifier of the zestel-white interaction in 
Drosophila (Kalisch and Rasmuson, 1974). The X-linked 
white locus is required for pigmentation of the Drosophila 
eye and its expression is repressed by the zl allele of the 
zeste (z) locus (Jack and Judd, 1979; Gelbart and Wu, 1982; 
Zachar et al., 1985). E(z) mutants also produce homeotic 
transformations caused by ectopic expression of segment 
identity genes of the Antennapedia and Bithorax complexes 
(ANT-C and BX-C). This is a phenotype seen in Pc (poly- 
comb) gene mutants and was the observation that led to the 
initial classification of E(z) as a Pc-G gene (Jones and 
Gelbart, 1990). 
E(Z) has been shown to co-localize with other Pc-G 
proteins, as part of a multimeric protein complex, at many 
chromosome sites (Carrington and Jones, 1996). In Droso- 
phila, E(Z) protein has been shown to be required for 
suppressor of zeste (2) [Su(z)2] and Posterior sex combs 
(psc) proteins to associate with chromosomes (Rastelli et 
al., 1993). Furthermore, E(Z) protein has been shown to 
directly interact and co-localise with the Pc-G protein, 
ESC (extra sex combs) at multiple chromosomal sites (Tie 
et al., 1998). The signals that initiate Pc-G gene silencing 
are currently unknown, but are thought to be strongly corre- 
lated with the initial transcriptional status of a target gene 
0925-4773/01/$ - see front matter ® 2001 Elsevier Science Ireland Ltd. All rights reserved. 
PII: S0925-4773(01)00304-5 
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when Pc-G silencing is implemented (Poux et al., 1996; 
Pirrotta, 1997). 
In vertebrates, the homologues of E(Z) and ESC, EZ(H)2 
(human Enhancer of Zeste homologue 2) and EED (embryo- 
nic ectoderm development), are also able to directly interact 
(Sewalt et at., 1998). In a recent study of the EED/EZ(H)2 
protein complex, it was suggested that Pc-G repression of 
transcription involves histone deacetylation via a direct 
interaction between EED and histone deacetylase proteins 
(van der Vlag and Otte, 1999). 
Although E(z) has been classified as a Pc-G protein, there 
is also evidence that it can act as a Trx-G protein (LaJeu- 
nesse and Shears, 1996). Trx-G proteins are characterized 
by the presence of a SET domain at their C-termini and all 
E(Z) homologues characterized in Drosophila and other 
species also contain SET domains (Goodrich et al., 1997; 
Grossniklaus et at., 1998; Jones and Gelbart, 1990; 
Tschiersch et at., 1994; Holdeman et al., 1998; Hobert et 
al., 1996a). At different developmental stages and in differ- 
ent tissues E(Z) can be involved in either the activation or 
repression of a given homeotic selector gene. The SET 
domain may determine whether E(z) acts as either a trx-G 
or Pc-G gene (LaJeunesse and Shearn, 1996). 
Enhancer of zeste is highly conserved in evolution and is 
found in plants, insects, nematodes and vertebrates (Good- 
rich et at., 1997; Grossniklaus et at., 1998; Jones and 
Gelbart, 1990; Holdeman et al., 1998; Hobert et at., 
1996a). It is interesting that the only Pc-G genes identified 
in C. elegans are homologues of E(z) and esc (mes-2 and 
mes-6 respectively) (Holdeman et at., 1998; Korf et al., 
1998), suggesting that these genes can function indepen- 
dently of other Pc-G genes in nematodes, and possibly 
also function at least partially independently in flies and 
vertebrates. Two homologues of Enhancer of zeste have 
been isolated in mice and humans, EZ(H)1 (also termed 
enx-2) (Abel et al., 1996; Ogawa et al., 1998) and EZ(H)2 
(also termed enx-1) (Chen et al., 1996; Hobert et al., 1996a). 
During Drosophila and mouse early embryogenesis expres- 
sion of Pc-G genes is uniform, their spatially defined range 
of action is thought to be refined by the localized expression 
of other transcriptional regulators (Paro 1990; Pearce et at., 
1992; Alkema et at., 1995). EZ(H)2 is ubiquitously 
expressed at very early stages of mouse embryogenesis 
but in later development becomes restricted to organs of 
haematopoietic activity and the nervous system (Hobert et 
at., 1996a). It has also been shown that the proto-oncogene 
product, Vav, which plays a critical role in haematopoietic 
signal transduction, interacts specifically with EZ(H)2 via 
the Box 2 and Box 3 regions (Hobert et al., 1996b). Studies 
in cell lines suggest that EZ(H)2 is necessary for prolifera- 
tion in haematopoietic cells (Fukuyama et at., 2000). EED 
and BMI-1 have an antagonistic role in haematopoietic cell 
proliferation; EED repressing and BMI-1 enhancing prolif- 
eration. (Lessard et at., 1999). BMI-1 enhances proliferation 
by repressing the ink4a locus (Jacobs et al., 1999); the gene 
products of the ink4a locus, p16INK4a and pI9ARF, antag- 
onize the formation and activation of cyclin D-CDK4 
complexes (reviewed by Vidal and Koff, 2000). It has 
been suggested that EZ(H)2 might interfere with the repres- 
sive effect of EED by interacting with EED (Fukuyama et 
al., 2000). Furthermore, EZ(H)1 expression has been shown 
to be elevated in Neuro-2a cells induced to undergo neuro- 
nal differentiation in response to serum deprivation (Ogawa 
et al., 1998). Less differentiated cells were observed to 
produce higher levels of EZ(H)1 protein than more highly 
differentiated cells, suggesting that EZ(H)1 functions at 
early stages of neuronal differentiation. 
Xenopus Pc-G genes show more spatially restricted 
patterns of expression than seen in higher vertebrates and 
are all expressed in the nervous system (Reijnen et al., 1995; 
Yoshitake et al., 1999). To date four Pc-G genes, XPoly- 
comb (XPc2), Xbmi-1, Xenopus Polycomblike-1 (XPcll) 
and Xenopus Polycomb homologue (XPc1) have been 
cloned in Xenopus laevis (Reijnen et al., 1995; Yoshitake 
et al., 1999; Strouboulis et al., 1999). Alf four genes are 
expressed at high levels maternally and expression declines 
around the time of gastrulation. It has been shown that XPc1 
mRNA is masked until the blastula stage, being complexed 
with storage mRNPs, and XPcI protein is first detected in 
embryonic nuclei in gastrula-stage embryos (Strouboulis et 
al., 1999). Zygotic expression of XPc2, Xbmi-1, XPcll and 
XPc1 begins at stages 15,19,19 and 22 respectively. Both 
Xbmi-1 and XPc11 are restricted to anterior domains of 
expression; Xbmi-1 is restricted to the head and anterior 
spinal cord whilst XPc11 is restricted to brain and eyes 
(Reijnen et al., 1995; Yoshitake et al., 1999). XPc2 is 
expressed along the anteroposterior axis in the nervous 
system and mesoderm (Reijnen et al., 1995) whilst spatial 
expression data for XPc1 is not available. Anterior neural 
defects have been produced by overexpressing Xenopus Pc- 
G genes (Yoshitake et al., 1999). Overexpression of Xbmi- 
1 or XPc11 results in thickening of the roof and floor plates of 
the forebrain and midbrain and represses expression of En- 
2. XPc1 has been shown to mediate gene repression but in 
contrast to EED, this repression has been shown to be inde- 
pendent of histone deacetylase activity (Strouboulis et al., 
1999). 
In an attempt to isolate novel genes expressed early 
during neural differentiation, we have exploited the Xenopus 
animal cap system. Anterior neural differentiation is 
induced in Xenopus when BMP-signalling is inhibited by 
the secreted proteins noggin, chordin, follistatin, Xnr3 or 
cerberus (Zimmerman et al., 1996; Piccolo et al., 1996; 
Temura et al., 1998; Hansen et al., 1997; Piccolo et al., 
1999). Xenopus animal caps can be induced to undergo 
anterior neural differentiation by dissociating the caps in 
saline lacking divalent cations, a mechanism that is believed 
to work by washing away BMPs which promote epidermal 
differentiation. We have used differential display to screen 
for genes that are upregulated when animal caps undergo 
dissociation. RNA fingerprints of animal caps dissociated 
and processed immediately were compared to RNA finger- 
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prints from caps dissociated and incubated over a range of 
times. One of the clones identified was Xenopus Enhancer 
of Zeste (XEZ). Unlike other known Xenopus Pc-G genes, 
XEZ is not expressed maternally. Zygotic expression of XEZ 
commences much earlier than other Xenopus Pc-G genes, is 
restricted to the anterior nervous system, and represents an 
early response to inhibition of BMP signalling. This study 
also identifies En-2 and Krox-20 as target genes of XEZ 
2. Results and discussion 
2.1ti Cloning and sequence analysis of Xenopus laevis 
Enhancer of zeste (XEZ) 
In order to identify novel genes expressed early during 
anterior neural differentiation, we used differential display 
to screen for genes upregulated when animal caps undergo 
dissociation. Animal caps were removed from Stage 9 
Xenopus embryos and disaggregated in BarthX A saline 
lacking divalent cations. Differential display was performed 
using cDNA, reverse transcribed from RNA isolated from 
disaggregated cells, taken at time 0 and samples taken after 
3,12 and 24 h of dissociation. Differentially expressed tran- 
scripts were identified by the appearance of new bands 
following disaggregation. One of the bands identified, 
termed P1B, was detected after 3h of dissociation and 
when cloned was found to be 198bp in length. P1B showed 
significant similarity to the 3' UTR of human enhancer of 
zeste homologue 2 [EZ(H)2J and was used as a probe to 
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screen a stage 10.5 Xenopus laevis XZAP cDNA library. 
This resulted in the isolation of a clone of 2772bp (accession 
number: AF351126) containing an ORF of 2244bp that is 
80% identical to human EZ(H)2. The clone, termed XEZ, 
codes for a protein of 748 amino acids (Fig. IA). XEZ shows 
high evolutionary conservation, being overall 96% identical 
to both mouse and human EZ(H)2,66% identical to both 
mouse and human EZ(H1) and 57% identical to Drosophila 
Enhancer of Zeste [E(z)] at the amino acid level. In common 
with Enhancer of Zeste homologues in mammals, insects, 
nematodes and plants, XEZ contains a C-terminally located 
SET domain. XEZ also contains the CXC domain (Hobert et 
al., 1996a), conserved between insects and mammals in 
which the spacing of 17 cysteine residues is conserved 
(Fig. 1 B). 
2.2. Temporal expression profile of XEZ 
We have performed RT-PCR to show the temporal 
expression profile of XEZ (Fig. 2). Levels of XEZ mRNA 
were analysed in the unfertilized egg and at a number of 
embryonic stages between 32-cell stage and stage 41 using 
XEZ gene specific primers. In contrast to XPolycomb, Xbmi- 
1 and Xenopus Polycomb-like (XPcll) which are expressed 
at high levels maternally (Reijnen et al., 1995; Yoshitake et 
al., 1999), maternal expression of XEZ was not detected. 
Zygotic expression of XEZ commences at low levels in 
the late blastula, increasing at mid- to late-gastrula stages, 
peaking in the early neurula and is still detectable at stage 
41. The onset of zygotic XEZ expression is much earlier 
A1 
HGQTGKKSEKGPVCWRKRVKSEYMALRQLKKFRRADEVKSNFNTNRQKIMERTEILNQEW 60 
61 KQRRIQPVHINI-rVSSLRGTRECSVTSDLDFPKQVIPLKTLTAVASVPIMYSWSPLQQNF 120 
121 NVEDETVLHNIPYMGDEVLDQDGTFIEELIKNYDGKVHGDRECGFINDEIFVELVNALAQ 180 
181 YSDYEDDEDGDDNQDDEQDDTAKDQDDNHEDKETQPLRKFPSDKIFEAISSMFPDKGTSE 240 
241 ELKEKYKELTEQQLPGALPPECTPNIDGPNAKSVQREQSLHSFHTLFCRPCFKYDCFLHP 300 
301 FHATPNTYKRK? U4FAANDGKPCGPHCYQLLEGAREFAAALTAERIKTPPKRPSGRRRGRL 360 
361 PNNTSRPSTPTVNVSEAKDTDSDREAGTETGGESNDKEEEEKKDETSSSSEANSRCQTPI 420 
421 KNKPNIEPPENVEWSGAEASLFRVLIGTYYDNFCAIARLIGTKTCRQVYEFRVKESSIIS 480 
481 PVIAEDVDTPI SRLWAAHCRKIQLKKDGSSNHVYNYQPCDHPRQPCDSSCPCVI 540 
541 AQNFCEKFCQCSSECQNRFPGCRCKAQCNTKQCPCYLAVRECDPDLCLTCGAADHWDS1Q 600 
601 VSCKNCSIQRGSKKHLLLAPSDVAGWGIFINDTVQKNEFISEYCGEIISQDEADRRGKVY 660 
661 DKYMCSFLFNLNNDFVVDATRKGNKIRFANHSVNPNCYAKVMANNGDHRIGIFAKRAIQT 720 
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Fig. 1. (A) Predicted polypeptide sequence of XEZ (ORF 2244bp) 748 amino acids. The nuclear localisation sequence (NLS) is boxed and the SET domain is 
underlined. (B) Comparison of XEZ protein sequence with mouse, human and Drosophila homologues. Human EZ(H)2 and EZ(H)1, mouse EZ(H)2 and 
EZ(H)1 and Drosophila E(Z) were compared to XEZ protein sequence using Align Plus Version 3.0. Each block represents 13 amino acids and identity to XEZ 
is shown as greater than 60%, greater than 50%, greater than 40% or less than 40% (shown as line). Box 2 and 3 are part of the region which interacts with the 
Vav proto-oncogene product. NLS is the nuclear localization sequence. CXC domain is found in E(Z) homologues and consists of a cysteine-rich domain in 
which the spacing of 17 cysteine residues is conserved between insects and mammals. The C-terminally located SET domain is conserved between Trx-G 
proteins. 
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Fig. 2. Temporal expression profile of XU. RT-IkR showing expression pattern of XFZ transcripts in Xenopus lae is unfertilised egg and embryo stages. 
Significant maternal expression is not detected. Zygotic expression of XEZ commences at low levels in the late blastula stages, increasing at mid to late gastrula 
stages. peaking in the early neurula stages and is still detectable at stage 41. Stage 41 cDNA is used for the linearity control and ODC is used as a 
loading 
control. 
than other Xenopus Pc-G genes; zygotic expression of 
XPolvcomb is first detected at early neurula stage (Stage 
15) whereas Xbmi-1 and XPcll are first detected in the 
late neurula embryo (Stage 19) (Reijnen et al., 1995; Yoshi- 
take et al., 1999). 
2.3. Expression of XEZ is restricted to the anterior nen'ous 
system 
Wholemount in situ hybridization shows that expression 
of XEZ is restricted to the anterior nervous system from 
stage 14 to 27 (Fig. 3A-C). In the stage 20 and 27 embryos 
this anterior neural expression appears graded, with the 
strongest expression in the most anterior regions (Fig. 
3B, C). XPc11 and Xbmi-I are similarly both restricted to 
anterior domains of expression at tailbud stages, whereas 
Xpolvcomb is expressed along the entire anteroposterior 
axis (Reijnen et al., 1995; Yoshitake et al., 1999). Expres- 
sion of XEZ later becomes restricted to the forebrain, eye 
and branchial arches in the Stage 35 tadpole (Fig. 3D). XEZ 
expression is not detected in the midbrain and hindbrain. In 
contrast, XPc11 is expressed in the forebrain, midbrain, 
hindbrain, anterior spinal cord and eye at Stage 33 (Yoshi- 
take et al., 1999). Expression of XEZ is highest in the first 
branchial arch, less in the second arch and is greatly reduced 
in the third and fourth arches. 
B p_ D 
Fig. 3. Wholemount in situ hybridisation of XEZ. Wholemount in situ hybridisation of XEZ DIG labelled antisense RNA probe shows that expression Of XEZ is 
restricted to the anterior nervous system. (A) Stage 14 embryo expression is restricted to the anterior nervous system (indicated by arrow) (B) Stage 20 embryo 
and (C) Stage 27 embryo, the XEZ transcripts are detected in the anterior nervous system. In (B) and (C) the expression pattern appears to be graded with the 
strongest expression in the most anterior regions. (D) Stage 35 embryo shows that expression orXEZ later becomes restricted to the forebrain, eye and branchial 
arches. The XLZ expression is highest in the first branchial arch, less in the second and is greatly reduced in the third and fourth arches. The sense probe control 
showed no staining pattern (data not shown). 
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Fig. 4. XEZ expression is anteriorly restricted. Dissection series of stage 25 Xenupuc lu -ris embryos analysed by RT-PCR. Stage 25 embryos were dissected as 
shown in the insert picture into three equivalent axial pieces, A, anterior; M, middle; P, posterior; the endoderm was removed. Duplicate samples I and 2 both 
consisted of 5 embryos. Analysis shows the expression of XEZ is highest in the anterior nervous system, is reduced in the middle section and is barely 
detectable in the posterior in both dissected embryo pools. Whole embryo control cDNA at stage 25 was used for the linearity and EFl a was used as a loading 
control. Since the sections of neural tissue were equal in terms of regional identity, but only approximately equivalent in terms of amount of biological material, 
it is not reasonable to equalize loading of cDNA between samples (as shown by the EFIa signal). 
The spatial expression of XEZ was further analysed by 
dissecting the nervous system from stage 25 embryos and 
cutting into three equivalent sized pieces (Anterior, Middle 
and Posterior). RT-PCR analysis showed that expression of 
XEZ is highest in the anterior tissue, is reduced in the middle 
section and is barely detectable in the posterior tissue (Fig. 
4), supporting the observation that expression of XEZ is 
anteriorly restricted and graded posteriorly. 
0.8 ng noggin mRNA and cultured to stage 9. Animal caps 
were taken and cultured to Stage 13,20,28 and 32. RT-PCR 
analysis showed that at stage 13, XEZ expression is highly 
induced in noggin injected caps compared to a much lower 
level of expression in control caps (Fig. 5). However, the 
high level of expression is not maintained and XEZ expres- 
sion is only slightly increased in animal caps overexpressing 
noggin analysed at Stage 20,28 and 32. 
2.4. XEZ is induced by noggin 
Since XEZ was isolated from a differential screen that 
selected for genes upregulated when BMP signalling is 
removed from animal cap cells, the expression of XEZ 
was analysed in animal caps from embryos injected with 
noggin mRNA which induces anterior neural markers. 
One-cell stage embryos were injected with approximately 
2.5. Overexpression of XEZ results in thickening of the floor 
plate in the forebrain 
Injection of an RNA into Xenopus embryos is often used 
to assess the developmental consequences due to overex- 
pression of a gene. The function of XEZ in the anterior 
nervous system was investigated by targeted injection of 
XEZ mRNA. Approximately 0.4 ng of XEZ mRNA was 
Stage 13 Stage 211 Stage 28 Stage 32 Q < < < 
z z z z 0 0 0 0 
cl. m. c CIL. CL -M CL m. c o. m. c j 
J 
6. 
U v3 U E i- u 
Ü -J 
u 
ý C 
CL Cl. 0. ca. 
p y C C p 
1) 
yC 
U C Ö Gý Q C C - r 
¢ 
N Ö Ö 
3 
0 
z 
0 0 
3 0 
0 
3 3 OG ýy 
r o O 
z cý tý z cý z v ö o ö -- 
XEZ 
EF1a ý.  .. ý 
Fig. 5. XEZis induced by noggin. RT-PCR showing induction of XEZ in noggin-injected animal caps. AnunaI caps were taken Irow stage') embryos preciously 
injected at the I cell stage with noggin mRNA. The animal caps were cultured to stage 13,20,28 and 32. RT-PCR analysis shows that at stage 13 XEZ 
expression is highly induced in noggin animal caps compared to a much lower level of expression in control animal caps. I lowever, this high level of expression 
is not maintained and XEZ expression is only slightly higher in animal caps overexpressing noggin compared to control caps at stages 20,2H and 32. Stage 32 
whole embryo cDNA was used as input for the linearity and EFlrx was used as a loading control. 
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Fig. 6. Occrexpression of XEZ results in thickening of the floor plate region 
in the forebrain of in Xenopus laevis embryos. Embryos were injected with 
XEZ mRNA and cultured to stage 37. The embryos were then wax 
embedded, sectioned at 6 µtn and stained with eosin and hematoxylin. 
(A) Section shows thickening of the floor of the midbrain (arrow) compared 
to (B) a normal control embryo. v, ventricle; nt. neural tube: fp, floor plate; 
ph, pharynx; ep, epidermis; e. eye. 
injected into both dorsal blastomeres (total of 0.8 ng) at the 
4-cell stage and the resulting tadpoles were inspected for 
morphological alterations compared to uninjected controls. 
Apart from a slight uneven appearance to the epidermis, no 
obvious gross phenotype alteration was noted. The tadpoles 
were then sectioned at stage 37 to examine the effects on the 
morphology of the internal structure, and in particular of the 
nervous system being the main region of XEZ gene expres- 
sion. Tadpoles consistently showed thickening of the floor 
plate region in the midbrain (Fig. 6) (phenotype observed in 
12/12 specimens, in randomly chosen embryos from two 
independent experiments). Thickening of the floor plate 
region appeared to occur at the expense of the ventricle, 
which may possibly be an expansion of the sonic hedgehog 
expressing floor plate domain. Sections through the nervous 
system of the tadpoles at different anterior/posterior regis- 
ters were inspected. Apart from the apparent thickening in 
the floor plate region the phenotype of the tadpoles in 
section appeared normal. Control injected embryos showed 
no such thickening. In contrast, overexpression of XPcll 
results in thickening of both the roof and floor plates of 
the brain and this phenotype is graded along the anteropos- 
terior axis, being most severe in the forebrain and less 
severe in the midbrain; this phenotype was only observed 
in -15% of embryos (Yoshitake et al., 1999). The more 
localized phenotype seen in embryos overexpressing XEZ 
might therefore reflect the more restricted expression of 
XEZ at later stages. Since Pc-G genes are known to maintain 
inactivated genes in a silent state and XPcII and XEZ over- 
expression both result in an increase in proliferation or 
decrease in apoptosis in the neural tube, it seems likely 
that the phenotype observed in XEZ overexpressing 
embryos is the result of XEZ acting to repress target genes. 
2.6. XEZ represses En-2 
Having observed phenotypic effects of overexpression of 
XEZ in the midbrain region, the midbrain-hindbrain junc- 
tion marker En-2 was chosen to further analyse the role of 
XEZ in the anterior nervous system and to assess the ability 
of XEZ to affect the expression of genes that mark the 
pattern of the anteroposterior neural axis. Uni-lateral injec- 
tion was decided upon in order to compare left side versus 
right side. Two-cell stage embryos were co-injected uni- 
laterally with 0.8ng XEZ and FLDX to mark the injected 
side. Embryos were cultured to late neurula stage (Stage 19) 
and the injected side recorded. Sorted embryos were then 
fixed and subjected to wholemount in situ hybridization 
with the midbrain-hindbrain junction marker En-2. Repres- 
sion of expression of En-2 on the side injected with XEZ 
mRNA was seen in 48% of embryos (Figs. 7A, C, and 
8A, B). Occasional embryos showed complete loss of the 
En-2 expression on the injected side (Fig. 7A). The level 
of En-2 expression was scored as repressed on the injected 
side when it was deemed as being outside the range of 
normal variation as assessed by analysis of control embryos. 
In contrast, repression of En-2 on the injected side was 
observed in only 2% of embryos injected uni-laterally 
with the fluorescent tracer FLDX alone. Uni-lateral over- 
expression of XEZ also resulted in an anterior shift of En-2 
expression on the injected side in 20% of embryos (Fig. 713, 
Fig. 8). An anterior shift in En-2 expression was observed in 
only 2% of embryos injected uni-laterally with FLDX alone. 
This is consistent with an expansion of tissue in the 
midbrain as identified by histology. Similar results were 
Fig. 7. Repression of En-2 by XEZ. Embryo, were uni-laterally co-injected at the two cell stage with XEZ mRNA and FLDX. The FLDX was used as a marker 
for the injected side. The embryos were cultured to stage 19 and subjected to wholemount in situ hybridisation using an En-2 antisense RNA DIG-labelled 
probe. The injected side is indicated by an arrow. (A) Complete ablation of En-2 expression on XEZ_ injected side. (B) Anterior shift of En-2 expression on XEZ 
injected side. (C) Repression of En-2 expression on XEZ injected side. (D) Normal control. The En-2 sense control probe showed no staining pattern (data not 
shown). 
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posterior shift of En-2. although this was only seen in 
--817c of embryos (Yoshitake et al.. 1999). The ability of 
XEZ to affect the expression of En-2 more strongly may 
reflect the much earlier expression of XEZ in the more ante- 
rior elements of the nervous system. 
A range of neural marker `genes was chosen to further 
investigate the ability of XEZ to affect the expression of 
genes that mark the pattern of the anteroposterior neural 
axis. The marker genes chosen were the forebrain marker 
Ot. v--2. midbrain-hindhrain junction marker En-2, hindbrain 
marker Krox-20 (rhombomeres 3 and 5). spinal cord marker 
Ho. vb-9 and the posterior nervous system and posterior 
mesoderm marker Xcur/-3. I -cell stage embryos were 
injected with 0.8 ng XE_-ZmRNA. cultured to stanze 19 and 
subjected to RT-PCR. The results show that XEZ does 
indeed repress En-2 expression but also shows a repression 
of Krox-20. Other marker genes were not affected (Fig. MB). 
further round of in situ hybridization was then carried out 
on stage 19 embryos which had been uni-laterally co- 
injected with 0.8 ng XEZ mRNA and FLDX (as before). 
sorted and probed with the neural marker genes. No obvious 
effects on the level of expression or the anteroposterior 
specification of Orv-2. Ho. vb-9 and Xcad-3 were observed 
(data not shown). 
Fig.. S. XF/reprc-e, 1_ll-2. I: A1 VenopL(. A /[iti ii Cmhl'Vos AACfc Uni-LatelalI\ 
co-injected at the 2-cell stage nth XEZinRNA and FLDX. Flic cnlhlso, 
were cultured to stage 19 and subjected to wholemount in situ hybridisation 
using the midbrain-hindbrain junction marker En -2 antisense RNA probe. 
The embryos were scored as hating reduced expression of En-2w hen the 
level of En-2 staining was lower (or absent) than control emhrco normal 
variation. The embryos showing reduced-expression were also scored for 
any shift in the anterior or posterior register of the En-2 marker staining 
relative to the uninjected side. Numbers in brackets are actual numerical 
scores. (B) XEZ represses En-2. Kro. r-20 but not other neural markers. 
Embryos were injected at the I cell stage with XEZrnRNA. cultured to 
stage 19 and subjected to RT-PCR. The figure shows that the expression 
of En-2 and Kro. c-20 are repressed compared to uninfected control, but 
other neural markers are not affected. EEI a was used as a loading control 
and the uninjected sample used for linearity input cDNA. 
obtained on repeat of this experiment (data not shown). 
Although it is possible that the observed shift reflects a 
change in anterior/posterior register in the injected embryos. 
the relatively low percentage of embryos displaying this 
phenotype suggests that this is not the case. The effects 
observed are more likely to he due to mechanical perturba- 
tion caused by increased cell numbers in this region. If a 
change in anterior/posterior register were to occur it would 
be expected to result in a posterior shift as the domain of 
expression of XEZ was increased. It was interesting to note 
that. on comparison of left side versus right side in respect to 
the gross phenotype. the injected side tended to appear 
somewhat enlarged and the epidermis seemed rather uneven 
and disorganised. This was not readily apparent in the 
sectioned embryos. Overexpression of Pc11 also results in 
repression of En-2. but was only observed in 15(/ of 
embryos. In contrast. overexpression of Pc11 results in a 
?. 7. Sum marry 
We have cloned XEZ. the Xenopus homologue of Droso- 
phila Enhancer of Zeste by a differential display strategy 
designed to identify genes involved in early anterior neural 
differentiation. XEZ is very highly conserved between Xeno- 
pus and mammals being 96% identical at the amino acid 
level to both mouse and human EZ(H)2. Unlike in 
mammals. where EZ(H)2 and other Pc-G genes exhibit 
ubiquitous expression during, early emhryogenesis. XEZ is 
restricted to the anterior neural plate and expression is later 
restricted to the forebrain. eves and branchial arches. XEZ 
was cloned using a strategy designed to identify genes upre- 
gulated in ectodermal cells deprived of BMP signalling. 
Expression of XEZ is highly upregulated in animal caps 
overexpressing noggin and XEZ expression increases in 
the embryo during late gastrulation and early neurulation. 
Up-regulation of XEZ is therefore a response to neural 
induction in Xen(pu. c. 
We have identified En-2 and Kros-20 as targets of XEZ by 
demonstrating that overexpression of XEZ results in repres- 
sion of these genes. Whether this repression is direct or 
indirect is currently unknown. Interestingly, Ot. v-2 is not 
repressed by XEZ and might indicate that the function of 
XEZ in the anterior neural plate is to inhibit posteriori/ation 
of anterior neural tissue. Anterior neuronal differentiation is 
normally delayed in comparison to posterior neuronal 
differentiation (Papalopidu and Kintner. 1996) and XEZ 
might he involved in the mechanism that facilitates this 
delay of differentiation. Furthermore. overexpression of 
XEZ results in thickening of the floor plate region of the 
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forebrain, a phenotype that may be caused by XEZ enhan- 
cing proliferation in the anterior nervous system. Since 
EZ(H)2 is necessary for proliferation in haematopoietic 
cells (Fukuyama et al., 2000) and EED represses prolifera- 
tion in haematopoiesis, it would be interesting to identify 
Xenopus EED and characterize its role in neural develop- 
ment. Further work will ascertain whether overexpression of 
XEZ enhances proliferation or decreases apoptosis in the 
forebrain, and the target genes involved in these processes 
will be identified. 
3. Experimental procedures 
3.1. Differential display 
Animal caps were removed from stage 9 Xenopus laevis 
embryos by manual dissection and washed three times in 
calcium and magnesium free Barth X (CFMF), and disagre- 
gated by placing on polyHEMA plates in CFMF. Undisag- 
gregated pigmented cells were removed, only fully 
disaggregated pigmented and inner epidermal cells were 
used for sample collection. The first sample was taken 
after 30 min when the cells were fully disaggregated, and 
thereafter +3, +12 and +24 h. Total RNA was prepared as 
described below. 150 µl XTB buffer (300 mM NaCl, 20 mM 
Tris, pH 7.5,1 mM EDTA, pH 8,1% SDS) and 45 µg 
proteinase K (Boehringer) was added to each sample and 
cells, homogenized by pipetting, were then incubated at 
37°C for 15 min. Five micrograms glycogen was added, 
samples were phenol extracted and ethanol precipitated at 
-20°C for 30 min. Following centrifugation for 20 min in a 
benchtop microcentrifuge, dried pellets were taken up in 30 
µl SP6 transcription buffer (Gibco) containing IOU DNase I 
(Boehringer) and lOU placental RNase Inhibitor (Boehrin- 
ger). Samples were incubated at 37°C for 15 min, 120 µl of 
XTB buffer containing 45 µg proteinase K was added and 
incubated at 37°C for an additional 20 min. Following 
phenol extraction and phenol/chloroform extraction, 
samples were ethanol precipitated at room temperature for 
no more than 30 min. After centrifugation in benchtop 
microcentrifuge for 20 min at 4°C, pellets were washed 
with 70% ethanol, dried and resuspended in 10 µl RNase- 
free H2O. A small portion of each sample was used for 
spectrophotometric quantification, and 2 p. g total RNA 
used to synthesize first-strand cDNA. Total RNA was 
combined with 2 µM of the anchor primer [(dT)12A, 
(dT)12C or (dT) 12G] in a total volume of 11.4 µl and incu- 
bated at 70°C for 10 min, followed by chilling on ice. After 
addition of 4 µl first strand synthesis buffer (Gibco), 2 µl 
100 mM DTT and 1.6 µl dNTPs, samples were incubated at 
37°C for 10 min. 1 µl Superscript II reverse transcriptase 
(Gibco) was added, followed by incubation at 37°C for 1 
hour. Samples were heated at 95°C for 5 min, placed on ice 
for 2 min and stored at -20°C before use in differential 
display PCR. 
1 µl of cDNA from each reaction was used for each 
display PCR, and was combined with 2 µM anchor primer, 
2 µM random 5' primer, 2 µl lox PCR buffer (Gibco), 1.6 
µl 25 µM dNTPs, 0.6 µl 50 mM MgC12,0.5 µl [a- 
35S]dATP (1000 Ci/mmol; Amersham Pharmacia Biotech) 
and 0.5 µl Taq polymerase (2.5 U; Gibco) in a total 
volume of 20 µ1. Tubes were overlayed with 30 µl mineral 
oil, incubated in a Hybaid Omnigene machine at 94°C for 5 
min, followed by 40 cycles of denaturation at 94°C for 30 
s, annealing at 40°C for 2 min and extension at 72°C for 30 
s. After a final extension step for 5 min, 4 µl loading dye 
(0.25% bromophenol blue, 0.25% xylene cyanol, 30% 
glycerol) was added to the sample. Samples were dena- 
tured at 95°C for 5mins before loading 2.5 µl onto a 6% 
polyacrylamide/7 M urea gel that had been pre-run for 1h 
at 50 W. The gel was run for 2-3 h at 50 W until the xylene 
cyanol front reached the bottom of gel, transferred to blot- 
ting paper (3MM; Whatmann), dried and exposed over- 
night to X-ray film. Differentially expressed transcripts 
were identified by the appearance of new bands following 
dissaggregation relative to control disaggregated cells 
harvested at time 0. 
Sequences of the random 5' primers were as follows: 
DD 1: 5'-GCTTACAACGAGG-3'; DD2: 5'-GCTTGGAT- 
TGGTC-3'; DD3: 5'-GCTCTTTCTACCC-3'; DD4: 5'- 
GC 1 ! TF1 GGCTCC-3'; DD5: 5'-GCTGGAACCAATC- 
3'; DD6: 5'-GCTAAACTCCGTC-3'; DD7: GCTTCGA- 
TACAGG-3'; DD8: 5'-GCTTGGTAAAGGG-3'; DD9: 5'- 
GCTTCGGTCATAG-3'; DD 10: 5'-GCTGGTACTAAGG- 
3'; DDII: 5'- GCTTACCTAAGCG-3'; and DD12: 5'- 
GCTCTGCTTGATG-3'. 
Gel regions corresponding to bands representing candi- 
date cDNAs were excised using sterile scalpels and trans- 
ferred to sterile 0.5 ml microcentrifuge tubes. 100 µl H2O 
was added, followed by heating to 95°C for 20 min. Samples 
were ethanol precipitated at -70°C for 20 min, centrifuged 
in a benchtop microcentrifuge, pellets washed with 70% 
ethanol, dried and resuspended in 10 111 H20. 
PCR products recovered from the gel were cloned using 
the pGEM-T Vector system (Promega). 
3.2. Library screening and sequencing 
Whole embryo stage 10.5 XZAP II library was plated at a 
density of 2.5 x 105 plaques on 25 cm2 plates and duplicate 
plaque lifts taken on Hybond N+ (Amersham) nylon filters. 
Probe was made by random-primed synthesis (Feinberg and 
Vogelstein, 1984), using the P1B fragment indicated in the 
text, and hybridized in 0.1%SDS, 5x SSC, 0.1% BSA, 0.1% 
poly vinyl-pyrollidone, 0.1 % Ficoll (type 400) at 62°C. The 
first wash was performed at 62°C in 2x SSC, 0.1% SDS, 
followed by washes in lx SSC/ 0.1% SDS, 0.5x SSC/0.1% 
SDS and 0.2x SSC/0.1% SDS. The XEZ clone was excised 
from XZAP II vector and sequencing was carried out on both 
strands using an Applied Biosystems 373A instrument. 
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Table 1 
Sequences of primers used for RT-PCR analysis' 
Marker Sequence (5' to 3? ) Reference 
XEZ f-ACACTCACTGCTGTAGCCTC This work 
r-CCTGCTCATCGTCTTGATTG 
ODC f-GGAGCTGCAAGTTTGGAGA Bassez et al., 1990 
r-TCAGTTGCCAGTGTGGTC 
EFIa f-CAGATTGGTGCTGGATATGC Mohun et al., 1989 
r-CACTGCCTTGATGACTCCTA 
Hoxb9 f-TACTTACGGGCTTGGCTGGA Wright et al., 1990 
r-AGCGTGTAACCAGTGGCTG 
Krox-20 f-AACCGCCCCAGTAAGACC Bradley et at., 1993 
r-GTGTCAGCCTGTCCTGTTAG 
Xcad-3 f-ACCGAGCGATTCCAGTTC This work 
r-CAGTGAATCCGGTGGAAC 
Otx-2 f-CATCGGACATAAAGCAGCTCATC Lai et al., 1995 
r-CTTTCCCTCCTCTGTTTCCTCG 
' f, forward primers; r, reverse primers. 
3.3. Embryo culture and dissection 
Embryos were obtained by in vitro fertilisation of 
hormonally stimulated Xenopus laevis and staged according 
to Nieuwkoop and Faber (1967). Standard embryological 
procedures were used as described by Jones and Woodland 
(1986). Embryos were dejellied in 2% cysteine hydrochlor- 
ide, pH8 and cultured in 1/10 BarthX. Dissected animal caps 
were cultured in BarthX or Ca2+ and Mg2+ free BX depend- 
ing on whether disaggregation was required, and staged 
using whole embryo controls. Whole embryo dissections 
were performed (Fig. 4, insert) in BarthX using an eyelash 
knife. 
3.4. mRNA synthesis and microinjection 
The complete XEZ cDNA was removed from pBluescript 
SK- and cloned into the pCS2+ vector at the EcoRI and 
Xhol sites. XEZ mRNA was synthesized from XEZIpCS2+ 
plasmid template, linearized by cutting with Sac II, using 
the mMessage mMachine (SP6 polymerase, Ambion). All 
micro-injections were carried out with RNA diluted to 
approximately 25 µg/ml. Approximately 0.8 ng (36 nl) 
was injected into the one cell embryo or one or two blas- 
tomeres at the two cell stage (as specified in the text) of 
dejellied embryos under 5% Ficoll in BarthX. 
3.5. RT-PCR 
Total RNA from whole embryos was isolated and used 
for RT-PCR as described by Barnett et al., 1998. Primers 
used in this study are shown in Table 1. 
3.6. Wholemount in situ hybridization 
The wholemount in situ hybridization procedure used was 
as described in Harland, 1991. The embryos were fixed in 
MEMFA (0.5 M MOPS, pH 7.4,100 mM EGTA, 1 mM 
MgSO4,4% formaldehyde) and hybridised with RNA 
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probes produced from cDNA clones. The XEZ antisense 
probe was transcribed with T7 RNA polymerase from a 
sub-clone of 1415bp of XEZ in pBluescript KS+. The 
engrailed antisense probe was transcribed with T3 RNA 
polymerase from a full-length clone of 1.51(b in pBluecript 
KS+ (a gift from A. Hemmati-Brivanlou, Rockefeller 
University, NY). Probes were synthesized and labelled 
using a DIG labelling kit (Boehringer) and visualised 
using anti-DIG-alkaline phosphatase secondary and NBT/ 
BCIP for the colour reaction according to manufacturer's 
recommendations (Boehringer). 
3.7. Histological analysis 
Tadpoles were fixed in MEMFA at Stage 37 and dehy- 
drated in an ascending series of ethanol to 100%. The 
samples were cleared in Histoclear II (Lamb) and incubated 
first in 1: 1 Histoclear II: Paraplast Xtra (Sigma) at 60°C for 
30 minutes and then transferred to molten Paraplast Xtra 
and incubated overnight. The samples were embedded on 
a cushion of Paraplast Xtra, allowed to cool, sectioned (6 
µm) and collected on to subbed slides. The sections were 
then cleared with Histoclear II and stained using 20% Harris 
hematoxylin solution (Sigma) and 1% eosin (BHD). 
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